<SEC-DOCUMENT>0001628280-24-012261.txt : 20240320
<SEC-HEADER>0001628280-24-012261.hdr.sgml : 20240320
<ACCEPTANCE-DATETIME>20240320172034
ACCESSION NUMBER:		0001628280-24-012261
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240320
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240320
DATE AS OF CHANGE:		20240320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		24768641

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cpix-20240320.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:d0df40ba-ff5b-407d-ad7c-1c0cf0f5b66c,g:eb368248-c98d-4905-b398-0325af6d224d,d:b4ae61c9316a470d96603d55fd9a18ee-->
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cpix-20240320</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001087294</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cpix-20240320.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-20</xbrli:startDate><xbrli:endDate>2024-03-20</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib4ae61c9316a470d96603d55fd9a18ee_1"></div><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:174%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">March 20, 2024</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CUMBERLAND PHARMACEUTICALS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Tennessee</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-33637</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">62-1765329</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1600 West End Avenue, Suite 1300</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">37203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(Address of Principal Executive Offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">615</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">255-0068</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Registrant's telephone number, including area code</span></div><div style="margin-top:6pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(Former name or former address, if changed since last report)</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:33.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CPIX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib4ae61c9316a470d96603d55fd9a18ee_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Item 8.01 Other Events.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At-the-Market Offering Program </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2024, Cumberland Pharmaceuticals Inc. (the &#8220;Company&#8221;) filed a prospectus supplement with the Securities and Exchange Commission (the &#8220;SEC&#8221;) in connection with the Company&#8217;s &#8220;at-the-market&#8221; offering program (the &#8220;ATM Offering&#8221;) for the offer and sale from time to time through or to H.C. Wainwright &amp; Co., LLC (the &#8220;Sales Agent&#8221;), as sales agent or principal, of up to $5,800,000 of shares of the Company&#8217;s common stock, no par value per share (the &#8220;Shares&#8221;), pursuant to the Company&#8217;s Sales Agreement with the Sales Agent dated March 20, 2024 (the &#8220;Sales Agreement&#8221;). </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Shares are being offered and sold pursuant to the Company&#8217;s shelf registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;) filed with the SEC on December 14, 2023, which became effective upon the notice of effectiveness filed December 26, 2023 (File No. 333-276052). </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time during the term of the Sales Agreement, the Company may deliver a placement notice to the Sales Agent specifying the length of the selling period, the amount of Shares to be sold, any limitation on the number of shares that may be sold in any one trading day and the minimum price below which sales may not be made. Pursuant to the Sales Agreement and upon its acceptance of a placement notice from the Company, the Sales Agent may sell the Shares, by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the "Securities Act"). The Company may instruct the Sales Agent not to sell Shares if the sales cannot be effected at or above the price designated by the Company in any placement notice. The Company or the Sales Agent may suspend the ATM Offering at any time upon proper notice and subject to other conditions.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay the Sales Agent a commission for its services in acting as agent in the sale of Shares. The Sales Agent will be entitled to compensation in an amount equal to 3.0 percent (3.0%) of the gross sales price of all of the Shares sold through it under the Sales Agreement.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ATM Offering will terminate upon the earlier of (1) the sale of all Shares subject to the Sales Agreement or (2) termination of the Sales Agreement. The Sales Agreement may be terminated by the Sales Agent or the Company at any time upon five days&#8217; notice, and by the Sales Agent at any time in certain circumstances, including suspension of trading of Shares on the Nasdaq Global Select Stock Market or the occurrence of a material adverse change in the Company&#8217;s business.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company made certain customary representations, warranties and covenants concerning the Company and the Shares in the Sales Agreement and also agreed to indemnify the Sales Agent against certain liabilities, including liabilities under the Securities Act.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baker, Donelson, Bearman, Caldwell &amp; Berkowitz, PC, counsel to the Company, has issued a legal opinion relating to the legality of the issuance and the sale of the Shares. A copy of such legal opinion, including the consent included therein, is attached as Exhibit 5.1 hereto. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to use the net proceeds from the ATM Offering, if any, for working capital and general corporate purposes, including research and development expenses and capital expenditures.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sales Agreement is filed herewith as Exhibit 1.1 to this Current Report on Form 8-K. The description of the material terms of the Sales Agreement is qualified in its entirely by reference to such Exhibit 1.1. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. </span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Cautionary Statement Regarding Forward-Looking Statements - Safe Harbor</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based upon management&#8217;s current beliefs, views, estimates and expectations, including as to the Company&#8217;s industry, business strategy, goals and expectations concerning its market position, strategic and transformation initiatives, future operations, margins, profitability, comparable store growth, capital expenditures, liquidity, capital resources, expansion of technology expertise, and other financial and operating information, including expectations as to future operating profit improvement. Such statements include without limitation those about the Company&#8217;s expectations for future financial and operating results, projections, statements about the ATM Offering and the use of proceeds therefrom, and other statements that are not historical facts. Forward-looking statements are subject to significant risks and uncertainties and actual developments, business decisions, outcomes and results may differ materially from those reflected or described in the forward-looking statements. The following factors, among others, could cause actual developments, business decisions, outcomes and results to differ materially from those reflected or described in the forward-looking statements: market conditions, competition, an inability of manufacturers to supply the Company&#8217;s products, maintaining an effective sales and marketing infrastructure, availability of additional debt and equity capital required to finance the business, our ability to continue to acquire brands, management of our growth and integration of our acquisitions, impacts on our business, as well as national and international markets and economies resulting from the rising rate of inflation, volatility in financial markets, the ongoing conflicts in Eastern Europe and the Middle East, and the other factors described in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and the Company&#8217;s other filings with the SEC. Forward-looking statements contained in this Current Report on Form 8-K speak only as of the date of this Current Report on Form 8-K. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. </span></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.103%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit11salesagreement.htm">Sales Agreement, dated March 20, 2024, by and between Cumberland Pharmaceuticals Inc. and H.C. Wainwright &amp; Co., LLC. </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51opinion.htm">Opinion of Baker, Donelson, Bearman, Caldwell &amp; Berkowitz, PC.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Baker, Donelson, Bearman, Caldwell &amp; Berkowitz, PC (contained in Exhibit 5.1 above).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib4ae61c9316a470d96603d55fd9a18ee_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:16.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:24.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.386%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: March 20, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ A.J. Kazimi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.J. Kazimi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>exhibit11salesagreement.htm
<DESCRIPTION>EX-1.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ie4dede619f6842428c8b47c80f0927cb_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 1.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:108%">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="margin-top:10.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">Common Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(no par value per share)<br></font></div><div style="margin-top:14.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:105%">Sales Agreement</font></div><div style="margin-bottom:12pt;margin-top:12.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">&#160;&#160;&#160;&#160;March 20, 2024</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:104%">H.C. Wainwright &#38; Co., LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:104%">430 Park Avenue</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:104%">New York, NY 10022</font></div><div><font><br></font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:95%">Ladies and Gentlemen&#58;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">Cumberland Pharmaceuticals Inc., a Tennessee corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">&#8221;), confirms its agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">&#8221;) with H.C. Wainwright &#38; Co., LLC (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">&#8221;) as follows&#58;</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;padding-right:3.6pt;text-indent:39.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.5pt;text-decoration:underline">Issuance and Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company agrees that, from time to time during</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through or to the Agent, as sales agent or principal, shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the Company&#8217;s common shares, no par value per share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that in no event shall the Company issue or sell through the Agent such number of Placement Shares that (a) exceeds the number of shares or dollar amount of Common Stock registered on the effective Registration Statement (as defined below) pursuant to which the offering is being made or (b) exceeds the number of shares or dollar amount registered on the Prospectus Supplement (as defined below) (the lesser of (a) or (b) the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided further, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that in no event shall the aggregate number of Placement Shares sold pursuant to this Agreement exceed the number of authorized but unissued shares of Common Stock.  Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitations set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> on the number of Placement Shares issued and sold under this Agreement shall be the sole responsibility of the Company and that the Agent shall have no obligation in connection with such compliance. The issuance and sale of Placement Shares through the Agent will be effected pursuant to the Registration Statement (as defined below) filed with and declared effective by the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement to issue any Placement Shares.</font></div><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company shall file, in accordance with the provisions of the Securities Act of 1933, as amended and the rules and regulations thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), with the Commission, a registration statement on Form S-3, including a prospectus relating to the offer and sale of the Placement Shares to be issued from time to time by the Company, if any, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended and the rules and regulations thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Company will, if necessary, prepare a prospectus supplement to the prospectus included as part of such registration statement specifically relating to the Placement Shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Company will furnish to the Agent, for use by the Agent, copies of the prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the offer and sale of the Placement Shares, if any. Except where the context otherwise requires, such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">registration statement, and any post-effective amendment thereto, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule&#160;430B of the Securities Act, or any subsequent registration statement on Form S-3 filed pursuant to Rule 415 under the Securities Act by the Company to cover any Placement Shares, is herein called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221; The prospectus, including all documents incorporated or deemed incorporated therein by reference to the extent such information has not been superseded or modified in accordance with Rule 412 under the Securities Act (as qualified by Rule 430B(g) of the Securities Act), included in the Registration Statement, as it may be supplemented by a Prospectus Supplement, in the form in which such prospectus and&#47;or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act is herein called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221; Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission incorporated by reference therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporated Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include the most recent copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval System, or if applicable, the Interactive Data Electronic Application system when used by the Commission (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EDGAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.5pt;text-decoration:underline">Placements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each time that the Company wishes to issue and sell Placement Shares hereunder (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Placement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), it will notify the Agent by electronic mail (or other method mutually agreed to in writing by the parties either of which must be acknowledged by the Agent) of the number of Placement Shares, the time period during which sales are requested to be made, any limitation on the number of Placement Shares that may be sold in any one day and any minimum price below which sales may not be made (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Placement Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the form of which is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Placement Notice shall originate from any of the individuals from the Company set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from the Agent set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> as such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> may be amended from time to time. The Placement Notice shall be effective immediately upon receipt by the Agent unless and until (i) the Agent declines to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares thereunder has been sold, (iii) the Company suspends or terminates the Placement Notice, which suspension and termination rights may be exercised by the Company in its sole discretion, or (iv) this Agreement has been terminated under the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The amount of any discount, commission or other compensation to be paid by the Company to the Agent in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  It is expressly acknowledged and agreed that neither the Company nor the Agent will have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to the Agent and the Agent does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of a conflict between the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Sale of Placement Shares by the Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions of this Agreement, for the period specified in a Placement Notice, the Agent will use its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq Global Select Market (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), to sell the Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. The Agent will provide written confirmation to the Company no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the compensation payable by the Company to the Agent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> with respect to such sales, and the Net Proceeds (as defined below) payable to the Company, with an itemization of the deductions made by the Agent (as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5(b))</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> from the gross proceeds that it receives from such sales. Subject to the terms of a Placement Notice, the Agent may sell Placement Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any day on which shares of Common Stock are purchased and sold on the Exchange.   </font></div><div style="margin-top:10.8pt;padding-left:0.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Suspension of Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company or the Agent may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3), suspend any sale of Placement Shares (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Suspension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such suspension shall not affect or impair any party&#8217;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice. While a Suspension is in effect, any obligation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> with respect to the delivery of certificates, opinions, or comfort letters to the Agent, shall be waived. Each of the parties agrees that no such notice under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be effective against any other party unless it is made to one of the individuals named on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto, as such Schedule may be amended from time to time.</font></div><div style="margin-top:10.8pt;padding-left:0.7pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Sale and Delivery to the Agent&#59; Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Sale of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, upon the Agent&#8217;s acceptance of the terms of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, the Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Exchange to sell such Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that the Agent will be successful in selling Placement Shares, (ii) the Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Exchange to sell such Placement Shares as required under this Agreement and (iii) the Agent shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement, except as otherwise agreed by the Agent and the Company.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Settlement of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the second&#160;(2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Agent shall notify the Company in writing or by electronic mail of each sale of Placement Shares no later </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">than opening day following the Trading Day that the Agent sold Placement Shares. The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Net Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) will be equal to the aggregate sales price received by the Agent, after deduction for (i) the Agent&#8217;s commission, discount or other compensation for such sales payable by the Company pursuant to Section 2 hereof, and (ii) any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Delivery of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being sold by crediting the Agent&#8217;s or its designee&#8217;s account (provided the Agent shall have given the Company written notice of such designee and such designee&#8217;s account information at least one Trading Day prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradable, transferable, registered shares in good deliverable form. On each Settlement Date, the Agent will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver Placement Shares on a Settlement Date through no fault of the Agent, then in addition to and in no way limiting the rights and obligations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto, it will (i) hold the Agent harmless against any loss, claim, damage, or reasonable, documented expense (including reasonable and documented legal fees and expenses), as incurred, arising out of or in connection with such default by the Company or its transfer agent (if applicable) and (ii)&#160;pay to the Agent (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such default. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Limitations on Offering Size</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such Placement Shares, the aggregate number or dollar amount of Placement Shares sold pursuant to this Agreement would exceed the lesser of (A) together with all sales of Placement Shares under this Agreement, the Maximum Amount, (B) the amount available for offer and sale under the currently effective Registration Statement and (C) the amount authorized from time to time to be issued and sold under this Agreement by the Company&#8217;s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to the Agent in writing.  Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement at a price lower than the minimum price authorized from time to time by the Company&#8217;s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to the Agent in writing.  </font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as disclosed in the Registration Statement or Prospectus (including the Incorporated Documents), the Company represents and warrants to, and agrees with the Agent that as of the date of this Agreement and as of each Applicable Time (as defined below), unless such representation, warranty or agreement specifies a different date or time&#58;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Registration Statement and Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The transactions contemplated by this Agreement meet the requirements for and comply with the conditions for the use of Form&#160;S-3 under the Securities Act so long as no act or omission by the Agent would make the statement by the Company untrue in any material respect. The Registration Statement has been filed with the Commission and has been declared effective under the Securities Act. The Prospectus Supplement will name the Agent as the agent in the section entitled &#8220;Plan of Distribution.&#8221; The Company has not received, and has no notice of, any order of the Commission preventing or suspending the use of the Registration Statement, or threatening or instituting proceedings for that purpose. The Registration Statement and the offer and sale of Placement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with said Rule. Any statutes, regulations, contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement have been so described or filed, as applicable. Copies of the Registration Statement, the Prospectus, and any such amendments or supplements and all documents incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to the Agent and its counsel. The Company has not distributed and, prior to the later to occur of each Settlement Date and completion of the distribution of the Placement Shares, will not distribute any offering material in connection with the offering or sale of the Placement Shares other than the Registration Statement and the Prospectus and any Issuer Free Writing Prospectus (as defined below) to which the Agent has consented, which consent will not be unreasonably withheld or delayed, or that is required by applicable law or the listing maintenance requirements of the Exchange. The Common Stock is currently quoted on the Exchange under the trading symbol &#8220;CPIX.&#8221; The Company has not, in the 12&#160;months preceding the date hereof, received notice from the Exchange to the effect that the Company is not in compliance with the listing or maintenance requirements of the Exchange. To the Company&#8217;s knowledge, it is in compliance with all such listing and maintenance requirements. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Misstatement or Omission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. At each Settlement Date, the Registration Statement and the Prospectus, as of such date, will conform in all material respects with the requirements of the Securities Act. The Registration Statement, when it became or becomes effective, did not, and will not, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendment and supplement thereto, on the date thereof and at each Applicable Time (defined below), did not or will not include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The documents incorporated by reference in the Prospectus or any Prospectus Supplement did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required to be stated in such document or necessary to make the statements in such document, in light of the circumstances under which they were made, not misleading. The foregoing shall not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished to the Company by the Agent specifically for use in the preparation thereof. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Conformity with Securities Act and Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or any amendment or supplement thereto, and the Incorporated Documents, when such documents were or are filed with the Commission under the Securities Act or the Exchange Act or became or become effective under the Securities Act, as the case may be, conformed or will conform in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Financial Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The consolidated financial statements of the Company included or incorporated by reference in the Registration Statement and the Prospectus, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and the Subsidiaries (as defined below) as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders&#8217; equity of the Company and the Subsidiaries for the periods specified (subject, in the case of unaudited statements, to normal year-end audit adjustments which will not be material, either individually or in the aggregate) and have been prepared in compliance with the published requirements of the Securities Act and Exchange Act, as applicable, and in conformity with generally accepted accounting principles in the United States (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) applied on a consistent basis (except (i) for such adjustments to accounting standards and practices as are </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">noted therein and (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) during the periods involved&#59; the other financial data with respect to the Company and the Subsidiaries contained or incorporated by reference in the Registration Statement and the Prospectus, are accurately and fairly presented and prepared on a basis consistent with the financial statements and books and records of the Company&#59; there are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the Registration Statement, or the Prospectus that are not included or incorporated by reference as required&#59; the Company and the Subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off balance sheet obligations), not described in the Registration Statement, and the Prospectus which are required to be described in the Registration Statement or Prospectus&#59; and all disclosures contained or incorporated by reference in the Registration Statement and the Prospectus, if any, regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Conformity with EDGAR Filing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Prospectus delivered to the Agent for use in connection with the sale of the Placement Shares pursuant to this Agreement will be identical to the versions of the Prospectus created to be transmitted to the Commission for filing via EDGAR, except to the extent permitted by Regulation S-T. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt;text-decoration:underline">Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and any subsidiary that is a significant subsidiary (as such term is defined in Rule 1-02 of Regulation S-X promulgated by the Commission) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), are, and will be, duly organized, validly existing as a corporation and in good standing under the laws of their respective jurisdictions of organization. The Company and the Subsidiaries are duly licensed or qualified as a foreign corporation for transaction of business and in good standing under the laws of each other jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such license or qualification, and have all corporate power and authority necessary to own or hold their respective properties and to conduct their respective businesses as described in the Registration Statement and the Prospectus, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the assets, business, operations, earnings, properties, condition (financial or otherwise), prospects, stockholders&#8217; equity or results of operations of the Company and the Subsidiaries taken as a whole, or prevent the consummation of the transactions contemplated hereby (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As of the date hereof, the Company&#8217;s only Subsidiaries are set forth on Schedule 6(g).  The Company owns directly or indirectly, all of the equity interests of the Subsidiaries free and clear of any lien, charge, security interest, encumbrance, right of first refusal or other restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable and free of preemptive and similar rights.  </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Violation or Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Company nor any Subsidiary is (i)&#160;in violation of its charter or by-laws or similar organizational documents&#59; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other similar agreement or instrument to which the Company or any Subsidiary is a party or by which the Company or any Subsidiary is bound or to which any of the property or assets of the Company or any Subsidiary is subject&#59; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority with jurisdiction or control over the Company, except, in the case of each of clauses (ii) and (iii) above, for any such violation or default that would not, individually or in the aggregate, have a Material Adverse Effect. To the Company&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">knowledge, no other party under any material contract or other agreement to which it or any Subsidiary is a party is in default in any respect thereunder where such default would have a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">No Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement and Prospectus, there has not been (i) any Material Adverse Effect, or any development that would result in a Material Adverse Effect, (ii) any transaction which is material to the Company and the Subsidiaries taken as a whole, (iii) any obligation or liability, direct or contingent (including any off-balance sheet obligations), incurred by the Company or the Subsidiaries, which is material to the Company and the Subsidiaries taken as a whole, (iv) any material change in the capital stock (other than (A) the grant of additional options or other securities exercisable, or convertible into, Common Stock of the Company under the Company&#8217;s existing stock option plans, (B) changes in the number of outstanding shares of Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof, (C) as a result of the issuance of Placement Shares, (D) any repurchases of capital stock of the Company, (E) as described in a proxy statement filed on Schedule 14A or a Registration Statement on Form S-4, or (F)&#160;otherwise publicly announced) or outstanding long-term indebtedness of the Company or the Subsidiaries, except for any advances under existing credit facilities of the Company or (v) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any Subsidiary, other than in each case above in the ordinary course of business or as otherwise disclosed in the Registration Statement or Prospectus (including any document incorporated by reference therein).  </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Capitalization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid and non-assessable and, other than as disclosed in the Registration Statement or the Prospectus, are not subject to any preemptive rights, rights of first refusal or similar rights. The Company has an authorized, issued and outstanding capitalization as set forth in the Registration Statement and the Prospectus as of the dates referred to therein (other than (i) the grant of additional options or other securities exercisable, or convertible into, Common Stock of the Company under the Company&#8217;s existing stock option plans, (ii) changes in the number of outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof, (iii) as a result of the issuance of Placement Shares, or (iv) any repurchases of capital stock of the Company) and such authorized capital stock conforms to the description thereof set forth in the Registration Statement and the Prospectus. The description of the Common Stock in the Registration Statement and the Prospectus is complete and accurate in all material respects. Except as disclosed in or contemplated by the Registration Statement or the Prospectus, the Company did not have outstanding any options to purchase, or any rights or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments to issue or sell, any shares of capital stock or other securities.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">S-3 Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  At the time the Registration Statement was or will be filed and declared effective, and at the time the Company&#8217;s most recent Annual Report on Form 10-K was filed with the Commission, the Company met or will meet the then applicable requirements for the use of Form S-3 under the Securities Act, including, but not limited to, General Instruction I.B.6 of Form S-3, if applicable.  As of the&#160;close of trading on the Exchange on November 30, 2023, the aggregate market value&#160;of the outstanding voting and non-voting common equity (as defined in Rule 405) of the Company held by persons other than affiliates of the Company (pursuant to Rule 144 of the Securities Act, those that directly, or indirectly through one or more intermediaries, control, or are controlled by, or are under common control with, the Company)&#160; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Affiliate Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), was approximately $17,487,995 (calculated </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">by multiplying (x) the price at which the common equity of the Company was last sold on the Exchange on February 22, 2024 times (y) the number of Non-Affiliate Shares as of the date hereof). The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in General Instruction I.B.6 of Form S-3) with the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Authorization&#59; Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company has the legal right, power and authority to enter into this Agreement and perform the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable against the Company in accordance with its terms, except to the extent that (i) enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally and by general equitable principles and (ii) the indemnification and contribution provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof may be limited by federal or state securities laws and public policy considerations in respect thereof.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt;text-decoration:underline">Authorization of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Placement Shares, when issued and delivered pursuant to the terms approved by the board of directors of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, will be duly and validly authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance, security interest or other claim (other than any pledge, lien, encumbrance, security interest or other claim arising from an act or omission of the Agent or a purchaser), including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar rights, and will be registered pursuant to Section 12 of the Exchange Act. The Placement Shares, when issued, will conform in all material respects to the description thereof set forth in or incorporated into the Prospectus.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Consents Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or any governmental or regulatory authority having jurisdiction or control over the Company is required for the execution, delivery and performance by the Company of this Agreement, and the issuance and sale by the Company of the Placement Shares as contemplated hereby, except for such consents, approvals, authorizations, orders and registrations or qualifications (i) as may be required under applicable state securities laws or by the by-laws and rules of the Financial Industry Regulatory Authority (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FINRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or the Exchange, including any notices that may be required by the Exchange, in connection with the sale of the Placement Shares by the Agent, (ii) as may be required under the Securities Act and (iii) as have been previously obtained by the Company.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Preferential Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. (i) No person, as such term is defined in Rule 1-02 of Regulation S-X promulgated under the Securities Act (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), has the right, contractual or otherwise, to cause the Company to issue or sell to such Person any shares of Common Stock or shares of any other capital stock or other securities of the Company (other than upon the exercise of options or warrants to purchase Common Stock or upon the exercise of options or other securities exercisable, or convertible into, Common Stock of the Company that may be granted from time to time under the Company&#8217;s stock option plan), (ii) no Person has any preemptive rights, rights of first refusal, or any other rights (whether pursuant to a &#8220;poison pill&#8221; provision or otherwise) to purchase any shares of Common Stock or shares of any other capital stock or other securities of the Company from the Company which have not been duly waived with respect to the offering contemplated hereby, (iii) no Person has the right to act as an underwriter or as a financial advisor to the Company in connection with the offer and sale of the Common Stock, and (iv) no Person has the right, contractual or otherwise, to require the Company to register under the Securities Act any Common Stock or shares of any other capital </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">stock or other securities of the Company, or to include any such shares or other securities in the Registration Statement or the offering contemplated thereby, whether as a result of the filing or effectiveness of the Registration Statement or the sale of the Placement Shares as contemplated thereby or otherwise, except in each case for such rights as have been waived on or prior to the date hereof. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">p.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Independent Public Accountant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Carr, Riggs &#38; Ingram CPAs and Advisors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accountant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company&#8217;s most recent Annual Report on Form 10-K filed with the Commission and incorporated into the Registration Statement, are and, during the periods covered by their report, were independent public accountants within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States).  To the Company&#8217;s knowledge, the Accountant is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) with respect to the Company.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Enforceability of Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All agreements between the Company and third parties expressly referenced in the Prospectus or required to be disclosed as an exhibit to any filing with the Commission or the Registration Statement, other than such agreements that have expired by their terms or whose termination is disclosed in documents filed by the Company on EDGAR, are valid and binding obligations of the Company and, to the Company&#8217;s knowledge, enforceable in accordance with their respective terms, except to the extent that (i)&#160;enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally and by general equitable principles and (ii) the indemnification provisions of certain agreements may be limited by federal or state securities laws or public policy considerations in respect thereof, and except for any unenforceability that, individually or in the aggregate, would not have a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;padding-right:3.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">r.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt;text-decoration:underline">No Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. There are no legal, governmental or regulatory actions, suits or proceedings pending, nor, to the Company&#8217;s knowledge, any legal, governmental or regulatory investigations, including any proceeding before the United States Food and Drug Administration of the U.S. Department of Health and Human Services (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or comparable federal, state, local or foreign governmental authorities (it being understood that the interaction between the Company and the FDA and such comparable governmental authorities relating to the clinical development and product approval process shall not be deemed proceedings for purposes of this representation), to which the Company or a Subsidiary is a party or to which any property of the Company or any Subsidiary is the subject that, individually or in the aggregate, if determined adversely to the Company or any Subsidiary, would have a Material Adverse Effect or materially and adversely affect the ability of the Company to perform its obligations under this Agreement&#59; to the Company&#8217;s knowledge, no such actions, suits or proceedings are threatened in writing or contemplated by any governmental or regulatory authority or threatened in writing by others that, individually or in the aggregate, if determined adversely to the Company or any Subsidiary, would have a Material Adverse Effect&#59; and there are no current or pending legal, governmental or regulatory actions, suits, proceedings or, to the Company&#8217;s knowledge, investigations that are required under the Securities Act to be described in the Prospectus that are not described in the Prospectus (including any Incorporated Document).  The Company is in compliance with all applicable federal, state, local and foreign laws, regulations, orders and decrees governing its business as enforced by the FDA, or any other federal, state or foreign agencies or bodies engaged in the regulation of medical devices, except where noncompliance would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. All preclinical and clinical studies conducted by or on behalf of the Company to support clearance for commercialization of the Company&#8217;s products have been conducted by the Company, or to the Company&#8217;s knowledge by third parties, in compliance with all applicable federal, state or foreign laws, rules, orders and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">regulations, except for such failure or failures to be in compliance as would not reasonably be expected to have, singularly or in the aggregate, a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">s.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:28.34pt;text-decoration:underline">Licenses and Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Subsidiaries possess or have obtained, all licenses, certificates, consents, orders, approvals, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as currently conducted, as described in the Registration Statement and the Prospectus (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), except where the failure to possess, obtain or make the same would not, individually or in the aggregate, have a Material Adverse Effect. Neither the Company nor any Subsidiary has received written notice of any proceeding relating to revocation or modification of any such Permit or has any reason to believe that such Permit will not be renewed in the ordinary course, except where the failure to obtain any such renewal would not, individually or in the aggregate, have a Material Adverse Effect.           </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">t.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">No Material Defaults</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Company nor any Subsidiary has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse Effect on the Company. The Company has not filed a report pursuant to Section 13(a) or 15(d) of the Exchange Act since the filing of its last Annual Report on Form 10-K, indicating that it (i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii) has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">u.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Certain Market Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Company, nor any Subsidiary, nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Broker&#47;Dealer Relationships</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Company nor any Subsidiary or any related entities (i) is required to register as a &#8220;broker&#8221; or &#8220;dealer&#8221; in accordance with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls or is a &#8220;person associated with a member&#8221; or &#8220;associated person of a member&#8221; (within the meaning set forth in the FINRA Manual).</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">w.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">No Reliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company has not relied upon the Agent or legal counsel for the Agent for any legal, tax or accounting advice in connection with the offering and sale of the Placement Shares.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Subsidiaries have filed all federal, state, local and foreign tax returns which have been required to be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where the failure to do so would not have a Material Adverse Effect. Except as otherwise disclosed in or contemplated by the Registration Statement or the Prospectus, no tax deficiency has been determined adversely to the Company or any Subsidiary which has had, or would have, individually or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been or might be asserted or threatened against it which would have a Material Adverse Effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;padding-right:3.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">y.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Title to Real and Personal Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The Company and the Subsidiaries have good and valid title in fee simple to all items of real property and good and valid title to all personal property described in the Registration Statement or Prospectus as being owned by them that are material to the businesses of the Company or such Subsidiary, in each case free and clear of all liens, encumbrances and claims, except those that (i) do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries or (ii) would not, individually or in the aggregate, have a Material Adverse Effect. Any real property described in the Registration Statement or Prospectus as being leased by the Company and the Subsidiaries is held by them under valid and existing leases, except those that (A) do not materially interfere with the use made or proposed to be made of such property by the Company or the Subsidiaries or (B) would not, individually or in the aggregate, have a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;padding-right:3.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">z.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Intellectual Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> To the Company&#8217;s knowledge, the Company and the Subsidiaries own or possess adequate enforceable rights to use all patents, patent applications, trademarks (both registered and unregistered), trade names, trademark registrations, service marks, service mark registrations, Internet domain name registrations, copyrights, copyright registrations, licenses and know-how (including trade secrets and other unpatented and&#47;or unpatentable proprietary or confidential information, systems or procedures) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), necessary for the conduct of their respective businesses as conducted as of the date hereof, except to the extent that the failure to own or possess adequate rights to use such Intellectual Property would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and the Subsidiaries have not received any written notice of any claim of infringement or conflict which asserted Intellectual Property rights of others, which infringement or conflict, if the subject of an unfavorable decision, would result in a Material Adverse Effect. There are no pending, or to the Company&#8217;s knowledge, threatened judicial proceedings or interference proceedings challenging the Company&#8217;s or any Subsidiary&#8217;s rights in or to or the validity of the scope of any of the Company&#8217;s or its Subsidiaries&#8217; patents, patent applications or proprietary information. No other entity or individual has any right or claim in any of the Company&#8217;s or any of its Subsidiary&#8217;s patents, patent applications or any patent to be issued therefrom by virtue of any contract, license or other agreement entered into between such entity or individual and the Company or any Subsidiary or by any non-contractual obligation, other than by written licenses granted by the Company or any Subsidiary. The Company has not received any written notice of any claim challenging the rights of the Company or its Subsidiaries in or to any Intellectual Property owned, licensed or optioned by the Company or any Subsidiary which claim, if the subject of an unfavorable decision, would result in a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;padding-right:3.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">aa.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.36pt;text-decoration:underline">Compliance with Applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and the Subsidiaries&#58; (A) are and at all times have been in material compliance with all statutes, rules and regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product under development, manufactured or distributed by the Company or the Subsidiaries (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), (b) have not received any Form 483 from the FDA, notice of adverse finding, warning letter, or other written correspondence or notice from the FDA, the European Medicines Agency (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), or any other federal, state, local or foreign governmental or regulatory authority alleging or asserting material noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Authorizations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which would, individually or in the aggregate, result in a Material Adverse Effect&#59; (C) possess all material Authorizations and such Authorizations are valid and in full force and effect and neither the Company nor the Subsidiaries is in material violation of any term of any such Authorizations&#59; (D) have not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from the FDA, the EMA, or any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">other federal, state, local or foreign governmental or regulatory authority or third party alleging that any Company product, operation or activity is in material violation of any Applicable Laws or Authorizations and has no knowledge that the FDA, the EMA, or any other federal, state, local or foreign governmental or regulatory authority or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding against the Company&#59; (E) have not received written notice that the FDA, EMA, or any other federal, state, local or foreign governmental or regulatory authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any material Authorizations and has no knowledge that the FDA, EMA, or any other federal, state, local or foreign governmental or regulatory authority is considering such action&#59; and (F) have filed, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations except where the failure to file such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments would not result in a Material Adverse Effect, and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission). </font></div><div style="margin-top:10.8pt;padding-right:3.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ab.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Compliance Program.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or EMA)&#59; except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ac.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.36pt;text-decoration:underline">Clinical Studies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company&#8217;s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company&#59; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described&#59; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.  </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ad.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Subsidiaries (i) are in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; (ii)&#160;have received and are in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses as described in the Registration Statement and the Prospectus&#59; and (iii) have not received notice of any actual or potential liability for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except, in the case of any of clauses (i), (ii) or (iii) above, for any such failure to comply or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">failure to receive required permits, licenses, other approvals or liability as would not, individually or in the aggregate, have a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ae.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.36pt;text-decoration:underline">Disclosure Controls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations&#59; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability&#59; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization&#59; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company is not aware of any material weaknesses in its internal control over financial reporting (other than as set forth in the Registration Statement or the Prospectus). Since the date of the latest audited financial statements of the Company included in the Prospectus, there has been no change in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting (other than as set forth in the Registration Statement or the Prospectus). The Company has established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 and 15d-15) that comply with the requirements of the Exchange Act. The Company&#8217;s certifying officers have evaluated the effectiveness of the Company&#8217;s controls and procedures as of a date within 90 days prior to the filing date of the Form 10-K for the fiscal year most recently ended (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Evaluation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Company presented in its Form&#160;10-K for the fiscal year most recently ended the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the most recent Evaluation Date, and the &#8220;disclosure controls and procedures&#8221; are effective.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">af.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.69pt;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. There is and has been no failure on the part of the Company or, to the knowledge of the Company, any of the Company&#8217;s directors or officers, in their capacities as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder. Each of the principal executive officer and the principal financial officer of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the Commission during the past 12 months. For purposes of the preceding sentence, &#8220;principal executive officer&#8221; and &#8220;principal financial officer&#8221; shall have the meanings given to such terms in the Exchange Act Rules 13a-15 and 15d-15.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ag.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Finder&#8217;s Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Company nor any Subsidiary has incurred any liability for any finder&#8217;s fees, brokerage commissions or similar payments in connection with the transactions herein contemplated, except as may otherwise exist with respect to the Agent pursuant to this Agreement.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ah.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Labor Disputes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No labor disturbance by or dispute with employees of the Company or any Subsidiary exists or, to the knowledge of the Company, is threatened which would result in a Material Adverse Effect. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ai.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.35pt;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Company nor any Subsidiary is or, after giving effect to the offering and sale of the Placement Shares, will be required to register as an &#8220;investment company&#8221; or an entity &#8220;controlled&#8221; by an &#8220;investment company,&#8221; as such terms are defined in the Investment Company Act of 1940, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">aj.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.35pt;text-decoration:underline">Operations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The operations of the Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial record keeping and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions to which the Company or the Subsidiaries are subject, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency having jurisdiction over the Company (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Money Laundering Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), except where the failure to be in such compliance would not result in a Material Adverse Effect&#59; and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ak.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Off-Balance Sheet Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. There are no transactions, arrangements and other relationships between and&#47;or among the Company, and&#47;or, to the knowledge of the Company, any of its affiliates and any unconsolidated entity, including, but not limited to, any structured finance, special purpose or limited purpose entity (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Off Balance Sheet Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that would affect materially the Company&#8217;s liquidity or the availability of or requirements for its capital resources, including those Off Balance Sheet Transactions described in the Commission&#8217;s Statement about Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations (Release Nos. 33-8056&#59; 34-45321&#59; FR-61), required to be described in the Registration Statement or the Prospectus which have not been described as required.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">al.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.35pt;text-decoration:underline">Underwriter Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company is not a party to any agreement with an agent or underwriter for any other &#8220;at the market&#8221; or continuous equity transaction.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">am.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.35pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the knowledge of the Company, (i) each material employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that is maintained, administered or contributed to by the Company or any of its affiliates for employees or former employees of the Company and the Subsidiaries has been maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred which would result in a material liability to the Company with respect to any such plan excluding transactions effected pursuant to a statutory or administrative exemption&#59; and (iii) for each such plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no &#8220;accumulated funding deficiency&#8221; as defined in Section 412 of the Code has been incurred, whether or not waived, and the fair market value of the assets of each such plan (excluding for these purposes accrued but unpaid contributions) equals or exceeds the present value of all benefits accrued under such plan determined using reasonable actuarial assumptions, other than, in the case of (i), (ii) and (iii) above, as would not have a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">an.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Forward-Looking Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) (a&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Forward-Looking Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) contained in the Registration Statement and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ao.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Margin Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ap.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as the Company and the Subsidiaries reasonably believe are adequate for the conduct of their business.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">aq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">No Improper Practices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. (i) Neither the Company nor, to the Company&#8217;s knowledge, the Subsidiaries, nor to the Company&#8217;s knowledge, any of their respective executive officers has, in the past five years, made any unlawful contributions to any candidate for any political office (or failed fully to disclose any contribution in violation of law) or made any contribution or other payment to any official of, or candidate for, any federal, state, municipal, or foreign office or other person charged with similar public or quasi-public duty in violation of any law or of the character required to be disclosed in the Prospectus&#59; (ii) no relationship, direct or indirect, exists between or among the Company or, to the Company&#8217;s knowledge, the Subsidiaries or any affiliate of any of them, on the one hand, and the directors, officers and stockholders of the Company or, to the Company&#8217;s knowledge, the Subsidiaries, on the other hand, that is required by the Securities Act to be described in the Registration Statement and the Prospectus that is not so described&#59; (iii) no relationship, direct or indirect, exists between or among the Company or the Subsidiaries or any affiliate of them, on the one hand, and the directors, officers, stockholders or directors of the Company or, to the Company&#8217;s knowledge, the Subsidiaries, on the other hand, that is required by the rules of FINRA to be described in the Registration Statement and the Prospectus that is not so described&#59; (iv) there are no material outstanding loans or advances or material guarantees of indebtedness by the Company or, to the Company&#8217;s knowledge, the Subsidiaries to or for the benefit of any of their respective officers or directors or any of the members of the families of any of them&#59; and (v) the Company has not offered, or caused any placement agent to offer, Common Stock to any person with the intent to influence unlawfully (A) a customer or supplier of the Company or the Subsidiaries to alter the customer&#8217;s or supplier&#8217;s level or type of business with the Company or the Subsidiaries or (B) a trade journalist or publication to write or publish favorable information about the Company or the Subsidiaries or any of their respective products or services, and, (vi) neither the Company nor the Subsidiaries nor, to the Company&#8217;s knowledge, any employee or agent of the Company or the Subsidiaries has made any payment of funds of the Company or the Subsidiaries or received or retained any funds in violation of any law, rule or regulation (including, without limitation, the Foreign Corrupt Practices Act of 1977), which payment, receipt or retention of funds is of a character required to be disclosed in the Registration Statement or the Prospectus. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ar.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.69pt;text-decoration:underline">Status Under the Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules&#160;164 and 433 under the Securities Act in connection with the offering of the Placement Shares.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.02pt;text-decoration:underline">No Misstatement or Omission in an Issuer Free Writing Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Issuer Free Writing Prospectus, as of its issue date and as of each Applicable Time (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below), did not, does not and will not, through the completion of the Placement or Placements for which such Issuer Free Writing Prospectus is issued, include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any incorporated document deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by the Agent specifically for use therein.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">at.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.35pt;text-decoration:underline">No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the execution of this Agreement, nor the issuance, offering or sale of the Placement Shares, nor the consummation of any of the transactions contemplated herein and therein, nor the compliance by the Company with the terms and provisions hereof and thereof will conflict with, or will result in a breach of, any of the terms and provisions of, or has constituted or will constitute a default under, or has resulted in or will result </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any contract or other agreement to which the Company may be bound or to which any of the property or assets of the Company is subject, except (i)&#160;such conflicts, breaches or defaults as may have been waived and (ii) such conflicts, breaches and defaults that would not have a Material Adverse Effect&#59; nor will such action result (x) in any violation of the provisions of the organizational or governing documents of the Company, or (y)&#160;in any material violation of the provisions of any statute or any order, rule or regulation applicable to the Company or of any court or of any federal, state or other regulatory authority or other government body having jurisdiction over the Company, except where such violation would not have a Material Adverse Effect.</font></div><div style="margin-top:10.8pt;padding-right:3.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">au.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:10.8pt;padding-left:3.6pt;text-align:justify;text-indent:104.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Neither the Company nor any Subsidiary (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) nor, to the Company&#8217;s knowledge, any director, officer, employee, agent, affiliate or representative of the Entity, is a government, individual, or entity (in this paragraph (uu), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that is, or is owned or controlled by a Person that is&#58;</font></div><div style="margin-top:10.8pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the subject of any sanctions administered or enforced by the U.S. Department of Treasury&#8217;s Office of Foreign Assets Control (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the United Nations Security Council (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UNSC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the European Union (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), His Majesty&#8217;s Treasury (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">HMT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), or other relevant sanctions authority (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), nor</font></div><div style="margin-top:10.8pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">located, organized or resident in a country or territory that is the subject of Sanctions.</font></div><div style="margin-top:10.8pt;padding-left:3.6pt;text-align:justify;text-indent:108.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.86pt">The Entity will not, directly or indirectly, knowingly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person&#58;</font></div><div style="margin-top:10.8pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions&#59; or</font></div><div style="margin-top:10.8pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise).</font></div><div style="margin-top:10.8pt;padding-left:3.6pt;text-align:justify;text-indent:108.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.53pt">The Entity represents and covenants that, except as detailed in the Registration Statement and the Prospectus, for the past 5 years, it has not knowingly engaged in and is not now knowingly engaged in any dealing or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">av.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.68pt;text-decoration:underline">Stock Transfer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On each Settlement Date, all material stock transfer or other taxes (other than income taxes) which are required to be paid by the Company in connection with the sale and transfer of the Placement Shares to be sold hereunder will be, or will have been, fully paid or provided for by the Company and all laws imposing such taxes will be or will have been fully complied with by the Company in all material respects. </font></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any certificate signed by an officer of the Company and delivered to the Agent or to counsel for the Agent pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to the Agent as to the matters set forth therein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;padding-left:0.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Covenants of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company covenants and agrees with the Agent that&#58;  </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Registration Statement Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. After the date of this Agreement and during any period in which a prospectus relating to any Placement Shares is required to be delivered by the Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Delivery Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (i) the Company will notify the Agent promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference or amendments not related to any Placement, has been filed with the Commission and&#47;or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus related to the Placement or for additional information related to the Placement, (ii) the Company will prepare and file with the Commission, promptly upon the Agent&#8217;s request, any amendments or supplements to the Registration Statement or Prospectus that, upon the advice of the Company&#8217;s legal counsel, may be necessary or advisable in connection with the distribution of the Placement Shares by the Agent (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the failure of the Agent to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#8217;s right to rely on the representations and warranties made by the Company in this Agreement and provided, further, that the only remedy the Agent shall have with respect to the failure to make such filing shall be to cease making sales under this Agreement until such amendment or supplement is filed)&#59; (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus relating to the Placement Shares or a security convertible into the Placement Shares (other than an Incorporated Document) unless a copy thereof has been submitted to the Agent within a reasonable period of time before the filing and the Agent has not reasonably objected thereto (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that (A) the failure of the Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#8217;s right to rely on the representations and warranties made by the Company in this Agreement and (B) the Company has no obligation to provide the Agent any advance copy of such filing or to provide the Agent an opportunity to object to such filing if the filing does not name the Agent or does not relate to the transaction herein provided&#59; and provided, further, that the only remedy the Agent shall have with respect to the failure by the Company to obtain such consent or the failure of the Agent to provide an objection as set forth above shall be to cease making sales under this Agreement) and the Company will furnish to the Agent at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR&#59; and (iv) the Company will cause each amendment or supplement to the Prospectus to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act or, in the case of any document to be incorporated therein by reference, to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed (the determination to file or not file any amendment or supplement with the Commission under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, based on the Company&#8217;s reasonable opinion or reasonable objections, shall be made exclusively by the Company).  </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Notice of Commission Stop Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will advise the Agent, promptly after it receives notice or obtains knowledge thereof, of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose&#59; and it will use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued. The Company will advise the Agent promptly after it receives any request by the Commission for any amendments to the Registration Statement or any amendment or supplements to the Prospectus or any Issuer Free Writing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prospectus or for additional information related to the offering of the Placement Shares or for additional information related to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Delivery of Prospectus&#59; Subsequent Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Prospectus Delivery Period, the Company will use its best efforts to comply in all material respects with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If the Company has omitted any information from the Registration Statement pursuant to Rule 430A under the Securities Act, it will use its commercially reasonable efforts to comply with the provisions of and make all requisite filings with the Commission pursuant to said Rule 430A and to notify the Agent promptly of all such filings. If during the Prospectus Delivery Period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such Prospectus Delivery Period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the Agent to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Company may delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interest of the Company.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Listing of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Prospectus Delivery Period, the Company will use its commercially reasonable efforts to cause the Placement Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such jurisdictions in the United States as the Agent reasonably designates and to continue such qualifications in effect so long as required for the distribution of the Placement Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Company shall not be required in connection therewith to qualify as a foreign corporation or dealer in securities, file a general consent to service of process, or subject itself to taxation in any jurisdiction if it is not otherwise so subject.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Delivery of Registration Statement and Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company will furnish to the Agent and its counsel (at the reasonable expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during the Prospectus Delivery Period (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as the Agent may from time to time reasonably request and, at the Agent&#8217;s request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Placement Shares may be made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Company shall not be required to furnish any document (other than the Prospectus) to the Agent to the extent such document is available on EDGAR.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt;text-decoration:underline">Earnings Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company will make generally available to its security holders as soon as practicable, but in any event not later than 15 months after the end of the Company&#8217;s current fiscal quarter, an earnings statement covering a 12-month period that satisfies the provisions of Section 11(a) and Rule 158 of the Securities Act.  </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#8220;Use of Proceeds.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Notice of Other Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without the prior written consent of the Agent, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock during the period beginning on the date on which any Placement Notice is delivered to the Agent hereunder and ending on the third (3rd) Trading Day immediately following the final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the sale of all Placement Shares covered by a Placement Notice, the date of such suspension or termination)&#59; and will not directly or indirectly in any other &#8220;at the market&#8221; or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock prior to the termination of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such restrictions will not apply in connection with the Company&#8217;s issuance or sale of (i) Common Stock, options to purchase Common Stock or Common Stock issuable upon the exercise of options, pursuant to any stock option, or benefits plan, stock ownership plan or dividend reinvestment plan (but not Common Stock subject to a waiver to exceed plan limits in its dividend reinvestment plan) of the Company whether now in effect or hereafter implemented&#59; (ii) Common Stock issuable upon conversion of securities or the exercise of warrants, options or other rights in effect or outstanding, and disclosed in filings by the Company available on EDGAR or otherwise in writing to the Agent, (iii)&#160;Common Stock or other securities convertible into common stock of the Company, or securities convertible into or exercisable for Common Stock, offered and sold in a privately negotiated transaction to vendors, customers, strategic partners or potential strategic partners or other investors conducted in a manner so as not to be integrated with the offering of Common Stock hereby and (iv) Common Stock in connection with any acquisition, strategic investment or other similar transaction (including any joint venture, strategic alliance or partnership).</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Change of Circumstances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will, at any time during the pendency of a Placement Notice advise the Agent promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document required to be provided to the Agent pursuant to this Agreement.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Due Diligence Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the term of this Agreement, the Company will cooperate with any reasonable due diligence review conducted by the Agent or its representatives in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during regular business hours and at the Company&#8217;s principal offices, as the Agent may reasonably request.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Required Filings Relating to Placement of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company agrees that on such dates as the Securities Act shall require, the Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act (each and every date a filing under Rule 424(b) is made, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Filing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which prospectus supplement will set forth, within the relevant period, the amount of Placement Shares sold through the Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Agent with respect to such Placement Shares, and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Representation Dates&#59; Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each time during the term of this Agreement that the Company&#58;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">amends or supplements (other than a prospectus supplement relating solely to an offering of securities other than the Placement Shares) the Registration Statement or the Prospectus relating to the Placement Shares by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents by reference into the Registration Statement or the Prospectus relating to the Placement Shares&#59;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">files an annual report on Form 10-K under the Exchange Act (including any Form 10-K&#47;A containing amended audited financial information or a material amendment to the previously filed Form 10-K)&#59;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">files its quarterly reports on Form 10-Q under the Exchange Act&#59; or</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">files a current report on Form 8-K containing amended financial information (other than information &#8220;furnished&#8221; pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange Act&#59;</font></div><div style="margin-top:14.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Representation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;)</font></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company shall furnish the Agent (but in the case of clause (iv) above only if the Agent reasonably determines that the information contained in such Form 8-K is material) with a certificate, in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 7(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The requirement to provide a certificate under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date on which the Company files its annual report on Form 10-K. Notwithstanding the foregoing, (i) upon the delivery of the first Placement Notice hereunder and (ii) if the Company subsequently decides to sell Placement Shares following a Representation Date when the Company relied on such waiver and did not provide the Agent with a certificate under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, then before the Agent sells any Placement Shares, the Company shall provide the Agent with a certificate, in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 7(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, dated the date of the Placement Notice.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt;text-decoration:underline">Legal Opinion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On or prior to the date of the first Placement Notice given hereunder the Company shall cause to be furnished to the Agent a written opinion and a negative assurance letter of Baker, Donelson, Bearman, Caldwell &#38; Berkowitz, PC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), or other counsel reasonably satisfactory to the Agent, each in form and substance reasonably satisfactory to the Agent. Thereafter, within five (5) Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as Exhibit 7(l) for which no waiver is applicable, the Company shall cause to be furnished to the Agent a&#160;negative assurance letter of Company Counsel in form and substance reasonably satisfactory to the Agent&#59; provided that, in lieu of such negative assurance for subsequent periodic filings under the Exchange Act, counsel may furnish the Agent with a letter (a&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reliance Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to the effect that the Agent may rely on the negative assurance letter previously delivered under this Section 7(m) to the same extent as if it were dated the date of such letter (except that statements in such prior letter shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of the date of the Reliance Letter). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On or prior to the date of the first Placement Notice given hereunder and within five (5) Trading Days after each subsequent Representation Date, other than pursuant to Section 7(l)(iii), the Company shall cause its independent accountants to furnish the Agent letters (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Comfort Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated the date the Comfort Letter is delivered, which shall meet the requirements set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Comfort Letter from the Company&#8217;s independent accountants shall be in a form and substance reasonably satisfactory to the Agent, (i) confirming that they are an independent public accounting firm within the meaning of the Securities Act and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PCAOB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to underwriters in connection with registered public offerings (the first such letter, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (iii)&#160;updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Market Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of shares of Common Stock or (ii) sell, bid for, or purchase shares of Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">p.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor the Subsidiaries will be or become, at any time prior to the termination of this Agreement, an &#8220;investment company,&#8221; as such term is defined in the Investment Company Act.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Offer to Sell</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, neither of the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder. </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">r.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will maintain and keep accurate books and records reflecting its assets and maintain internal accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and including those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, (ii) provide reasonable assurance that transactions are recorded as necessary to permit the preparation of the Company&#8217;s consolidated financial statements in accordance with GAAP, (iii) that receipts and expenditures of the Company are being made only in accordance with management&#8217;s and the Company&#8217;s directors&#8217; authorization, and (iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on its financial statements. The Company will maintain disclosure controls and procedures that comply in all material respects with the requirements of the Exchange Act.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Representations and Covenants of the Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Agent represents and warrants that it is duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which the Agent is exempt from registration or such registration is not otherwise required. The Agent shall continue, for the term of this Agreement, to be duly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which it is exempt from registration or such registration is not otherwise required, during the term of this Agreement.  The Agent shall comply with all applicable law and regulations in connection with the transactions contemplated by this Agreement, including, but not limited to, the issuance and sale through the Agent of the Placement Shares.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Payment of Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation, filing, including any fees required by the Commission, and printing of the Registration Statement (including financial statements and exhibits) as originally filed and of each amendment and supplement thereto and each Free Writing Prospectus, in such number as the Agent shall deem reasonably necessary, (ii) the printing and delivery to the Agent of this Agreement and such other documents as may be required in connection with the offering, purchase, sale, issuance or delivery of the Placement Shares, (iii) the preparation, issuance and delivery of the certificates, if any, for the Placement Shares to the Agent, including any stock or other transfer taxes and any capital duties, stamp duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement Shares to the Agent, (iv) the fees and disbursements of the counsel, accountants and other advisors to the Company, (v) the reasonable and documented out-of-pocket fees and disbursements of counsel to the Agent, payable upon the execution of this Agreement, (x) not to exceed $45,000 in connection with the execution of this Agreement and (y) not to exceed $2,500 per calendar quarter thereafter in connection with updates at the time of Representation Dates&#59; (vi) the fees and expenses of the transfer agent and registrar for the Common Stock, (vii) the filing fees incident to any review by FINRA of the terms of the sale of the Placement Shares, and (viii) the fees and expenses incurred in connection with the listing of the Placement Shares on the Exchange.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conditions to the Agent&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The obligations of the Agent hereunder with respect to a Placement will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein (other than those representations and warranties made as of a specified date or time), to the due performance in all material respects by the Company of its obligations hereunder, to the completion by the Agent of a due diligence review satisfactory to it in its reasonable judgment, and to the continuing reasonable satisfaction (or waiver by the Agent in its sole discretion) of the following additional conditions&#58;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Registration Statement Effective</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Registration Statement shall remain effective and shall be available for the sale of all Placement Shares contemplated to be issued by any Placement Notice.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Material Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. None of the following events shall have occurred and be continuing&#58; (i) receipt by the Company of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus&#59; (ii)&#160;the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or receipt by the Company of notification of the initiation of any proceedings for that purpose&#59; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for sale in any jurisdiction or receipt by the Company of notification of the initiation of, or a threat to initiate, any proceeding for such purpose&#59; or (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material Incorporated Document untrue in any material respect or that requires the making of any changes in the Registration Statement, the Prospectus or any material Incorporated Document so that, in the case of the Registration </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Statement, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus or any material Incorporated Document, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">No Misstatement or Material Omission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Agent shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in the Agent&#8217;s reasonable opinion is material, or omits to state a fact that in the Agent&#8217;s reasonable opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Material Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as contemplated in the Prospectus, or disclosed in the Company&#8217;s reports filed with the Commission, there shall not have been any Material Adverse Effect, or any development that would cause a Material Adverse Effect, or a downgrading in or withdrawal of the rating assigned to any of the Company&#8217;s securities (other than asset backed securities) by any &#8220;nationally recognized statistical rating organization,&#8221; as such term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rating Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), or a public announcement by any Rating Organization that it has under surveillance or review its rating of any of the Company&#8217;s securities (other than asset backed securities), the effect of which, in the case of any such action by a Rating Organization described above, in the reasonable judgment of the Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Company Counsel Legal Opinion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Agent shall have received the opinion and negative assurance letter of Company Counsel required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> on or before the date on which such delivery of such opinion and negative assurance letter are required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt;text-decoration:underline">Agent Counsel Legal Opinion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Agent shall have received from Duane Morris LLP, counsel for the Agent, such opinion or opinions, on or before the date on which the delivery of the Company Counsel legal opinion is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, with respect to such matters as the Agent may reasonably require, and the Company shall have furnished to such counsel such documents as they request for enabling them to pass upon such matters.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Agent shall have received the Comfort Letter required to be delivered pursuant </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> on or before the date on which such delivery of such letter is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Representation Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Agent shall have received the certificate required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> on or before the date on which delivery of such certificate is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Secretary&#8217;s Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On or prior to the first Representation Date, the Agent shall have received a certificate, signed on behalf of the Company by its corporate Secretary, in form and substance satisfactory to the Agent and its counsel.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">No Suspension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Trading in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not have been delisted from the Exchange.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Other Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On each date on which the Company is required to deliver a certificate pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Company shall have furnished to the Agent such appropriate further information, certificates and documents as the Agent may reasonably request and which are usually and customarily furnished by an issuer of securities in connection with a securities offering of the type contemplated hereby. All such opinions, certificates, letters and other documents will be in compliance with the provisions hereof.  </font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt;text-decoration:underline">Securities Act Filings Made</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.67pt;text-decoration:underline">Approval for Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Placement Shares shall either have been approved for listing on the Exchange, subject only to notice of issuance, or the Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement Notice.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Termination Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. There shall not have occurred any event that would permit the Agent to terminate this Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Indemnification and Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-top:14.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company agrees to indemnify and hold harmless the Agent, its partners, members, directors, officers, employees and agents and each person, if any, who controls the Agent within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act as follows&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:25.17pt">against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.98pt">against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission&#59; provided that (subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below) any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed or withheld&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.79pt">against any and all expense whatsoever, as incurred (including the reasonable and documented out-of-pocket fees and disbursements of counsel), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i) or (ii) above,</font></div><div style="margin-top:14.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:14.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">statement or omission made solely in reliance upon and in conformity with written information furnished to the Company by the Agent expressly for use in the Registration Statement (or any amendment thereto), or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto).</font></div><div style="margin-top:14.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification by the Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Agent agrees to indemnify and hold harmless the Company and its directors and officers, and each person, if any, who (i) controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (ii) is controlled by or is under common control with the Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with information relating to the Agent and furnished to the Company in writing by the Agent expressly for use therein.</font></div><div style="margin-top:14.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any party that proposes to assert the right to be indemnified under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and (ii) any liability that it may have to any indemnified party under the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict of interest exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable and documented out-of-pocket fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable and documented out-of-pocket fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such reasonable and documented out-of-pocket fees, disbursements and other charges will be reimbursed by the indemnifying party promptly after the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:14.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">indemnifying party receives a written invoice relating to fees, disbursements and other charges in reasonable detail. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (1) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (2) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</font></div><div style="margin-top:14.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or the Agent, the Company and the Agent will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than the Agent, such as persons who control the Company within the meaning of the Securities Act or the Exchange Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and the Agent may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Agent on the other hand. The relative benefits received by the Company on the one hand and the Agent on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation received by the Agent (before deducting expenses) from the sale of Placement Shares on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Agent, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering.  Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Agent agree that it would not be just and equitable if contributions pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be deemed to include, for the purpose of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof. Notwithstanding the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, any person who controls a party to this Agreement within the meaning of the Securities Act or the Exchange Act, and any officers, directors, partners, employees or agents of the Agent, will have the same rights to contribution as that party, and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:14.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">each officer and director of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Representations and Agreements to Survive Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The indemnity and contribution agreements contained in Section 11 of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any investigation made by or on behalf of the Agent, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or (iii) any termination of this Agreement.</font></div><div style="margin-top:10.8pt;padding-left:0.7pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">The Agent may terminate this Agreement, by notice to the Company, as hereinafter specified at any time (1) if there has been, since the time of execution of this Agreement or since the date as of which information is given in the Prospectus, any Material Adverse Effect, or any development that would have a Material Adverse Effect that, in the sole judgment of the Agent, is material and adverse and makes it impractical or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (2) if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Agent, impracticable or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (3) if trading in the Common Stock has been suspended or limited by the Commission or the Exchange, or if trading generally on the Exchange has been suspended or limited, or minimum prices for trading have been fixed on the Exchange, (4) if any suspension of trading of any securities of the Company on any exchange or in the over-the-counter market shall have occurred and be continuing, (5) if a major disruption of securities settlements or clearance services in the United States shall have occurred and be continuing, or (6)&#160;if a banking moratorium has been declared by either U.S. Federal or New York authorities. Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 9 (Payment of Expenses), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Indemnification and Contribution), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Representations and Agreements to Survive Delivery), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Governing Law and Time&#59; Waiver of Jury Trial) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination. If the Agent elects to terminate this Agreement as provided in this Section 13(a), the Agent shall provide the required notice as specified in Section 14 (Notices).</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Company shall have the right, by giving five (5) days&#8217; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Payment of Expenses), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Indemnification and Contribution), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Representations and Agreements to Survive Delivery), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Governing Law and Time&#59; Waiver of Jury Trial) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">The Agent shall have the right, by giving five (5) days&#8217; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Payment of Expenses), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Indemnification and Contribution), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Representations and Agreements to Survive Delivery), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Governing Law and Time&#59; Waiver of Jury Trial) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Unless earlier terminated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, this Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through the Agent on the terms and subject to the conditions set forth herein except that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Payment of Expenses), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Indemnification and Contribution), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Representations and Agreements to Survive Delivery), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Governing Law and Time&#59; Waiver of Jury Trial) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">This Agreement shall remain in full force and effect unless terminated pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above or otherwise by mutual agreement of the parties&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that any such termination by mutual agreement shall in all cases be deemed to provide that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Payment of Expenses), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Indemnification and Contribution), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Representations and Agreements to Survive Delivery), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Governing Law and Time&#59; Waiver of Jury Trial) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Consent to Jurisdiction) shall remain in full force and effect. Upon termination of this Agreement, the Company shall not have any liability to the Agent for any discount, commission or other compensation with respect to any Placement Shares not otherwise sold by the Agent under this Agreement.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt">Any termination of this Agreement shall be effective on the date specified in such notice of termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agent or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise specified, and if sent to the Agent, shall be delivered to&#58;</font></div><div style="margin-top:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">H.C. Wainwright &#38; Co., LLC </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">430 Park Avenue</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">New York, NY 10022</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; Head of Investment Banking</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; &#160;&#160;&#160;&#160;atm&#64;hcwco.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with a copy to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Duane Morris LLP</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1540 Broadway</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">New York, NY 10036</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58; &#160;&#160;&#160;&#160;James T. Seery</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Telephone&#58; &#160;&#160;&#160;&#160;(973) 424-2088</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; &#160;&#160;&#160;&#160;jtseery&#64;duanemorris.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:129%">and if to the Company, shall be delivered to&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc.</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1600 West End Avenue, Suite 1300</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nashville, TN 37203<br>Attention&#58;  &#160;&#160;&#160;&#160;John Hamm<br>Telephone&#58; &#160;&#160;&#160;&#160;(615) 225-0058</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;jhamm&#64;cumberlandpharma.com</font></div><div style="padding-left:72pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with a copy to&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baker, Donelson, Bearman, Caldwell &#38; Berkowitz, PC</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1600 West End Avenue, Suite 2000</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nashville, TN 37203<br>Attention&#58;&#160;&#160;&#160;&#160;Tonya Mitchem Grindon<br>Telephone&#58; &#160;&#160;&#160;&#160;(615) 726-5607</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;tgrindon&#64;bakerdonelson.com </font></div><div><font><br></font></div><div style="margin-top:12.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally, by email, or by verifiable facsimile transmission on or before 4&#58;30 p.m., New York City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean any day on which the Exchange and commercial banks in the City of New York are open for business.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement shall inure to the benefit of and be binding upon the Company and the Agent and their respective successors and the affiliates, controlling persons, officers and directors referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither the Company nor the Agent may assign its rights or obligations under this Agreement without the prior written consent of the other party.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Adjustments for Stock Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any share consolidation, stock split, stock dividend, corporate domestication or similar event effected with respect to the Placement Shares.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.5pt;text-decoration:underline">Entire Agreement&#59; Amendment&#59; Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Agent. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">GOVERNING LAW AND TIME&#59; WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. THE COMPANY AND THE AGENT EACH HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">CONSENT TO JURISDICTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Use of Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Agent may not use any information gained in connection with this Agreement and the transactions contemplated by this Agreement, including due diligence, to advise any party with respect to transactions not expressly approved by the Company.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile transmission or email of a .pdf attachment.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Effect of Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The section, Schedule and Exhibit headings herein are for convenience only and shall not affect the construction hereof.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Permitted Free Writing Prospectuses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company represents, warrants and agrees that, unless it obtains the prior consent of the Agent, and the Agent represents, warrants and agrees that, unless it obtains the prior consent of the Company which shall not be unreasonably withheld or delayed, it has not made and will not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a &#8220;free writing prospectus,&#8221; as defined in Rule 405, required to be filed with the Commission. Any such free writing prospectus consented to by the Agent or by the Company, as the case may be, is hereinafter referred to as a &#8220;Permitted Free Writing Prospectus.&#8221; The Company represents and warrants that it has treated and agrees that it will treat </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">each Permitted Free Writing Prospectus as an &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto are Permitted Free Writing Prospectuses.</font></div><div style="margin-top:10.8pt;padding-left:0.7pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Absence of Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company acknowledges and agrees that&#58;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">The Agent is acting solely as agent in connection with the public offering of the Placement Shares and in connection with each transaction contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party, on the one hand, and the Agent, on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether or not the Agent has advised or is advising the Company on other matters, and the Agent has no obligation to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly set forth in this Agreement&#59;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">it is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated by this Agreement&#59;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">the Agent has not provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate&#59;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">it is aware that the Agent and its affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and the Agent has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise&#59; and</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">it waives, to the fullest extent permitted by law, any claims it may have against the Agent for breach of fiduciary duty or alleged breach of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees that the Agent shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company, other than in respect of the Agent&#8217;s obligations under this Agreement and to keep information provided by the Company to the Agent and its counsel confidential to the extent not otherwise publicly-available.</font></div><div style="margin-top:10.8pt;padding-left:0.9pt;text-indent:35.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As used in this Agreement, the following terms have the respective meanings set forth below&#58;</font></div><div style="margin-top:12.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) each Representation Date and (ii) the time of each sale of any Placement Shares pursuant to this Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuer Free Writing Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433, relating to the Placement Shares that (1) is required to be filed with the Commission by the Company, (2) is a &#8220;road show&#8221; that is a &#8220;written communication&#8221; within the meaning of Rule 433(d)(8)(i) whether or not required to be filed with the Commission, or (3) is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Placement Shares or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g) under the Securities Act.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 172</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 405</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 415</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 424</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 424(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 430B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 433</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; refer to such rules under the Securities Act.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All references in this Agreement to financial statements and schedules and other information that is &#8220;contained,&#8221; &#8220;included&#8221; or &#8220;stated&#8221; in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to EDGAR&#59; all references in this Agreement to any Issuer Free Writing Prospectus (other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission) shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR&#59; and all references in this Agreement to &#8220;supplements&#8221; to the Prospectus shall include, without limitation, any supplements, &#8220;wrappers&#8221; or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Remainder of the page intentionally left blank&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent.</font></div><div style="margin-top:12.6pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="margin-top:12.6pt;padding-left:220.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="margin-top:48.6pt;padding-left:225pt;text-indent:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;        &#47;s&#47; A.J. Kazimi</font></div><div style="margin-top:1.8pt;padding-left:273.6pt;padding-right:9pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:260px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; A.J. Kazimi</font></div><div style="margin-top:1.8pt;padding-left:273.6pt;padding-right:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  Chief Executive Officer</font></div><div style="margin-top:52.2pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ACCEPTED as of the date first-above written&#58;</font></div><div style="padding-left:216pt;text-indent:18pt"><font><br></font></div><div style="padding-left:216pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">H.C. WAINWRIGHT &#38; CO., LLC</font></div><div style="padding-left:216pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:216pt;text-indent:18pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:260px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;         &#47;s&#47; Edward D. Silvera</font></div><div style="padding-left:274.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  Edward D. Silvera</font></div><div style="padding-left:274.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  Chief Operating Officer</font></div><div><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33 </font></div><div style="text-align:right"><font><br></font></div></div></div><div id="ie4dede619f6842428c8b47c80f0927cb_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:19.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:99%">SCHEDULE 1</font></div><div style="margin-bottom:19.8pt;margin-top:14.4pt;text-align:center"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:263px"></div><div style="margin-bottom:19.8pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:19.8pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%">FORM OF PLACEMENT NOTICE</font></div><div style="margin-top:39.6pt;padding-left:36pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:263px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">From&#58;&#160;&#160;&#160;&#160;Cumberland Pharmaceuticals Inc.</font></div><div style="margin-top:14.4pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">To&#58;&#160;&#160;&#160;&#160;H.C. Wainwright &#38; Co., LLC</font></div><div style="margin-top:14.4pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Attention&#58; &#160;&#160;&#160;&#160;&#91;&#8226;&#93;</font></div><div style="margin-top:10.8pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject&#58;&#160;&#160;&#160;&#160;          At the Market Offering--Placement Notice</font></div><div style="margin-top:10.8pt;padding-left:36pt"><font><br></font></div><div style="margin-top:14.4pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Ladies and Gentlemen&#58;</font></div><div style="margin-top:12.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Cumberland Pharmaceuticals Inc., a Tennessee corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and H.C. Wainwright &#38; Co., LLC (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated March 20, 2024, the Company hereby requests that the Agent sell up to &#91;____&#93; of the Company&#8217;s Common Stock, no par value per share, at a minimum market price of $&#160;&#160;&#160;&#160;per share, during the time period beginning &#91;month, day, time&#93; and ending &#91;month, day, time&#93;.</font></div><div style="margin-top:10.8pt;padding-left:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">34 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SCHEDULE 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________</font></div><div style="margin-bottom:2pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compensation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company shall pay to the Agent in cash, upon each sale of Placement Shares pursuant to this Agreement, an amount equal to 3.0% of the gross proceeds from each sale of Placement Shares. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">35 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SCHEDULE 3</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Notice Parties</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">The Company</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A.J. Kazimi&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;akazimi&#64;cumberlandpharma.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">John Hamm&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;jhamm&#64;cumberlandpharma.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adam Mostafa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;amostafa&#64;cumberlandpharma.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">H.C. Wainwright &#38; Co., LLC</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Craig Schwabe&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;cs&#64;hcwco.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Charles Worthman&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;csworthman&#64;hcwco.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with a copy to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">atm&#64;hcwco.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">36 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SCHEDULE 6(g)</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Subsidiaries</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">                                                                                 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Jurisdiction</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:96.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumberland Pharma Sales Corp. <br>Cumberland Emerging Technologies, Inc. <br></font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee<br>Tennessee<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br><br><br></font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:16.2pt;padding-right:16.2pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">37 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><font><br></font></div><div style="padding-left:16.2pt;padding-right:16.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:215%;text-decoration:underline">EXHIBIT 7(1)<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:215%">Form of Representation Date Certificate </font></div><div style="padding-left:16.2pt;padding-right:16.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:215%">___________, 20___</font></div><div style="margin-top:16.2pt;text-align:justify;text-indent:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">This Representation Date Certificate (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%;text-decoration:underline">Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">&#8221;) is executed and delivered in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%;text-decoration:underline">Section 7(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%"> of the Sales Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">&#8221;), dated March 20, 2024, and entered into between Cumberland Pharmaceuticals Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">&#8221;) and H.C. Wainwright &#38; Co., LLC. All capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">The Company hereby certifies as follows&#58;</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:13pt;font-weight:400;line-height:109%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;padding-left:23.47pt">As of the date of this Certificate (i) the Registration Statement does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading and (ii) neither the Registration Statement nor the Prospectus contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (iii) no event has occurred as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein not untrue or misleading for this paragraph 1 to be true.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:13pt;font-weight:400;line-height:111%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%;padding-left:23.47pt">Each of the representations and warranties of the Company contained in the Agreement were, when originally made, and are, as of the date of this Certificate, true and correct in all material respects.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:13pt;font-weight:400;line-height:109%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;padding-left:23.47pt">Except as waived by the Agent in writing, each of the covenants required to be performed by the Company in the Agreement on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement, has been duly, timely and fully performed in all material respects and each condition required to be complied with by the Company on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement has been duly, timely and fully complied with in all material respects.</font></div><div style="margin-top:12.6pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:13pt;font-weight:400;line-height:111%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%;padding-left:23.47pt">Subsequent to the date of the most recent financial statements in the Prospectus, and except as described in the Prospectus, including Incorporated Documents, there has been no Material Adverse Effect.</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:13pt;font-weight:400;line-height:111%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%;padding-left:23.47pt">No stop order suspending the effectiveness of the Registration Statement or of any part thereof has been issued, and no proceedings for that purpose have been instituted or are pending or threatened by any securities or other governmental authority (including, without limitation, the Commission).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">38 </font></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:9pt;text-align:justify;text-indent:39.6pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:13pt;font-weight:400;line-height:110%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:23.47pt">No order suspending the effectiveness of the Registration Statement or the qualification or registration of the Placement Shares under the securities or Blue Sky laws of any jurisdiction are in effect and no proceeding for such purpose is pending before, or threatened, to the Company&#8217;s knowledge or in writing by, any securities or other governmental authority (including, without limitation, the Commission).</font></div><div style="margin-top:10.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The undersigned has executed this Representation Date Certificate as of the date first written above.</font></div><div style="margin-top:12.6pt;padding-left:223.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="margin-top:25.2pt;padding-left:223.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:23.4pt;padding-left:223.2pt;padding-right:18pt"><img alt="image_4a.jpg" src="image_4a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:256px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">Name&#58; &#160;&#160;&#160;&#160;<br>Title&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">39 </font></div><div style="text-align:right"><font><br></font></div></div></div><div id="ie4dede619f6842428c8b47c80f0927cb_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT 23</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Permitted Issuer Free Writing Prospectuses</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">None.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51opinion.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i1ce2d539b0364c659e7c1c1d77775f92_1"></div><div style="min-height:133.92pt;width:100%"><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><img alt="image_01a.jpg" src="image_01a.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:384px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1600 WEST END AVENUE </font><font style="color:#6c6f70;font-family:'Calibri',sans-serif;font-size:4.55pt;font-weight:400;line-height:125%;position:relative;top:-2.44pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> SUITE 2000 </font><font style="color:#6c6f70;font-family:'Calibri',sans-serif;font-size:4.55pt;font-weight:400;line-height:125%;position:relative;top:-2.44pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> NASHVILLE, TENNESSEE 37203</font></div><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:125%">615.726.5600 </font><font style="color:#6c6f70;font-family:'Calibri',sans-serif;font-size:4.55pt;font-weight:400;line-height:125%;position:relative;top:-2.44pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> bakerdonelson.com</font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Exhibit 5.1</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Nathan Kibler, Shareholder</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Direct Dial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#58; 865.549.7125</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Direct Fax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#58; 865.633.7125</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">E-Mail Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#58; nkibler&#64;bakerdonelson.com</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">March 20, 2024</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Board of Directors</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cumberland Pharmaceuticals Inc.</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1600 West End Avenue, Suite 1300</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nashville, TN 37203</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Re&#58; 333-276052 on Form S-3&#59; Shares of common stock, no par value per share, having an aggregate offering price of up to $5.8 Million</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We have acted as counsel to Cumberland Pharmaceuticals Inc., a Tennessee corporation (the &#8220;Company&#8221;), in connection with the sale and issuance of shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, no par value per share (the &#8220;Common Stock&#8221;), having an aggregate gross sales price of up to $5.8 Million, pursuant to that certain Sales Agreement, dated as of March 20, 2024 (the &#8220;Sales Agreement&#8221;), by and between the Company and H.C. Wainwright &#38; Co., LLC (the &#8220;Agent&#8221;).</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Shares are included in a Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the &#8220;1933 Act&#8221;), under File Number 333-276052, including the base prospectus, filed with the SEC on December 14, 2023 and which became effective upon the notice of effectiveness filed December 26, 2023 (the &#8220;Base Prospectus&#8221;), and a related prospectus supplement, dated March 20, 2024, filed with the Commission pursuant to Rule 424(b) under the 1933 Act (the Base Prospectus and the prospectus supplement are referred to herein collective as the &#8220;Prospectus&#8221;). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the 1933 Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares.</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:0.25pt"><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ALABAMA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> FLORIDA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GEORGIA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LOUISIANA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MARYLAND </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226; </font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MISSISSIPPI </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> NORTH CAROLINA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226; </font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SOUTH CAROLINA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font></div><div style="padding-right:0.25pt"><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TENNESSEE </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226; </font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TEXAS </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> VIRGINIA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#6c6f70;font-family:'Century Gothic',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WASHINGTON, D.C.</font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:133.92pt;width:100%"><div style="margin-bottom:8pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the Tennessee Business Corporation Act (the &#8220;Act&#8221;), and we express no opinion with respect to any other laws.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In our aforesaid examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the accuracy and completeness of all documents submitted to us, the authenticity of all original documents, and the conformity to authentic original documents of all documents submitted to us as certified, telecopied, photostatic, or reproduced copies. We have also assumed the accuracy, completeness and authenticity of the foregoing certifications of officers and statements of fact, on which we are relying, and have made no independent investigations thereof. This opinion letter is given, and all statements herein are made, in the context of the foregoing.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and have been issued by the Company against payment therefor (not less than par value) in accordance with the terms of the Sales Agreement, the Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that (i) the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the Act&#59; and (ii) upon the issue of any of the Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under the Company&#8217;s charter.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Company&#8217;s Current Report on Form 8-K, dated March 20, 2024, and to the reference to our firm in the Prospectus under the heading &#8220;Legal Matters.&#8221; In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the 1933 Act or the rules and regulations of the Commission thereunder or Item 509 of Regulation S-K.</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Very truly yours,</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">BAKER, DONELSON, BEARMAN, CALDWELL &#38; BERKOWITZ, a professional corporation</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Nathan Kibler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nathan Kibler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Authorized Representative</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cpix-20240320.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:d0df40ba-ff5b-407d-ad7c-1c0cf0f5b66c,g:eb368248-c98d-4905-b398-0325af6d224d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cpix="http://cumberlandpharma.com/20240320" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cumberlandpharma.com/20240320">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20240320_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20240320_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument">
        <link:definition>0000001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cpix-20240320_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:d0df40ba-ff5b-407d-ad7c-1c0cf0f5b66c,g:eb368248-c98d-4905-b398-0325af6d224d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_19fbf7df-0d4d-4b88-8c94-ba024476a4a9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_972a7a76-44b4-4841-a2de-161b28dd9b63_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1c741eb4-8ca9-419c-bb20-d74e9757c396_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_87b0b9e4-521e-4ffe-b664-147bc5ef7f4e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8c916aa8-db2b-442a-9736-440a03222f55_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6be8ab29-2222-415b-ab6c-6a2fd3d4247a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ecb47050-a12f-4f45-8360-34101a907613_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_e9b7c8e5-f31e-471d-8136-1d8da7342a73_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2c40f073-fcd3-429e-811f-3a6203286f9f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_39ae51cc-c415-4d54-aa38-f4f073ff1819_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_cb1202e7-b7e0-4faf-a866-4f4274f4e878_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8436d178-ad71-4158-89c2-d029d7a13cfe_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c2a22677-8e46-4237-8df4-8fe7da1afd91_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2ca1686d-adac-4dc3-bbd4-3b4c86a4dae2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7dab4c08-dd82-4965-bb41-507f67b31225_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1429ee02-93c5-4a1c-8e72-a4fa17237a94_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_837d504d-3520-4da9-b82d-970db7d397a0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9236e902-54f1-40f0-98d7-6ea9d34e305b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7b0f6e25-4a96-476f-8030-ac98f1d9eef1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c9d076b6-8fbf-43b7-ac17-db6fd193ff8d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_165740cb-e121-4572-b96f-c3e0d5628e9e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_01bf45af-7253-4c50-ac76-5fe1f2159af5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9d1de1dc-a332-470b-a392-efaf68cd69a3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cpix-20240320_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:d0df40ba-ff5b-407d-ad7c-1c0cf0f5b66c,g:eb368248-c98d-4905-b398-0325af6d224d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="cpix-20240320.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8e8e4b15-f923-4735-8720-5516d709d2f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_DocumentType_8e8e4b15-f923-4735-8720-5516d709d2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2e6664d0-903b-4f7d-aa50-080c90812c04" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_DocumentPeriodEndDate_2e6664d0-903b-4f7d-aa50-080c90812c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4cc1d174-654b-4937-bdbd-53ceb31cd34b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityRegistrantName_4cc1d174-654b-4937-bdbd-53ceb31cd34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5644a458-9460-4171-a946-aa99a5b250a9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityCentralIndexKey_5644a458-9460-4171-a946-aa99a5b250a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2fe2ccb5-504f-414e-ad6e-091b75d7de29" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_AmendmentFlag_2fe2ccb5-504f-414e-ad6e-091b75d7de29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_413d8e2d-b9bc-42cf-84a8-e9a3ddfc53cf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_413d8e2d-b9bc-42cf-84a8-e9a3ddfc53cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8c4efea6-0f1c-4f76-8b3f-4eed1179854d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityFileNumber_8c4efea6-0f1c-4f76-8b3f-4eed1179854d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ad770b8f-0909-4927-9e1f-6aaa31883b67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityTaxIdentificationNumber_ad770b8f-0909-4927-9e1f-6aaa31883b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a20951d1-1a1e-4716-8c2b-e1952eeaa9bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_CityAreaCode_a20951d1-1a1e-4716-8c2b-e1952eeaa9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_fc55ece0-8c72-42f4-9dd8-538c8275b56c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_LocalPhoneNumber_fc55ece0-8c72-42f4-9dd8-538c8275b56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5dde4198-6ef1-4100-b3f5-99cca1f72549" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_WrittenCommunications_5dde4198-6ef1-4100-b3f5-99cca1f72549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b9c26a64-2005-46c9-a280-722b41086617" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_SolicitingMaterial_b9c26a64-2005-46c9-a280-722b41086617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_3e40f476-8143-47ac-ba8a-9abc9d95d4bc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_PreCommencementTenderOffer_3e40f476-8143-47ac-ba8a-9abc9d95d4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_d2493cbd-c66d-408d-bf85-0b5a2383891a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_d2493cbd-c66d-408d-bf85-0b5a2383891a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3fffb4a4-1196-44e0-832c-be292a1f68a4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_Security12bTitle_3fffb4a4-1196-44e0-832c-be292a1f68a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8811c1b9-f700-4f8d-95b6-4b1d8b9b014c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_TradingSymbol_8811c1b9-f700-4f8d-95b6-4b1d8b9b014c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b75e5b08-dacf-421a-9fb4-c0260e2d2fa8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_SecurityExchangeName_b75e5b08-dacf-421a-9fb4-c0260e2d2fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_32242d9a-118c-4a30-b25b-bde5a15ff313" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityEmergingGrowthCompany_32242d9a-118c-4a30-b25b-bde5a15ff313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ad4bea09-a5bd-435a-a935-7b0d9dc27f81" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityAddressAddressLine1_ad4bea09-a5bd-435a-a935-7b0d9dc27f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_84ffdac3-befc-4789-a176-b156744c4a09" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityAddressPostalZipCode_84ffdac3-befc-4789-a176-b156744c4a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a57e3a86-f046-46fe-b10b-008b27162b87" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityAddressCityOrTown_a57e3a86-f046-46fe-b10b-008b27162b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4790e2a0-8909-44ca-9b79-e4f5709f6571" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cf92df73-c819-4b8f-af63-8577347214fd" xlink:to="loc_dei_EntityAddressStateOrProvince_4790e2a0-8909-44ca-9b79-e4f5709f6571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_01a.jpg
<TEXT>
begin 644 image_01a.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M.G\[64_11L?\7 _/#H/[:D]QE]@GZB7>4_ ]I[_LOLR?7@^G3^=K*?HHV/\
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MZD7>?_)C_P!QQ/\ 7T^NA]-+]Y+_ ,G=^?\ "P/SM<OOPA_L+G["GZD7>?\
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MP[#U'85RX^JX: B B B B B B B B B B B B B B B B B B B B B B B
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M-$].\R4EM2_D(TFOQ[D]S;<_+]I'EF-A>/G)7,_C,D]#YO2L!R_R9^FY6N.
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M&+?[05/W6'EEI]5C_?-_;3X"SGVG=^XR>Q3\.<*_[X8M_M!4_=8>66GU6/\
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M^<Z*+-7=53B4F1FB3':623(S+H9&)"QF?PF9;Q8J[M[@TK1DC7.'FM!XF^>
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MW:.!YINW.5:]2?*,\ULM!-98?#8&SLYF/8>T;=7$H:X4\5XN(8ZTKM,)!J*
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MD45UIR;=Q:^1/.6=VE23*.UV>69&1]2%AN6VAKW1-M=1WTT4TEPZ,^UAU&\
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M)@\\JS^CN\/R1U[P,TQJ;%2W+_2PRR^2SGP"WNA#,?#1AHL/ABJF9 1 1 1
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M*,U*49F9]1'#G.>XN<27$U).\GK*M=%%'#&V&%K60L:&M:T !H H  -@ &P
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M@6%D70P<'K9G@]K<UV%PF>Z/B%61LW*1@9ZJUH"("("("("("("+"7E[Z?\
MQNYGXY/A[.PR#6YX<'W;']NXQ#A5NP\??81VP27;I8ZY%3QC+M.NL2D1?+4K
MRR:=-+J,0U3H? :MMW,R,+6WO#1L[ !*WJ\;U31ZUU12M*':)SY-]XCF9R2R
M<<^EKZ273_:<4V/G<Y]G,"?'I'7VF1V_MH>"2H'$7LJPT3N5?&?8'$;>&8Z0
MV*R3EGCDE,FDOX\=V/5YCB=@IQS'\MIDNJ</W&VBMF2V^]Q464V]&6HW65]*
M9:ET]?:7S$N'OQ[9&:M<!02,/I7M\#AT;:.!:=H*WZ<I.:.G><6A++7>FC2U
MN6\,L1(,EM<,H)K>2E/&C<=AH!)&62M' ]JQU'0J24!$!$!%+[P4](G/.<6H
M7=R46Y,1U_0QLXN\)DUEMC5S>VZ7Z.OI;!ZP83#FU\-UI]-VA*6U.MF1H,S/
MY!*>C.5U[K'%_"T-W%! )G1D.8YSO%#3780/5;JA4VY^=\;3_(?60T5?X6\R
M.0=81737QSQQ1TE?*P,/$U[@1V1)(:=XV+.7^&]S7]Z_%OHEMOQ]&9?F"N_P
MG'[@[[(H%_Q,L'^2-W_ZA'_5$_AO<U_>OQ;Z);;\?0_,%=_A./W!WV1/\3+!
M_DC=_P#J$?\ 5$_AO<U_>OQ;Z);;\?0_,%=_A./W!WV1/\3+!_DC=_\ J$?]
M47^'/AO<Y)"S:Y6XHMPD*-M#FJ+=M"ED1]B5N)SEU3:%*\#425&1>/0_D'\/
M(*\ILR<5?YEWV1?IORF6!+@'Z1NPVNVF0C)IX!Y**^94>:%UA7PY&["2KMY'
M:L-70^TE8MEJ4FKIX$I1+6:2,_E/H?3_  #C?F$S'V_;?O'KM1\I9H:NW3.6
MI_/VZZ5/^'7Y8MQS56;EX\3)7>DB9GVNR:Z.:#/VU')CZYM'"6DOD+RC(_\
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M9S+?&AQ8*,<0)+QHIVMR2*D/JR ^)$!1SWR6"056! 1 1 1 1 1 1 1 1 1
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MHB4E1&E25$1I4DRZ&1D?@9&0;U_02#4;"%C!M/A1Q)W6S(1LWCMJ;)94GO\
M-NOP/JJ7*/MG_.>5EN/LU.3Q^\_$_+EIZF1'\I$8QS):0TQEP1D;"UD<?5<
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M65E:F.0 <3?,-0YIZ6D=-0/.]SUY.9SD?S!NM&9?BELOIMG<4HVYM7DB.0=
M>"#'*T>DE8X EO"XY=C*%#B B B B B B B B B B B B BKV_$&<CSP?0N
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MTL'%N[1C''LY0/6RQEDK>GA>*@'8O81VJPQ 1 1 1 1 1 1 1 1 1 1 1 1
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M=J#[<RQOG$?.OEMPW;NVECO,IX0K*XL"M82 B B BPVY4<!^,',2JD,[AUU
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M9H22Z)Y&U\;HY'Y?C*5#2 B B B B B B B B B B B B B B B B B B B
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MHWRU^"=9XOFC8QTM,O;^271&[RJU [)[CZZ6V(8T=5J3YMBX3RM;" B B B
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MM_S5H:[^MTZ?O'9&(@ 06%BP>$&V9)4^?(1Y@"F $IJFB B B B B B B B
MB\XW!J[&-V:LV#J/,X_O.,;&Q&\Q&X2E/5YB-=0'H93XA]R#;GUKSB9$=PC2
MIM]I"B,C(C' RN.M\OC9\7=BMM<1.8[P!PI4>$;P>@@%9-HS5>5T-JS':QPC
MN'*XR\BN(^HNB>'<#NMCP"QXV@M<0005K9LYP'(L V+F&KKN(O\ "S"LUR#
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M?+[G"[&M?Z:6$=%"=KXQTL/C-'I#1H8Z@_>5[DNF^945QK'EG'!BN8&V22$
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MY+ZJY':UFTEJ1IDM35]I=-:6Q7=O7Q9&5)X7M]+-$7%T4E15S"Q[\M1DZA]
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MAPXM=#B5\%AN-"@QF(<2,T7:U'BQFDLQV&D_Y+;32"2DOL$0V'L8V-@8P48
M !U ;EY:IYI;F9]Q.XOGD<7.<=Y<XU)/A)-2OI'Z7R0$0$0$0$0$0$0$457K
M6US$WTV]^R75.I<IY^H;&,3:D$A;[NZ-?5*DODI"S4T4:T<41)-)]Y)/KT(R
M.->;L8?H"^<:U:Z CWQ$W]@E6T[CER^#O-Z>B8 6S1Y%CJ] &-O)-FW?Q, V
MUV$[*T(H?BEZW^("("("+8(^E77,5?I[<6HT=;JVW=>OV*C>4A2R?N,GO[>2
M@C0AM/E(DSEI;+IU)!$1FH^IG>+ELP1Z&QK6UIV%?WSW./S2O.QWM+F2[[QF
MK)9  X9$,V=4<$,;=Y.TM:"?#6@ V*009PJ[("("("("("+PKDSHC&.3.AMG
MZ-RUMKYKV#BTVJBS7$>8JCR!@T6&+9)'+M7_ )UCF20XLULNADI3!)41I,R/
MIM0X6WU#A;G#75.SGC+0?6NWL>/"QX#AYBS[E=K_ "O*[F!BM>8<GRK'7;9'
M-!IVL)JR>$_.S0NDB/4'5!! *UO>3XY<X=DF0XCD<%VLR'%KRVQR]K7R-+]?
M<T<^166D%Y)D1I=B3HJVU%]@TB@MQ;RVEQ):W +9XGN8X'>'-)!'G$$+TR8O
M)V6:QEMF,;()<==P1S1/&Y\<K ]CAX'-<"/-7!CX+G("("+E*.ZL\;NJ?(J2
M8[7W-#:5]U43V#[7X-G5RV9T"8RK_)=C2F$+2?V#2/K#-);S,GA);*QP<TCH
M(-0?.(7%O[&UR=C-C;Y@DLKB)\4C#N<R1I:]I\#FD@^:MF+JS.(NSM8ZXV3!
M0VU"V%@>(9Q#;:7YK3<7+,?KKZ.AISJKS&T-3R)*NI]2\1L(QMXW(XZWR#-C
M)X62#S'M#A^RO+SJS RZ6U3D],3DF?'9"XM7$BA+K>9\1)'0:LVA=\'-6/H"
M("("("("("("("("("+!7U)>1Q<7.'&X=D0+!,#,+*C5@.NE$XA$H\YSA#M+
M5S8"5^R]*QR$[)M^P^I*:KE]2,O \,U_G_BYI2[R#'<-TYG91=?:2>*TCPL%
M7^8TJ?.[)RT/-;G5A=,W$9DPT4_E=YLJWR6U(ED:^FYLS@RWKT.F:M>H*,+T
M:*0OTM^-1<H>:&J<-LX!S\(PV<K:NQD*9-Z*O$L%DPYR*R>@NG^8Y/DS]=4/
M'W)43<]2DGU(AG?+C3_QCU;;6DC>*SB/;2]7!&0:'P/?PL/@<JY=Z[F?^:KD
MCE\U:R=GG;V/R"S-:.%Q=-<TO9\]! )KANPBL0!%"O4_6:XW_P!7[FWG-K4P
MO=L+WE'1N/&S::[(S%GD4N5'SNL)Q/1GWAG-8<R63223Y,2?'+IT,E*['FS@
M/@/5\TL0I:7@[=G4"\D2#S>T#G4Z&N:L3[DW,S\XG(NPM+Q_%F\"XXZ:I\8L
MA:TVKZ;Z&V=''Q&O%)%(:[P(H1&:MR@(@(L]O3,Y''Q@YG:>S^?.]QP^^NDZ
MVV&MQY3,-.%9X['IIMA8&E:#7"QFU5#N%)]KJNN3[*CZ$>;<O<_\7-66M\]W
M#:/?V4O5V<E&DGP,=PR?N%7WO1<M/SJ<DLUIZWC[3,V\'EMF *N\IM 9&L9L
M]-/'VEL#LV3':-ZV#XO(O.B@(@(@(@(@(@(@(@(@(@(@(@(@(@(L-/42_84Y
M:?H%V/\ T<FC$]=_B9E/N*7^(5-?=O\ T^:/_O!9?7FK7:BB*](J B B BOP
M^CG7+J_3<XT1G'$.J=KME6)*01I(D7&YMBV[39DKQ[V6YQ(4?R&I)F7@+L<J
M8S%H#'M.VK93^^GE=_E7GR[Z5RV[[S6J)6@@"6R9MZX\;9QD^>6U'@*DT$A*
MKB B B B B B B@[];;G,WQXT>K0& W)1]Q;XIYD*>[!D^78X7JAYQVOR"],
MVE>=$G9>XT]40%&1&;937FU)=C(,X=YOZR&"P_P)9/IE;UA!H=L<.YSO 7[6
M-\'&006A7O[B_(5W,?7?YP]0P\6B]/S-<P.;5ES?@!\,6W8YMN"VXE'KNP8X
M%LKE2N%1UO!7.8SC.09GD-)B6)TUED63Y+:0:2@H:>(]/M+BWLI#<2!75\..
ME;TF5*DNI0A"2,S,Q][>WGNYV6MJQTEQ(X-:UHJ7.)H  -Y)7!RF4QV$QL^8
MR\\5MBK6)TLTLC@R..-@+GO>XT#6M:"22KQ?I<>F;CO";!BS?8,6FR/DGFD!
M)9+?QTIG1=?4DIMAS\G^*3E*<:<['4=]I8,)1[](Z-I-<=AI2[B<N.7L&D+/
MRR^#)-03-\=PVB)II[4P_P =P],=FUH%=#_>M[T62YYY[X"TX^>VY8V,GM,1
M\5UW*TD>5SMV$5!I!"XGLF>,0)'O#9;A)ZIZ@(@(@(@(@(@(@(@(@(@(@(@(
MH\/5AK';;T\.4,5DV26UA-19F<@U$CRJ7-L7N7R3V-N'YQL0%$WX$7F=O4TE
MU46"<S(S+H3(M%-D+3M^=D8[_)L\*L?W1+IEGWC]*2OXJ&^D9LWUEMIXQTC9
M5XXO!6@.XZ_D4@7HA0$0$0$5[?T2ZYV#Z<&CI+BVUHN+C;=BPE'=W---;=S>
MH-#O<DB\PWZM:BZ=2[%)\>O4BN?RAC+- V;CN>^<_P"WD;_D6@COS7+)^\QG
MHF@@PPX]AKTDX^UDJ/!20#;T@J5X26JC("("("("("("("("("*C/ZF6JHN,
M>K'EM!'9.'4['V7I[+HWNB.UY2\\@X@O(92$K2M"I+V4KL%]>BB4H^IEU,R*
MG',+&MMN9LL+12*XN('BG^D#.(^;Q\16^;NNZMERO=#L\A([CO,9B\C;NXCL
MI:/N!"TTIXH@$(Z"!Z*O,"XZT,H"("("("("("+6(YM1'B^9Y=C)MFT>.Y/?
MT1M*=2^ILZBUEUYMF^DS2\:#C].\O!73J-=UY#Y-=RV^[LY'-_>N(_R+U.8*
M_P#A7"6>4!J+FUBEK2E>TC:^M.BM=W0NL#C+M$!$!%;<^'(_W*\C_P!*.*?T
M3=%G^0G_ "C(?=+/XBT^?*6?CQIG^RKC[X"L<B>UK20$0$0$0$0$7"9+C=#F
M..WV(Y54P;_&<HI[+'\AH[-A$JNN*2XAO5]I63XSA&A^'.A2%M.(/P4A1D/C
M<6\-W ^UN6M?;R,+7-(J'-<*$$=1!H5SL7D\AA<E;YC$S26^4M9F30RL/"^.
M6-P?&]A&T.8X!P/00M?3ZB'$*RX6\F\QU8VB4_@=KTS34]Q)-;J[+7][*EE6
MPY$E:E*D6F,S(S]5,6KM4\_#-\DI;>;ZT=UWI:326HI<:*FR=[9"X],3B: G
MI+""QW66\5*$+T5=V_G):\[^5MEJQQ8W4$/]&R$;:#@NXFMXW!HW1SM<R>,"
MH:V3LZES'+!L8:IX0$0$0$5R/T .2,G97&W,=!9!.5*O= 9(R]CJGE*-U>N=
MA.VEM5PR6Z:G)2Z3*X%LV9DKM8B2(C))2E*.MKN2.?=D-/RX2<UFL9/%_FI:
MN \/"\/'@:6C9L6E?Y0[EE%ICF;9<PL=&&6&HK8B:FX7EF&1R.H-C>UMWVYI
M2KY&3/))+J3Y";%KW0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$7EN\:7\)-*;@QWW;WWY_U;L"E]S\[W;WOYUQ.V@^[>\>:
MQY'G^?V]_>CMZ]>XNG4=;F(?*,1=04KQVTK:;JU8X4KLI6JRO0=]\&:XPV2X
MN#R?+6DO%3BX>SN(W\5*&M*5I0UW4.Y:SP:]UZA4!$!$!%:C^&XKF&L>Y=VR
M5.G)FW.DJYU!J1Y"6*N%M.3'4VDD$X3JW+=TEF:C(R2GH1=#-5D^0,8$&4EV
M\1?;CT!,1_&/S%J:^4TN7NR.C;,@=E'!DW@]-7NL&FNVE (VTV=)J3LI9R%A
MUJT0$0$0$0$0$0$0$0$7!9/B^-YMCUOB>8T%/E.+Y!!>K+S'L@K8EO2V]?)3
MVOPK&MGM/Q)D9TOE0XA1=2Z_*0^-Q;6]Y ^UNF,DMGBCFN <UP/00:@CS5V&
M*RN3P>1AS&%N)K3*V\@?%-"]T<L;V[G,>PAS7#K!"J7^I?Z*]MJ2/D.]^(U9
M9Y+K&*4JXS+4"79-KE&O8#:%R)=QA[\EU^RRO$(:4F;T5:GK2O1T<ZRF"=<C
M5CY@\HY<6U^:TNUTF.%720;7/B&\N96I>P=(-7MW^,VI;M\[K_?@M-826V@.
M<4L5KJE_#';9&C8X+QY-&QW : RWN';.%X#8)3XM(I.!LM=<0.MDB B B B
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M<:3*(>=L FT6)#_)7D3O1#V?YZO-\GKDG6/> -JT[+S!7D)VC:&OM[CIW[8
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M7#CXKF("("*P?\.I3^?RBW=D'NIK.LT&_3^^>8HDL?/NP\)F^ZFSYA)6<O\
M!WO)1H4:?(,B-/<9*G/D/%74=Y/3TMEPUZN*6,T\_A^8M=/RDU[V?*K!8[CI
MVNH1)PTW]E9W+>*M-G#VU*5%>+<:;+@PM.M,J B B B B B B B B B B B
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M]WQ%G[,&D/T]-?J]S00;SX_%RS^[?_"D6Q?Y-G]*N=_N^?ORV5/L576YE 1
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M7G"[S5S)=]X#5\L@ <,Y<LV=4;^S;O)VEK03X:T &Q9MC+U!B B B B B B
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M:BLFDI(C)Y;NY<!J#;<,_%*";M5+ZEX]R"+Y#,1KS=C#] 7KCZAT!_V\3?\
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M?=42&F&&$*=>>=6KH2&VVTFI1GX$1#^.<UC2YQHT"I/@7[BCDFD;#$"Z5[@
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M=V[2W5DO<BVV5FM[E*XBE$M-5 GS'#IJ-E9$7=%H*9$>$R9]5&U'3U,SZF=
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M:[;IC8[F1C!1C9' >8":+U08B:6XQ-K<3'BFDMXW./6YS&DG9LVDK@!QUV"
MB BMV?#F5SK7'_D%;FMLV)VXJBN;:+N\U#M7A5;)>6OJGL\MQ%P@D]#,^J5=
M2+PZVBY"QD8.^E]2Z[:/WL8/^<%IS^4JN6/YB:=LP#VD>%D>3T4DN7M 'A'9
MFOFCPJQ2)X6MM 1 1 1 1 1 1 1 1 1 1 15&/6L]-2/JNUM.7VC*#W?7.36
MZ'-RXC5L'[I@V574M+3.;545EOLAXGE5H^3<QKJ2(-H^@V_M,E+<>KW-WE\W
M&R.U3AF4L)'>WL V1O<?I@'0QY-'#U+R*;'4;N)[CG>>DU;:1<F]>W'%J6UA
MIC;B0^-=01-J;:1Q/C7$$8)C=OE@8>+QXBZ2NB(&6R= 1 1 1 16N_0>YY/Y
M13O<+=I7AOW>+U\N[T3:64@UR;+%X:52<@UR3[RN]Y[%VNZ?5M^VHJWWEHNQ
MF&R@68Y+ZU=<Q'262?6:-I=;$G:6#:Z*OSGIF#UG$-@8 M1O?_[O\>*O6\[]
M*0<-C=2-BRL;!1K)W>+#>4&X3FD4YV#MNR>:OF>Y66A8):P4!$!$!$!%Q=Y=
MU&,TEQDF06,6HH<?J["[N[:<ZEB%5U%5$>GV5C,?5[+,6%#CK=<4?@E"3,?.
M::*WA?<3N#86-+G..X-:*DGP "I7+L+&\RE]#C,=&^;(7$K(HHV"KGR2.#&,
M:.ESG$- Z25KY?4/YB77-7DGE>S3>FQ]>TJW,0U'0226R51@55+?.#.DPS49
M,7F4R7'+*?U-:T/2"8):FH[))HWKO54VKM02Y&I%BSQ(&GU,8)H2.ASS5[O"
M>&M&A>BONX<E['D=RQL]+!K':CG N,A,W;VEW(T<36NZ8H !#%N!:PR<(?(\
MG!@8:IZ0$0$7JNC=29)OK<.M=-8BDOP@V3F5'B<&0XA;D>N1:S6F9US-2V2G
M"KJ.O\V9)-)&:6&%F1'T'9X;%W&:RMOB;7Z?<2M8#T"IVN/@:*N/@!6)Z\UA
MC.7^C,IK;,'_ (=C+*6X< 0"_LVDMC;79QROX8V [WN 6R$U=KC%M/ZXP;5>
M$PS@8EKW%:/$,?C+43CZ:RAKV*^,[+>)*3DSI*6/-?=,NYUY:EJ\5&+]8VPM
ML580XVS'#:P1-8T>!H %>LG>3TFI7F;U7J;*ZSU-?ZLSK^TS&1NY;B9PV#CE
M>7N#1ZEC:\+&[FM :-@7?!S5CZ B B B B B B B B B B B B B BI&^M[Q
M&C\>N4?Y4\1K$0=;\C&K3,HS$5DVX5-L> _&1L2I:2DC0TU:2K"-<M]3(C<L
MGVVTDVP1"H'.#2[<%J/X2M6\./OP9!3<V44[5OGDB0>%Y %&K>GW%.<4G,;E
M3\4\Q*9-3::++9Q<:NDLWAWD<AZRQK'VQV'9"QSB72*%P1(KNH"("("*?3T)
M>:CFG]T2N+V<6_DZXWK9-O84J8\OW;'MQ)8CPJYB.1F;;+6P:Z,W7.%T-3EA
M'@)3VD;AG-O)C5QQ67.G+Q]+"]=[77<V?8 !_.@!IZW!GA6O?O\ ?(]NL]$,
MYJX&'BU-@(B+GA XIL=4N>3TDVCW&8= A?<$UHU7(1:U:5T!$!$!$!%U;.?^
MQ68?ZK9!_HF6.->?[I+_ #;OXI7:X+_GEG]UP_7&K6)C7<O4VNR8:TT_E^*L
M/M-O,/9)1M/,NH2XTZTY:14.-.MK(T.-N(,R4DR,C(^ACDV@#KN)KA4&1O[(
M769M[X\-=R1DM>VUE((-""&.(((W$=!4[/J^^E@]H&WM^3''O'WGM'Y!8NS,
M_P *IX1&UIVYG/(Z6-;&BEU9US<RWC)M)()JGD*)CJ4=V.EN9N:7+<X25^H<
M&PG#O=66-H^D./2 /Y)QW=##L]*6TH+W-N]BSF'9P\KN8UPUNN[>,-M+F1VW
M(QL!\1[G;[R-HVFO%<L!DH9&2%T 0A!;#4!$!$!%Z7I[;VP=#;)Q+;6K<BEX
MQG&%6S%M36<5:O+6IL^V56V47N2S9TEM$4N--B.DIB5%=6TXDTJ,AV.*RE]A
M<A%D\;(8[R%P<TCYH(Z6N&QS3L<"0=A6,:ST;ISF!IB\TAJNV9=8*^A,<C';
M]OI7L=O9+&ZCXI&T=&]K7M(("OJ^GYSRU[SKU"UE=+[IC^S\49KJ_;6NDO.*
M>QF\E-OICVM3[PI3\W$,C5#>=KY!J6I!(7'=5Y[+G6ZFA]:6.L\6+F&C,C$
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M'F20ESW$DDFI).\D])/25Z$888;:%EO;L;';QM#6M: UK6M%&M:T4 :
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M7./_ .J?$A??1WXHXK^S;;ZRQ>:7GO\ IPUG_>O+_P#4+A91C(U%* B B B
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M$75<Z2E>$9DE224E6*Y"E25$1I4DZB81I41]2,C(_$AQKS;9R@[NS=_%*[;
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M3X=/]F#=_P"GIW]7N%BU'(?\7+S[M_\ "C6F;Y2;]*N"_N^/ORY5A$3DM="
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M86N;Y1KF&["\O,7RZLY*76;O#/.!TVMEPN#7#H#[E\+V'I-NX=!5P$6F6FA
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MA!!V$$;"#O"\M-G>7>.NXLA82R0WT$C9(Y&.+'QR,<',>QS2'-<UP#FN!!!
M(-0J37JP^F':</LMD[@U'72[+C1F=PAF*PA<JPGZCR&P+O3BE[)=\U]_&+"2
M2_F:Q=4I1$90I*CD)9?FU#YF<NI-*W1RN+:7:>F?L&TF!Q]0X[RPGZ6X_0.\
M:A?O,[HG>HM><V';HS6,K(N:%C"2X^*QF0A9_P#,1-% )V-IY3"T ;YX@(R^
M."& 1*KMH"("("+WOC3R0V?Q2V]C.Y=3W!UV0T#WE3ZR2Y*.ARS'Y#C2K7%,
MH@Q9$95E0VR&D][?<E;3R&WVE-OM-.([O3^?R.F<I'EL8_AG8=H->%[3O8\
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M(7N8]CVEKV/:2US'M< YKFN!#FD @@@BJ^T?M?! 1 1 1 1 1 1 1 1 1 1
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M?6>263)7#:^E:QKK:UJ.D/+[K?0#LP=M=EJ(626IM 1 1 1 1 1 1 1 1 1
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ME?1 13D>DSZ6-SRAR.EW[N^F>K...,VR9512V+#K,G=5S523)53":4;:T8#
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M3X=/]F#=_P"GIW]7N%BU'(?\7+S[M_\ "C6F;Y2;]*N"_N^/ORY5A$3DM="
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M=PW#HNR9U\<IX 1X6@E_[E6 [KF@AS&Y[:>P,\?:8R*\%W< ^E["S!N'-?\
M.RNC9">LR@5%:C7N"C*]&" B B B^ZLK9US95]/5QG)EG:SHE;70VNWS9<Z<
M^W%B1FNXTI\Q^0ZE*>ID74Q](XWS2-BC%9'.  ZR30#SROA=75O96LE[=.#+
M6&-SWN.YK& N<X^  $E;,K56!U^K=8:YUG4I:35Z\P3$L'KR82:6?<L4H*^B
MC&V2B)1)4S (RZEU\?'Q&PG&V4>-QUOCHJ=G!"R,>8QH:/V%Y=M6Y^XU7JK)
MZHO*FZR60N+I]=_%<2OE=7SWKOHYJQ] 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MW"Q:CD/^+EY]V_\ A1K3-\I-^E7!?W?'WY<JPB)R6NA 1 1 1 1 1 1 1 1
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M%R=S9P>N\?);.+CV4[:OM;AH]5!.!P/%*$L/#*P$"2-CC19*C(%&" B B B
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M^<T,=Q"^"8!T3VEK@>D$4(\\%<NPOKK&7T.2L7F.^MY62QO&]KXW!['#PM<
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MJ!;4,F4L86'8:DOOH&-J.';Q74;0T,H;@5!EX;/@L2M5Z B B B B B B B
MBK%_$CUR':+B%;FXHG(-MO"N0R1%V+1:0]4R7'%*_E$II5.DB(O R6?7Y"%=
M^?T8,&+EKM:^X'[X0G_-6TSY,JY<S(:RLZ#ADAQ;Z](,;K]H'G]H:^8%5>%;
M5MD4FOHY5S5IZDG&B,\MQM#5CLNQ)37;W&[3Z8V-;L(/N2HO+=?@I2O[/89]
M#(^AB0^5,8DU_CVG<'2G][!*[_(JN=]*Y?:=V75$K "3'9,V]4F2LXR?- <2
M/#2JOP"ZZ\^2 B B B B B B B BPT]1+]A3EI^@78_]')HQ/7?XF93[BE_B
M%37W;_T^:/\ [P67UYJUVHHBO2*@(@(@(MDUQ5_9?XW_ *!-/_J]QT; --_B
M[8?<4'UIJ\R'-K]*NIO[P9'[\F7O8[I1\@(@(@(@(NHY[GN&ZNPW(]A;"R.K
MQ'"L1JY%UD>1W4@HU=5UT8B[W75]%..NNN*2VRRVE;TAY:&FD+<6E)\6]O;3
M'6DE]?2-BM(FESWN-  /_B@ VDT !) 7<:?T_F]5YNVTYIRVEO,Y>2B.&&,<
M3WO=N &X "KG.<0UC07.(:"11!]37G[><Z-T)GTQ65-I'7JK"HU3B\[[1)D,
M27&DVF;7\5M:VT9#DYQ6C\KN44*&VTPDU+)YUVF',/6\VLLMQQ<3,/!5L+#O
M-=\CAZY]!L]2T!N^I._ONN=WFPY":(\GO>RGUUD0R2_G;M:"T'L[6%Q )A@X
MG>-0&61SY" TL:R-81\K.K[ZJJM+VSKZ6DK9]Q<VTV-6U5350Y%A9V=C->1'
MAP*^!$;>E39LN0XEMIIM"EN+424D9F1#Z1Q232-AA:Y\KB UH!)).P  ;22=
MP&]<>[N[6PM9+Z^ECALH6.?))(X,8QC02Y[WN(:UK0"7.<0  23163?3Q]#.
M]OY5#N'FK7R,?QUE4>TH= I=4SD%_P!2;?BR-FSXCZ7,<JB(R-5,PHK%Y1]L
MIR)Y:X[T_P"A>3<T[F975S2R 4+;;U3ND&8CTK?]&/&/JBVA:=9'>/[^=ACX
MKC1G(Z1MQDG LERU*PQ;PX6+'"DTG5<N'8M&V)LW$V1EJ>GIJC':FLH,?JJV
MBHJ2!$JJ:EIX,6LJ:BKKV&XL"MK*V$TQ#@0(45I+;++2$-MMI)*2(B(A9.**
M*")L$#6LA8T-:UH :T 4  &P #8 -@"U+WM[>9*\ER&1FEN+^>1TDDLCG/DD
MD>2Y[WO<2Y[W.)<YSB2XDDDDKDA]%QD!$!$!$!$!$!$!$!$!$!%5I^(BY($]
M,T[Q4H;$^V&V[N/8L9AU78;\@I^-Z]K9*FC)).,,)N)CT=PS/M>B.]I>PHZX
M<]L_5]IIJ!VP>WR@=9JR('SN-Q!ZVGJ6U[Y-[EGP0YKFUD(MKR,=9N(Z!P37
MCVUZ"?)XVO'2V9E3XP%8 5T6U)6T/AXN.98_K?;'*"[@FBSV%:HUA@LAY"DK
M1B&*/LV>6SHBB]EV'>Y8Y&C*Z]32]1F1=.I];.<BL#V&/N=1S-]LG=V,9^<9
MM>1X'/H/-C6H+Y1[F5\(ZFQ'*JQDK:XZ$WUT!N\HN 66['=3HK</>.MMT-^R
MED43\M9B B B BKZ?$$\<$YUQ^P;D;203<OM(Y$G'\J>9;+N=U[L"7#KFY$M
M:4J<=*CS1FO0PGP2VFSD*/Y1!W/' >6X.'/0CVZSDX7_ ,U*0*GZ&3AIU<;E
ML4^3KYF' <Q+_EK?24Q^=MNV@!.Z\M&N>6MZ!VML9B\[R8(PJ>HJLMSB B B
M^RML9]/8P+:KER*^SJYL6QKI\1U3,J%/A/HDQ)<9Y!DMJ1&D-)6A1&1I4DC(
M?N.1\3VRQDMD:001O!&T$>$%?&YMK>\MI+.[8V2UE8YCV.%6N8X%KFN!V$.!
M((Z05L=.'N_H'*#C/IS>,-<;WS.,.@/Y-%B]/)K,VJ3<H\WJFT]K:DLU^5UL
MMMHS2GO92A9$1*(7WTKFV:CT]:9AE..:(<8'1(WQ9&^<\. \%"O-)SGY>W'*
MOFCFM!S!W8V%Z\0.=O?:R4EM9#OVOMWQN=0FCBYM:@K)49 HP0$0$0$0$0$0
M$0$0$0$0$0$7EV\?]RNX/T7; _HG;#K<S_RBZ^YI?XCEE>@_QXPW]K6GWQ&M
M9V->Z]0J B B BV.7!W]BKB!_9<X_P#ZI\2%]]'?BCBO[-MOK+%YI>>_Z<-9
M_P!Z\O\ ]0N%E&,C44H"+YIDR'70Y5A82HT"! C/S)TZ8^U%APX<5I3\F5*D
MOJ0S'C1V4*6M:U$E"2,S,B(?E[V1L,DA#6-!))-  -Y)Z .DKZP037,S+:V8
MZ2XD<&M:T%SG.<:-:UHJ2XD@  $DF@5'+U:_46F\R-I?D[UU9R&>.FK+>8UB
MS;#KS36Q<H9)V!-V+9L>P3D,F5.1Z1IQ)KCPG''C[');K:*=<SM>/U7DO(+!
MQ&!MGG@_TK]QE/@WB,'<TD["X@;X>Y_W;(.2NE/C)J6)KN966A:9R0";. T>
MVS8=M'5H^Y<TT?*&L\9L+'.B$::=?=;88;<>>><0TRRTA3CKKKBB0VVVV@C6
MMQ:S(B(B,S,^A"+0"30;25<E[V1L,DA#6-!))-  -Y)Z .DJ[WZ0GIU-<0]7
M_E5VA4-IY$;6IXKEQ%EL).5K+#I"FYT' XZE]5LW<Q:6I-XI/;_G2&XI=R8O
MFO7!Y6Z#&EL=\)9%O_';E@X@=\,9VB,?/'89/#1OJ:G1/WR.\F_G'JOXI:5F
M/YM\1,X1N:?%OKD5:Z[/08FCB9:@U\0NE-#+PLF6$L*E" B B B B B B B
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MSKZ6ML;FWFQJVJJ8,NSL[&8ZB/#@5\".Y*FS9;[AI;9C18S2EN+49$E*3,_
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M B B BV.7!W]BKB!_9<X_P#ZI\2%]]'?BCBO[-MOK+%YI>>_Z<-9_P!Z\O\
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MW3J7_6G:_P"L?(Q<7D]^(=K_ #DWUUZT.=^W_N4S'W)8?>4*EN$GJGR B B
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MCN[7G(6NX9+N>Q@&^NV]@E<!3K9$X&NPM)&^@5[<7.6@A 1 1 1 1 1 1 1
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M2*_D6!92P@_<<AHG9*?_ .#,C=[:)T-QQA2D]Q+1CFJ=,8W5F)?B\B*5VLD
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M;1ODS(WG,:OE#3V0ML<":; 2^\(!.X$AKB!TT--Q55(5J6VI3T?#O?MJ[/\
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M-2E*,U*49F9]14-SG/<7.)+B:DG>3UE;S(HHX8VPPM:R%C0UK6@ - %  !L
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M@@BWJ"#M!&Y=<_K4\G_WC]]?3!L+\8AQ_C+J/\(7ON\OLEV?YI>57Y,Z?_\
M3K/["O/LMV?LK/C(\[V'G.:F3AND>6Y;?Y&9.FEI)N$=Q83.CAI807=\O1"?
M\!#@W61R%]_OL\TWT;W/_C$K(L/I73&GMF QMA8BE/Z/;Q0[-NSVMC=FT[/"
M>M=&'"7?("*]/Z'W]W3J7_6G:_ZQ\C%R^3WXAVO\Y-]=>M"'?M_[E,Q]R6'W
ME"I;A)ZI\@(@(@(@(@(@(@(J%_K0_P!Y;R2_\'?U!ZL%+.;7Z0<A_J/O:%>@
M3N1?]L&F/_,?^K7ZBZ$<*UB B BN"?#I_LP;O_3T[^KW"Q:CD/\ BY>?=O\
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MQCJ-DS]FUP]<!%<OI^^:'><KK@MTM'" B B B B B B B B B B B B B B
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MFH]:9"YR69DWR3/XN%M20R-HHR*,$GACC:R-OJ6A>GCL5BJ B B B B B B
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M)\.G^S!N_P#3T[^KW"Q:CD/^+EY]V_\ A1K3-\I-^E7!?W?'WY<JPB)R6NA
M1:\/U(;!^SYY<L),DFR<;W;FM>GRDFE/D5%BJJBF9&I1FX<6$CO/KT-?4^A=
M>@HKK]YDUIDW.W^62#]Z:#Y@7H^[LUM':]W_ $A%%7A."MG[>N1G:.\[B<:>
M"BPF&'J<D!$!$!%/'\/$^PSS7V0VZ\TTY*XPYLQ&0XXA"Y#Z=HZ9DJ982HR-
MYU,:.XX:4]3)#:E?(DS*:>11 U?< D5..DIX?;H#^P"50#Y1Z-[^1N,<QI+6
M:JM2X@5H/(<DVIZAQ$"IZ2!O(5S(6Q6DY 1 1 1 1 1 1 1 1 1 1 1 1 1
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M(;BM[@QZ&@^]+$>#$:BUVPTM-^!*KFHU@XKHE$!?BL5JU=R8RV++KS3A=>V
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MMO)#O-\LN>EL+?3]P;/5;&<4N.N2UMP !5[X2"6W,337QXCQ-%#+'%Q &/\
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M:N?=7^R7Q^(>A_P-BO>EO]C3\N.ZOSP;1^D#+/OL'PQE_MJY]U?[)/B'H?\
M V*]Z6_V-/RX[J_/!M'Z0,L^^P?#&7^VKGW5_LD^(>A_P-BO>EO]C3\N.ZOS
MP;1^D#+/OL'PQE_MJY]U?[)/B'H?\#8KWI;_ &-/RX[J_/!M'Z0,L^^P?#&7
M^VKGW5_LD^(>A_P-BO>EO]C3\N.ZOSP;1^D#+/OL'PQE_MJY]U?[)/B'H?\
M V*]Z6_V-?Y<W;N=U"VG=N[/<;<0IMQMS/LK6AQ"R-*T+0JV-*D*2?0R/P,A
M_#E\L10W5Q3^<?[)?INA=$L<'LP^*#@:@BTMP01TCVM>8#KEE* B B BG9]
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MT^USL-ODCVN=!\\.DQ>$U+.DENT;FNZ3WQ8^91AY<\SYHH=>@!MK=$-CCR
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MR@THJI@K2MMJ B B B B B B B B B B B B B[CKO.\CU=GV%;)Q"8=?E6
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MH"("("+8Y<'?V*N(']ESC_\ JGQ(7WT=^*.*_LVV^LL7FEY[_IPUG_>O+_\
M4+A91*2E232HB4E1&E25$1I4DRZ&1D?@9&0R/>HJ!(-1L(50+UB/2R/2UA>\
MJ>/-!TU!<SUV&T\$JV&6V=6W=I-:;3D..P8Z&_+U_=3Y1)<C-I,J:4LB1TA.
M(1$JSS5Y;_!#WZEP3/\ A3W5FC'\BXGTS0/Y)Q.T#Z6=WB$!NY3N7][#X\6U
MOREYCW'_ .^4$89874A)-_%&TGL9GFM;N)C:M>3_ $E@\;V]I,U>@06MC: B
M B BRNX:\NMD<+MV4.W=?ON3(2#159UAC\MV-3YYATAYM=E0678EQ+,E'83\
M&5V+7"FMMNDE:26VYDVD]49#2679E+$U9Z62.M&R1G>T^'I:ZAX7 ':*@Q)S
MKY.Z9YW:&N-':B:&3GVRUN0T.DM+D ADS-U6^IECJ!)&7-JT\+F[ 30.]]<\
MEM2X=N?55Q\[X?F5:F9&)Y+;-I36+1FQ;8Y?PVW7TP+^AL$.1I31+6CS$=S:
MW&E-N+N]A,U8:@Q<66QK^*UE;4=;3N<QPZ'--01M%1L)%"?._P P] :EY8:P
MO=$:MA[',V4O"ZE3'(P[8YHG$#CBE80^-U :&CFM>'-'L8[984@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(O!.57[+_ "0_0)N#]7N1#I=2?B[?_<4_UIRD'E+^
ME73/]X,=]^0K6RC7^O3>@(@(@(MB5Z=O["G$O] NN/Z.0A>[0GXF8O[BB_B!
M>;KO(?I\UA_>"]^O.698RQ0H@(@(@(@(@(@(@(J%WK"\>F./G.79;--7-UV'
M[99@[EQ1B.T349E&9.S&LKBLH;0B.PW'SRKM?*8;(DLQ5LET(N@I7S4P3<'K
M*X$3>&UN@)V ;O;*\8ZA20/H!N%%Z!>YCS&DYB\AL6^]D,N9P[G8VX)-7$VP
M:;=Q))))M'P<3CM<\/-2:JS'Z'W]W3J7_6G:_P"L?(Q87D]^(=K_ #DWUUZU
M=]^W_N4S'W)8?>4*EN$GJGR B B B B B B BH7^M#_>6\DO_!W]0>K!2SFU
M^D'(?ZC[VA7H$[D7_;!IC_S'_JU^HNA'"M8@(@(LW^*7IX<HN9M/<Y-I'$J&
M?B6/7QXQ=Y1D698[C]?77A5L2V."NODSG<DD]($]A?FL0'6>KA)[^XEDG,=-
M:$U'JR)]QAXF.M8W\#GND:T!U ZE">,["-H:1MW[U!/-SO(<J>2=[#B]=7EQ
M'F+FW[>*"&VFF>^+C='Q!X:(6^.QPX7RM=XM:4()E+U_\.?ONU3'<V=R U1A
M*74MK>9PVBRO8LN*2S(UM.(M6]<Q')#*#]HD/J;-9&25FGHLY'L>0V;EH<C?
M6T(/U-KY2/WW9"OGT\/2JH:B^4HY?6A<W2VG<O?$$@&YEM[-KJ=(,9O' $[J
MM!IM+0=BS@P#X=OC#2^0]L;<>Y\[E,GW.,4)XC@E+*^UDDT2(;E'EMPEOO,U
M%Y5@THO9(U&1'W9C8\B=.PT-_=W<SAT-X(VGS1PO=Z#@H)U#\I%S3ON)FFL+
MA,?"[<9?*+J5NWH<);>.M*#QH7#?LVBF;^O_ $@O3RUXF.Y#X\4V4V#*&TNV
M6P,DS#-53%M&1D[(J+R_DXTA:S+VB9@M(47@:>G@,PL>5NA;$ LL&2/'3*]\
ME?-:YQ9Z#0%!.HN^3WCM1ES9M23VENXFC+2&VMN$'H$D439SX"Z5Q'6L/?4C
M]&G6VYL,D;(XFX1BFKMQ8E4-H3KO$JJFQ# =FU%<V\LZIJIKHU?38]G/EJZ0
MYY$U'F*23$SH2T2H^*Z_Y3X_+6AR&F88K;*Q-^E,#61RM'J>$ -;)ZUVP.]*
M_>'-F;NR]]?4^B<VW3/-Z^N\KHN\F)\LN))+B[LI'D#M#(]SY)K6OTR(\3XP
M3)#6CHI*==U2W&.7%ICV0U=A1WU'83*BZI;>'(KK6IM:Z0Y$GUME EMM2H4Z
M%*:4VZTXE*VUI-*B(R,A56:&6WE=!.US)V.+7-<""T@T((.T$'80=RW0V-]9
M9.RBR..ECGQ\\;9(I8W!\<D;P',>Q[26N:YI!:X$@@@@T7&#Y+E("("+]XDN
M5 E1IT&3(AS8<AF7#F1'G(\J+*CN)>CR8TAE2'6)##J"4A:3)25$1D9&0_37
M.8X/82'@U!&P@C<0>@A?.:&*XB=!.UKX'M+7-< 6N:10M<#4$$&A!V$;"K8'
MI;>LO#S9..\=N7V21Z_-$HBTVO\ =]W*0Q S)9&XW%H-DV,A;<>MRGL)MJ+;
M.&3-FKV92D2S)V99CEQS89>"/ ZID#;O8V*X<:"3J;*3L#]P#SL?N=1VU^HO
MO7=RB;!&YYD<FK5TF$JZ6[QD327VPV%TMDP5+X*\3I+<>- -L0=#XD-DX6 6
ML= 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1:SO>/^^K<'Z4=@?TLMAKWS'_ #>Z^Z9?X[EZA=!_B/AO[*M/O>->
M7#K5E: B BN"?#I_LP;O_3T[^KW"Q:CD/^+EY]V_^%&M,WRDWZ5<%_=\??ER
MK"(G):Z$!$!$!$!$!$!$!$!$!$!$!$!$!$!%K:^6ES^$7*GDQD'FQW_GWD%N
M:Y\Z)_T5[YSV-DDWS8WM+_S=SS^J/$_9,O$Q0+4\O;ZER,]0>.^G=LW;97G9
MX%Z;.4%E\&\I=+XZCF^3Z=QL='>F'!9PMH[=M%-NS>L?AT2D1 1 1 17NO13
MP=S#/3OTY*D,G'FYQ;;#SB4TI':KR[#.;RHJ7C/J?F%+H:.(\D_#V'"+[ N?
MRBLS::$M'.%'S.ED/GR.:WT6M:?/6@?OQ9YN;[R&:BC=Q06$-G:M->EEK%)(
M/!PRRR-(ZP2I6Q):J.@(J'/K28LYC/J,[W>[%HB91%UKE, U^89N-SM8XC!G
MK)2T))2#NZV62>WN2E)$GKU(R*EW-NV-OKV]/J9!$\>?"P'^$"M__<ARS<IW
M:L RH,UH^]@?2FPMOKA[!L_T3XZUH2=NXA18"-E;% 1 1 12E^B]DJ<<]1O0
M:'G":BY"SLO&I*S\TS-5AJS,WJYM*6E$2C>N8<9'MDI!$KNZ$9$921REN/)]
M>V0/I9!*P^?#(1_" 54.^YC#DN[3J$L%9;9UE,W=ZB_M@\[>J-SSLH=E.D@W
MRA=)>?Y 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 18J\Z;L\=X6<LK9"Y#;[
M''/<K$1V,2#>8GV&O[^N@2$^8M"21'FRVUK/J9DA)F1*/HD\:UE-V&D<G**A
MPL)Z4Z"8G 'SB0I:Y"6(R7/#2%FX-,;M2XTN#JT+&7<3WC97>UI \)%2!M6N
M4%"EZ5D!$!$!$!%>P]$C#UXKZ=NHYSS9-2,VR#968.H(T*5V.YY>8["<6:$$
M1&_68XPX1&I9DA9=3(_83<WE!:&VT):O.QTSY9/]HYH]$,!_^*+09WZ,T,MW
MD<Q PUCL;>RM@?,M(IG 5/0^9PW#:#L.\RRB354) 1 183>I%8,5G WEA)DD
MX;;FD\TKT^6DE*\^VKE544S(U)(FRE34=Y]>I)ZF1'TZ#$-?R-CT7DW.W&SD
M'GN'"/FE3GW9K:2Z[P&D(HJ<0SML_;U1O[1WG\+33PT6O#%%%Z/4!%L[,&_[
M%8?_ *K8_P#Z)B#8C9_[I%_-M_BA>63._P#/+S[KF^N.7:1R5U2 B B B B
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M#T\!%..(G?XA(+2=["-I(<M_'=$Y_P#Y\.7O8YR1IU]A^"&^V =NUP/87@
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M\/RSU7_ZOD/ZPG]1WA5^Z!Q<_P#3_J?\4@^)VD?P5C?>T/L$_/OSP_+/5?\
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M.13&2<[M'1R .8[56)!!%00;^WJ".D'I"UQ(H.O2X@(@(@(MB5Z=O["G$O\
M0+KC^CD(7NT)^)F+^XHOX@7FZ[R'Z?-8?W@O?KSEF6,L4*("("("("("("("
M*N%\1;J%NWU#H;>42,1S<)SRZUQ</ME]M749Y2JO:QR3_AC5UIA+C;9_Y+D\
MR_RO" ^?&+$N+LLRT>/#,Z)WT,C>(5\ ,9 \+O"ME_R;&LG6>LM0:#F=[1?8
M^.\C!W"2TD[)X;\\^.Y!/6(O LS_ $/O[NG4O^M.U_UCY&,MY/?B':_SDWUU
MZA'OV_\ <IF/N2P^\H5+<)/5/D!$!$!$!$!$!$!%0O\ 6A_O+>27_@[^H/5@
MI9S:_2#D/]1][0KT"=R+_M@TQ_YC_P!6OU%T(X5K$!$!%;^^'1DL*XT;TB)>
M;5*8WFB2\P2B-UMB5@&*-1GEH^5+;[D-U*3^0S;5_@%IN0SFG3UZROC"]K3P
M&)E/V#Z"TU?*3Q2#FA@)B#V3L!P@]!+;NX+@/" YI/FCK5A<3HM<B B B BA
M5]4;TH<7Y<4]SN;34&OQCDQ55[3CS9.,5U#M^#5QUMM4>1+5Y46!F"8J4,UU
MNX:4J)MN+,5Y'E/PXCYC\M+?5$3\MB6MCU"UO@#9P!Z5W0'TV,>>H-?XM',O
M#W4^]SE>3U[!HG6TDEURNFD(!H7RXYSS4RPC:Y]OQ5=-;BI'$Z6$=IQQS4KL
MDQO(,.R"ZQ3*Z6SQS)L<LYM+?4-U"?KK:GMJY]<6=76,&4AN1$F1)#:D+0M)
M*2HA4>XMY[6=]M<L='<1N+7-<"'-<#0@@[00=X6\'&9/'9K'09?$3Q7.+N8F
MRQ2Q.#XY(W@.8]CVDAS7 @@@T(7"CXKG("("("*Q9Z7WK,6>J2QWCYRUNYMW
MK!OW:GP7<$]4RRR#7;)))B%0YHYUDS+W!V"2AN++2E4RI3["_.ADV4.>>7/-
MB3&]G@]3O+\=L;'.:ET70&R;RZ/H#O3,W&K*<&MGO5=R>UU:;GF-R?@9!JH\
M4EUCF<+(;P[W2VP\5L5T=KI(R1'<'QF\$W$9[;=99UMW70+BFL(-O46D2/85
MEI62X\^NL8$MI#\2; G17'8TN)*86E;;K:E(6@R,C,C%GHY(YHVRQ.:Z)P!!
M!!!!V@@C80>@A:?+JUNK&YDLKV.2&\B>6/C>TL>Q[31S7M< YKFD$%I ((H1
M5?</VO@@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(M9WO'_?5N#]*.P/Z66PU[YC_F]U]TR_QW+U"Z#_ !'PW]E6GWO&
MO+AUJRM 1 17!/AT_P!F#=_Z>G?U>X6+4<A_Q<O/NW_PHUIF^4F_2K@O[OC[
M\N581$Y+70@(@(@(@(@(@(@(@(@(@(@(@(@(OCL)\2J@3K.>\4:!6PY,^;(4
ME:TL1(;*Y$EY2&TK<433+:E&22-1]/ C,?E[VQL,CS1C023U ;2OM;V\UW<1
MVMNWBN)7M8T;-KG$!HVT&TD#;L6L2R:\D9/DF0Y++)92\AO+:\E$XZ3ZRD6T
M^1/>);Q-LD\LG)!]5=B>X_'H7R#7=<3.N;B2X=Z:1[G'S7$G_*O4YB["/%8R
MVQ<-.QMH(XFT%!2-@8*"IIL&ZIIUE<&/@N<@(@(OT::=?=;88;<>>><0TRRT
MA3CKKKBB0VVVV@C6MQ:S(B(B,S,^A#^@$F@VDK^/>R-ADD(:QH)))H !O)/0
M!TE;*;C;K$M+<?-):E-M#<C76J\$Q"Q[#2HG[>CQJN@W4Q2D$3:W9ULT\\LT
MD236X9D1%T(; L!CO@C!V>,]5;VT;#]$U@#CY[JGSUYB>9NJ?COS%SNL 28\
MEEKJX9X(Y9GOB;MVT;&6M .V@%=J]K';K!D!%3T^(CUV[1\G=/;+:92U7[ T
MU^#ZUD2NLB]U_EERY8O*4?LF::;,:QOH7R$CJ?RBJ_/:P,.HK3( 49/:</FN
MB>ZO\&1@6YSY-[4C+_E9FM+O=6XQV;[8#JBN[>,,'NEM.?/\"KZB#5L40$0$
M0$64'";.DZTY?<9LW>=\B%1;PUJY;.^/5%%.RJLK+XT]%)ZK^99KY%U/IU^7
MP&1Z0O1C]4XZ\.QC+R+B^A+P'?P25%?// '5')K5."8.*>XP-Z(QURM@>^+_
M &C6+8ZB^Z\T: B B B B B B B B B B B B B B B B BC4]7_ "I.)>G3
MR1F>827[>EP_%8K9D@U/JRG8V(4<IM!.)4GJW6S7W#^0R2V9I,E$0C[FG<BU
MT'D'^J<R-@_=RL:?F$GSE9[N:XDYCO)Z9AI6.&>YG<=NSL+.XE:33K>UK>JI
M%=E505%)EZ$D!$!$!$!%LBN(>M'-.<6N/>L)+1L6.&:@P&HNVU%VG^$:<<@/
MY*YV=5>63U^_)62>JNTE=.I].IW\TMCSB=-V..<*20VL;7?1\ +_ .$2O,QS
MCU0W6G-?4>JHCQ6U[F;N2(_Z'MGB$5Z:1!@KLK2M!N618[Y1L@(@(L"_5!_N
M_N5/Z+I_^DJP85S&_$?)?<Q_9"L#W5?^XC27]JL_B/6O>%&EZ+T!%L[,&_[%
M8?\ ZK8__HF(-B-G_ND7\VW^*%Y9,[_SR\^ZYOKCEVD<E=4@(@(@(@(@(@(@
M(JZ/K#^E6K;$:^Y6\;\;<>VG"9.PVQK>BAM=VQ:V*RM4K-<;@QTH<>SZ R@C
MFQ&R6NZ83YC9>_(-$Z!N:O+4Y-K]2X".N2 K-$T?30-\C /Y4>J;_*#:/'%'
M[)^YAWM!I&6WY2<S+D#2<CN#'WLKC_0WN(X;:9QJ!:/)]JD) MG'A<>P<#!4
M8%7EN)0$0$0$7[Q)<J!*C3H,F1#FPY#,N',B/.1Y465'<2]'DQI#*D.L2&'4
M$I"TF2DJ(C(R,A^FN<QP>PD/!J"-A!&X@]!"^<T,5Q$Z"=K7P/:6N:X M<TB
MA:X&H((-"#L(V%7(?2-]52+R+J*CCER$R)IG?]+%5&PO+;-3<=O<5%7Q?,)B
M5)-26E['J8K*SDH,D*M(R/>4=[Z9(M;ROYE-ST3<!G9 ,XP4C>=G;M Z3]5:
M-_KP.(5/$M+'?$[I<O+:\FYE\N;8NY>3OXKFW94G'2O=2K6[Q92.(X#M$#SV
M3N&,Q*>T36M?2 B BUK')F#&K.2'(*MAH-N)7;NVO!BMJ6IQ2(T3/+Z.PA3B
MS-:S2TV1&9F9G]D:_=0L;'G[Z-GI&WDP'F"1P"].W*ZXEN^66G;J8UFDP5@]
MQW5<ZTB)V#=M*\1'3K.ELFN*O[+_ !O_ $":?_5[CHV :;_%VP^XH/K35YD.
M;7Z5=3?W@R/WY,O>QW2CY 1 1 1 1 1 1 1 14$_6 GR++U'>34B2:#<;O,$
M@)-"207N]5J? JN(1D7RK*)#02C_ ,I74_LBDW--[I-?9%SM_'&/.$,8'S O
M0GW-+>.V[M&EHXJ\)@NG^?)D+M[OX3C3J&Q1K"/E9U 1 16BOAL?_K/_ /LZ
M_P#SU%C>[_\ _5O_ ,+_ /F%JG^4X_\ X(_\X_\ TI6BQ8U:IT!$!$!$!$!$
M!$!%AWZ@.F2W[PSY$:R9A^_6]EKBYOL7C)0E3KV88236:XG'96HC-E<V_H([
M"E%XDVZHO$C,CQ77&)^&])W^. XI76[G,'S\?MC!Y[F@>85-'=WUM^;WG9IO
M5+W]G9Q9..*=U=@M[JMM<$]?##,]X'6T*LM\.]^VKL_^RYFOZV-)BO/(G\;K
MG^S9/KUNMHWRD'Z#\5_>NV_Z?DU<M%L%I10$0$0$0$0$0$0$0$6N,YQ?MJ\O
M_P"U'R _6QEHH3K'\;LK_:5S]>>O2UR(_0?HS^ZF(_Z?;K%T8VI60$0$5RWX
M=[]BK9_]J/-?U3Z3%L.1/XHW/]I2?6;=:4?E(/TX8K^ZEM_U#)J>@34M?J B
M B B B B B B B B B B B B B B B B B B B B B B B BCLYE>F)QAYFP
MY]ME>,IP/;#K!IK]OX-&C5^2F^A"RCIRJO(FZG-X!.&DEIG(.8EI'EQY4<C,
MQ@FK.7>G=6,=+<Q]CDZ;)XP ^O1QCTL@^B\:FQKFJR/)3O3<T^24T=GB+HY#
M2 =X^.NG.?!0D5[!^V2U?2M#$>S+CQ2124HJ@'-?TVN17"&U<FYQ3(S#5,R?
M[GCVX<2C27\5F+>=<3!K\CC+\R9AF0R64D91)AFRZON3%D2B;6LJLZOT!GM'
MR\=XSM<874;.P$L/4'C?&X^M=L.WA<ZA*W+<C>\WRVYZV@@P4YLM6LCXIL=<
M.:)V@ <;X7"C;F%I_E(_&:*&6.(N:#'X,&5B4!$!$!$!%DOP_P"1^1<3^1>L
M=Y8^N2ZSB601T9741E)ZY)@MJ95V98\:'%ICJ>LJ&0\45;G<F/-2R^1=S21D
M.E<_/IG/6^9@J1$\<;1ZN-VR1O5M:32NYU#T*+^<W+/&\W>6N5T'D0T/O+<F
MWD=_(W4?CVTU1MHR4-XPVA?$7QUH\K8SX_?4^54-)E&.V$>VQ_)*BMOJ.UB&
MI46SI[B&S85EA&4I*%*CS84A#B#,B,TJ+P%]()HKF%EQ X.@D:'-(W%KA4$>
M @U7FKR./O<3D)\5DHW0Y&VF?%+&[TS)(W%CV.\+7 M/A"Y<?5<-<=;U<*\J
M;.DLF2D5UQ73:N>PHDFEZ%81G8DIDR42DF3C#RB\2,O$?.6-DT3H9!6-[2"/
M 10_,7)L[N>PNXKZU/#<PR-D8>IS'!S3YQ *UD^>XC88!G6:8';$96F$Y9D>
M(V1*2:%%88W<3*:81H/J:#*1"5X?8&O.]M7V-[-92_3(97L/FL<6GYH7J0T_
MF+?46 L=06G^Z7UG#<,Z?$FC;(W;YC@NICBKMT!$!$!%:.^&_P X0;7*C6SZ
MS):5ZOSBJ;(D=JD*3F-#D"UJZDX1I-%822(E$?577M,B[K'<@KP4R6/=O]ID
M;_M&N_S%JE^4QP)X])ZGC'BTOK60[?\ [M+"!T=,]=QV#?T6AQ8Q:J4!$!$!
M$!$!$!$!$!$!$!$!$!$!$!$!$!$!%3E^(@RY-IRSU1AS+A.,XEH:KL)!$1$;
M%KE.<YJJ1'5UCH6H_FNEA.=Q.N-]'2(B0HE]U4^>UUVFI[:T&Z*R!/FODDJ-
MW4UIWG?T;5ND^3?PYM.4&7S3Q1]YJ"1@\,<%K;4.\CT\LK:<(/BU)(+:0""$
M5L,0$0$0$4L?HG:S<V+Z@^K)ZX_O-9K&ASK9EL@T*43;=9CDK&J20:B2HF_=
MLMRJN61GT(U)(NO4R$F\H<>;_7-L\BL=NR25WG,+&GSGO:54/ORZH;IONZ9:
MW:[ANLK<6ME'MWE\S9I1X>*W@F%.HUW J]D+FK06@(@(@(JCOQ&LEA6\^.L1
M+S:I3&I\CDO,$HC=;8E9@XU&>6CY4MON0W4I/Y#-M7^ 5?Y].'PS8-KXPM7&
MGFOV?L'T%N'^34BD&@M2S$'LG9>%H/02VW!< >L!S2?-'6JY@@5;*5-_\/\
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MWT=^*.*_LVV^LL7FEY[_ *<-9_WKR_\ U"X648R-12@(NI9W@F'[/P[)-?;
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M=2\ZKM;3D.0T$O&\9)71;:E$YD%O&3VI4E2NO0C(S(8SK.^&-TGD;RM'-M)
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MIBIS"!%:-RWKF4-DI*53(K?D>>U#MSRTYCQ:HMVXG+/:W4,;? !.T#TS>CC
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M#_\ O%]2?ZK[7_5OD@E#D]^/EK_-3?6G*GW?M_[;,Q]UV'W["KU N4M"" B
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MZ7MHV^33M'SU8HYG^&<'I*F@$M*D: B B B B B B B B B B B B B B B
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M+>#BBMFN'2R:<RO'3Q6HZ-]L@6:6H9 1 1 11C>LE/D5WIL\EI$8TDXY#U=
M4:TDLO=[3=FMJR61$?R*.+,623_R5=#^P([YKO='R_R#F[Z0CSG7$0/S"K2]
MRJWCN>\WI>.6O"'WS]G7'C+U[?X317K&Q4(Q2E>@M 1;,31W^Y73_P"B[7_]
M$ZD;",-_RBU^YHOXC5Y>M>?CQF?[6N_OB1>HCLEBB B B B B B B B B_BD
MI4DTJ(E)41I4E1$:5),NAD9'X&1D&]?T$@U&PA4_/6"]*]6D+"\Y2<>,?/\
M(S;2_?\ 9^$5ZC<5J^]M9Q-JOZ*%V$M.OK>;*02V$*7\T2G.U))A+;3%JQS4
MY;? [WZCP4?_  EQK-&/Y%Q/IFCZDXG=Z@G9XA'#N7[F7>R&N[>#E1S(N/\
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M^G&-)J=K67MX6BF[87NV@5-=M:"E@<3@M=J B B B B B B B B B B B B
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M[/YGF+43\IAB6PZGTIG0VC[FPO8"[9M%M+!(!OKL\J)VBGC;"36EE(6 6L5
M15I_B)N/Z[?"=*\F*:!YDG#[2?J?.);2%+>^8,D-[(,*DR3(NC,"HOH=FP:C
M\#?MVT_*9"OO/?!F6SL]0Q-\:)QAD/SK_&C)\#7!X\UX6S[Y-SF(VSSN<Y7W
MLE(KV)F0M6G8.UAI#<M;UODB= ^GK;=QZ%5"%9UMR0$0$0$7KN@-J3M';QU'
MN&O)UR1K38N(YFY&9_ESX5#=PY]G5F7>WW-6M:R[&<3W)[D.F74NO4=K@\D_
M#YBURL=>*WG9)3K#7 D?NA4'P%8=S#TE!KS0>8T7<T$>4QMQ;!Q]0Z6)S&2;
MCMC>6O!H:%H-"ME356E=>5=;=T\R/8U-Q AVE781'"=BSZZPCMRX4R,ZGV7(
M\J,\E:%%X&E1&-@44D<T;9HB'1/:""-Q!%01X"%YB+NTN;"[EL;UCHKR&1T<
MC'"CF/82US7#H+7 @CH(7WC]KCH"("("("("("("("("("("("("("("+C;F
MXK,>J+6_NIC5?3T=;.N+:>_W>1!K*V*[-GS'NQ*U^5&BLK6KH1GT3X$/G++'
M!$Z>8AL3&ESCU "I/G!<FRL[K(WD./L6&2]GE;'&P;W/>X-8T5V5<X@#S5K/
M]N;!G[9VMLO:5J3B++8^?9?G4UMU9N+9DY7D%A>NL&ON5U)A4[L+H?0B21%X
M#7QE+Y^3R=QDI/IEQ.^0^:]Q=3SJKU":.T[;Z0TEB]*6E#;8S'V]JT@4!;;P
MLB!\_@KYZ\\' 61H"("+^I2:C)*2-2E&24I21F:C,^A$1%XF9F/[O0D 5.P!
M;#WT[>/2^,/#K2>J[&$4+*VL81EN>MJ:0U*1G&;O.9/D$":I"E%(?QYZR35(
M<Z^TQ ;^0NA%>O0F".G=*6>-D%+D1\<G7VDGCN!Z^&O!7J:%YP>\CS';S4YT
M9W5EL_M,0;HV]H:U;Y+:@00O;7<)@PSD=#I7+-<9<H-0$0$0$5-?XB)]]7,[
M5D93SJHS7&'$'VHYN+-AI^1M7<K<AYMHS\M#K[<5I*U$1&HFTD?7M+I5#GLX
M_&RV;4\(QS#3S9IZ^C0>@%NL^3>C8.266E#1VIU5< FFT@6&-(!.\@%SB!T5
M--Y4"0A1;!%,MZ#W]X#COZ+ME_Z-AB6.2_X\1_<TO[ 5*._]_P!N]S_:ME_'
M<KOXN$M$R B B B B B B B B BQZY0<9-5\M]0W^F]MT_SA16O2?3VT7RVK
M[#LHBQY+%1EV,S5H7[E<U?O;B2ZDIF1'==COH<8>=;7T6HM/8W4^+?B<HSBA
M=M:X>FC> >%[#T.%3X""6D%I(,C<J^:6K>3VLK?6NCYNSOX?$DC=4Q7,#BTR
M6\[13BBDX0>AS'M9)&6R,8X4%.7_ !'VGPPW'<:CV=$1()"#M,.S& P^WC^>
M8H\\XW!R&E6]W*:5W-FS,B*4IV%+0MI1K(D.+I-JG2^2TEE7XO(BO3'( >&1
MG0YO[#F[VNJ-NPGT)\FN<.D^=NBX=8Z6>6U/9W-L\@S6EP "^&6F_?Q1R !L
ML9:\ $EK<6AC:E= 1 1 19[^G_SVV3P6VQ'R2D>G9!JK)I<&)M;6IOE[GD=.
MTOR_GBF;?<;C5^:4;#JUP)75!+\8[RC8<60S;1&M<AHW)BXA+GXV0@315V/;
MZYM=@D;O:=GK3XI*K[WA^[[IGGWI!V,OFQVVK;5CW6%[3QH9"*]G(0"Y]M*0
M!+'0TV2,':-:5?*TKNK6O(76N,[:U+DT+*\(RN$4JNL8I]C\5]'L3JBW@KZ2
M:F\J9)*9EQ'DI=8=2:5%\AG=+$9?'YW'QY3%R"6SE%01O!Z6N&]KFG8YIV@K
MS^ZXT/J?ESJ>ZT?K"U?:9VT?PO8[:' [6R1N'BR12-HZ.1I+7-((*P*]:1II
MSTU>1JW&FW%L.:>=84M"5*9=/>^L&#=:4HC-MPV'EH-1=#[%J+Y#,85S; /+
MZ_)WCL/OF%6"[D+WM[SVFFM) <,B#0[Q\%7QH>L5 -#T@'H5#,4L7H"4MOH?
M_P!XOJ3_ %7VO^K?)!*')[\?+7^:F^M.5/N_;_VV9C[KL/OV%7J!<I:$$!$!
M$!$!$!$!$!$!%%;ZU<^/#]-GD#'>-9.6LW4,"(24FHCD-[LUW:*)P_\ (1[K
M6NGU_P#:(B^R(VYN/:WE_?-.]Q@ \WRB(_L JV?<=MY)N\WIV1E.&)F1>[S#
MC+QFSK\9[?.J50\%+EO]0$0$0$6R+X@6+%OQ+XNVT9+J(UIQUTG8QT/I0E]#
M$W6F,R6DO);6ZVEU+;I$HDJ41'\AG\HOYI:02Z8QTK:\+K"W(KX8F%>9CG+;
M/L^;^J[.4@RQ:DR;"1N);>SM-*@&E1LJ!YBR*'?*-D!$!$!$!$!$!$!$!%0*
M]76$U ]1GDZPRJ(I#F2XA-,X1I-DG;+6>$V+Z5FE""][0_*44@NG4GR61F9]
M3.DG-%@9KW(M%*=HP[/##&3Y]3M\-5Z&.YS.^X[M6EI'\8(M;AOC;Z,OKI@I
MO\6C1P?.<-*;E&^, 5F$!$!$!%L3/3P;6WP6XE)<0M"CT'K1PDK2:3-#N,P'
M6ED2B(S0XVLE)/Y#29&7@8O?H4$:-Q=?M&+^(%YN>\>YKN?>L"T@CXPWH\\3
MO!] [#X5F2,K4*H"("+P_DKNVDXX:$VOO'(":=@:WPRVOX\)Y?EHM[PFTPL9
MH27WM]CN0Y)+B06S[D^W(+Q+Y1T^H,Q#@,)<YB>G!;Q.<!ZYVYC?W3RUH\U9
MWRPT+?<S.8.(T'CJBXR=['"7 5,<5>*>6E#LAA;)*=AV,.Q:WC*LGN\URC),
MRR:>[:9)EM]<9/D%F^?5^QN[ZPD6MK/>,O W9D^6XXK_ !J%!+FXFO+F2[N'
M%UQ*]SW$[RYQ+G'SR25Z9<3B['!XJVPF+C$6,L[>."%@W,BB8(XV#P-8T >8
MN!'P78*_5Z1NB5:%X'Z9JY\$X.3;(@R]R96E;1L/.3]AJ9L,?*2PHB=8EP<"
MCT\1Y#A]Z78RNI)_D)NSROPWP+HNTC>*7%P#._S9=K:CH(C#&FO2/.7GM[X>
MOAS!Y_YN[MY.TQ>,D;C;>AJ RSJR;A.XM==FYD:1L+7BE?3&2L2"JPH"("("
M("("("("("("+QKD/IZFY Z,VOI:])E,#9.#9!B[<I\EFBKM)\%WYBO$DV2E
M&]0WB(TUOV5%YC">J5%U2?4YW%19S#7.(FIP7$+F5/02/%=^Y=1P\(6:\N-9
MWO+O7N(UQ8<7E&,OX9RT4J^-CQVL6WHEB+XG;1L>=HWK6T9'CUSB60WV*9'7
MR*G(<9N;3'KVJEH-N56W-+.?K;2ODMGXHD0YT9;:R^PI)B@-Q!+:SOMKAI;/
M&\M<#O#FD@@^$$47INQF1LLQCK?+XV1LV.NH&312--6OCE:'L>T](<UP(/45
MPP^*YJ B BL@?#R<CBQS9NUN+]Y.\NMV/4(V9@C#[R4,IS'$6&Z_*ZZ$T:R6
M[/R#$769:^B3(F*%1]2^S/O(K/\ D^1N=.3.]KN&]K&/](P4>!X7,H[S(UK.
M^4=Y:'):6Q'-6PCK<XR8V5T0-ODUP2^W>X]#(;@.C&W:^[&_HMJBSJU ("("
M("("("("("("+&KF?8/U/#SE?:Q2;.36\:MZV$<G4FMHWX>KLIDLDX@E(-39
MN-EU(C(S+[(Q_5LCHM*Y.5OIFX^X(\T0O*D_DE;QWG.?2-I+7LI=3XICJ;Z.
MOH&FGAH=BUOXH*O3"@(@(@(MB5Z=O["G$O\ 0+KC^CD(7NT)^)F+^XHOX@7F
MZ[R'Z?-8?W@O?KSEF6,L4*("("("+$#FSPVUKS:TK;ZMSIEJLOHJ)5KKC/6(
M;4FXP++RC&W$M(O<;;LREFJ2AFT@>8VB=$]DEMO(8?9Q;5^D\?J_$.QMZ V8
M5=%(!5T;Z;".MIW/;4<3>D$-<)EY&<ZM3\C-<0ZKP#C+CWEL=[:%Q;'=V_%5
MS';PV5NUT$M"8I-M',=)&^@1OG1>Q^-VULNTWM:C<HLRP^P5$EMD:G:^T@ND
M3U7D%',-#:;&BO(*T2(KY$DU-K(EI0XE:$TCS6&O\!DY<3DV<%W$ZAZB.AS3
MTM<-H/5OH:A>AGE_KW3/,W25GK724XN,+>Q\33N?&X;)(96U/!+$\%DC=M'"
MH+FD./D ZI9D@(@(ONK+.QI;*ON:>?,J[:IG1+.KLZ^0[#GUUC ?;E0I\&6P
MMM^+,B26DN-.(4E:%I)1&1D/I'))#(V6)Q;*UP((-""#4$$;B#M!7PNK6VOK
M62RO8V2V<T;F2,> YCV/!:YCFFH<US20X$$$$@[%> ])WU**[F7K[\FNSK&#
M!Y(ZZJ8_S\VI42$C:&-QTMQ6\_I(+1,(19LN]K=W$8;)F/(<;?:)#,E++%PN
M6?,"/5EC\'Y%S6Z@@:.+<.V8-G:M'7T2- H"0X4#J-T2][ONQ7/)34?QGTM%
M))RRR4Q[(^,XV,QJXVDKC4\!%3:R./$]@=&^KXB^28<2HJ8("("("("("("(
M"("("("("("+!/U.)4B'P#Y5NQG5LN+U-<Q5+09$9QYTB%"EM'U(_8?BR%H5
M_P E1C#.8CG,T1DBTT/DKAYQ(!]$&BGWNM11S=X;23)0'-&8B=0];0YS3YS@
M"/"%KUA1A>C- 1 1 1; STI;/YV]//BY*\CW?RL"G5GE^9YO=\RY;D=/Y_=Y
M;?3WGW#S.WH?9W]O573N.\/+23M-"XUU*4@(_>O>WYM*KSM][>U\C[QVJXN+
MBKD&OK2GTVWADIO/I>/AKTTK05H)"1G*KF@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(M?/ZIDN3-]07E,]*=-YU&R5Q$K422,HU?0TL"&UT0E)=&(D9""/Y
M3)/4S,^IBCG,A[GZXR1<:GRBGG!K0/0 "]%?=0AB@[NNDV1#A8<9Q?NGRRO<
M?/<XGS]BP"&$*PJ B BM1?#<6+3M!R\J20X3T*XTC8N.'V^4MJTA;5C,H1T5
MW^8VNG6:NI$712>AGX]+)\@9 8,I%TM?;G]\)A_FK4W\II;/9D-&WA(X)(<F
MP#IK&ZP<2? >T%/,*LYBPZU9H"("("("("("*,[U%_38UGSIPIRTCI@89O\
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MF[[P'-";G!S9R^M@7?!DL_96C37Q+.#VN#8?2N>T=M(WHED>LP!E2AE 1 1
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M$L<E_P >(_N:7]@*E'?^_P"W>Y_M6R_CN5W\7"6B9 1 1 1 1 1 1 1 1 1
M18B\TN&VK^;6G+'5NPV?FRUBK>M< SV##CR;_ LI)GRV;2O\XVSF54TDI9LH
M!N-MSHWL][;R&'V<7U;I/':OQ3L;?#AE'C12  NC?UCK:=SVU <.D$!PF+DA
MSJU7R,UI%JO3;NUM'@1W=HYQ;%=P5J6/I7AD;M=#+PN,3]M',=)&^@OR-XZ[
M2XL;9R/3FWJ%RDRBA<)^));[W:;)\?DO/MU.5XQ8*0VBTQ^Y1'6;3I$E;;B'
M&'D-2&7FFZ3Y_ Y+3>3DQ649P7+-H/J7M->%[#TM=38>@@M(#@0/0CRTYDZ3
MYLZ0MM::-N!/BK@4<TT$D$S0#);SLJ>":/B'$W:'-+9&%T;V/=X8.E6>H"("
M("*2?TX/44S[@KLE+3RYV4:'S2VAGL[7I.]ZF#43$)6=8>AU:68.95,%M)*3
MU0Q:QFDQI!I-,:1%D'0.O+W1F0H>*3"S.';1=6X=I'U2-'G/ X7;FN;6/O,=
MVW3W/S3)>P1VG,"QA=Y#>4W[W>2W--K[:1Q-#M= ]QEC!!ECELZ>JAL3"]U>
MDUN[9&J\@@YOA674^G[V@O:-3DF/,KFM[ZR>F+<:[$RH4FK]V>1-COH;?A.L
M.MOH;6VM*;#\R;^TR_+*\R&->)K.5D#FN;M!'E,-?""VAX@0"T@AP!!6K/NF
MZ;SFA^][@M,ZLMI+#.6<V1BEBEHTM><5?!H!KPN;)Q-,3V%S)6N:Z-SFN:31
MD%-UOH4MOH?_ -XOJ3_5?:_ZM\D$H<GOQ\M?YJ;ZTY4^[]O_ &V9C[KL/OV%
M7J!<I:$$!$!$!$!$!$!$!$!%$%ZYMBQ"]/'8L9U+JG+C.-6UT8VTH-"'VLSK
MK92GS4M!I:.-5N)(TDH^\TETZ&9E%O.21K-"SM-:OFA \WM [;YS3YZN5W"[
M:2?O'XV5A ;#87[W5Z0;9\>S9OXI =M-@.VM :,XINM\R B B BV./!Q25<*
MN(!I,E%_5>T"GJ1D9=R=4XFE1=2^RE1&1_X#(7WT=^*.*_LZV^LL7FFY\ CG
MCK.OY5Y;[_N%E(,C44("("("("("("("("+7Y^JU:Q[GU#.4<N+U)MG/(%4K
MJI"C]XHL1QNDE^+:EI(CEUZ^A=>XB\%$1D9%1_F7*V;762>W<)@WSVL8T_-"
M]$G=(M)++NXZ4AE],['ODZ=TMQ-*W?\ .O'@/14*/88*K&("("("+99<=<,?
MUQQ]T5KR4TIF3@>G-8X9(97WDMI_%\)I*-UI9.+<<)3;D$R/N4H^I>)G\HV"
MX&T-A@[*P<*.@M(8S^XC:W_(O,)S)S<>IN8N?U)$0Z+(9J^N01N(GN99010
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M:X':""-A!Z"%JER&.O\ $WTV+RL$MMDK>1T<L4K'1R1O::.8]C@'-<TBA:X
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M#Z4$L1H^"=HZ&S0N9*T;P'T.T%>YCN5@2 B B B B B B B B B B B B B
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M"([B$G=)&2=A\5["^-X+'N:;_G%#E+K#F#IG'-R:OL"5!M&_<LCQJ5(8<O\
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M:",O/AIN:/GG&C6CI<0%EFA=&YGF%K#':)T^SCR^2NF0Q["0WB/CR/IM$<3
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M_FJI7?DMFS]V74$I)!AEQ[QX2<E:1T/G2$^: KWPN>M B B B B B B B B
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M7+Z7F9SLP&FC'VF.;>LNKK95HM;0]O,'[P!*&"$$[..5HZ5KQA15>CM 1 1
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M?)Q-/!=W;:216K:^*]C/%ENAM C[.)P_I#2(5/0(T'^4GEO>[BLX7O&/\?\
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MMYN/%B18[:GI$F3(>4AIB.PT@U+6HR2E)&9F1$/RYS6-+WD!@%23L  WDGH
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M?V-GE+&;&9&)D^/N(GQ2QO <R2.1I8]CVG8YKVDM<#L()!5^KTT^==!SAT/
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MJ.86=U'<%QFOLQ>3GBWCM;B1X&S8.$$- &P  #8 O8QVJPM 1 1 1 1 1 1
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M?=5Z\M67&9EBN0T:EU^89;%4J/6(3VR8D1;LXE,K*$MZ&N;.O&X&P.!Q;_\
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MG^3&J\/&*SS:>OPP=<@MI'1]#MG:-;6@)IZ7;0K8[B^Z\T2 B B B B B B
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M#YUS2'-/40O1YH'6^!YD:.Q^M]-2=IALC;B5E?3,.ULD3QT20R-?%(-H#V.
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M&6U*49)(S+FXK'39;)V^+M_IUQ,R,> N<!4^ 5J? %CVM-4V&B-(Y/6&4/\
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M=).]Q<YSB2YQ.TDD[23TDK:;C\?88FQAQF+@BML;;QMCBBB8V..-C11K&,:
MUK6@4#6@ #<%Q(^2Y: BEZX >D1NOF!)IL^SUJTT]Q\==:E.9A90O)RS.H"5
M$IR/K:DL&5)?CR4EV%<RV_FUKN-3*9JVUQQ*6B.5V7U2YE]>\5K@R:\9'CR#
MJB:>@_5'#@&\<9!:J;]X?OCZ&Y,Q3Z>T\8LUS% +1;L=6WM7]#KV5AV%N_R:
M,]LZE'F!KFR*YIH7C[J/C-KFIU9IC#J[#\3JB)UQN,DWK.\M%LM,R[_)+9[N
MG7E[/)E/FR7UJ5VI2V@D-(0A-LL)@\7IZP;C<3$V*U;U;W'I<]V]SCTD^8*
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M)_\ +R?5?.KXWS,)Q&G+228N(JTW-RU]O;QGP\+IYFGH, KM(5*(5$6\= 1
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M+.Y'F,?,FMDED[,24CJ1JBWE_#@UJ^GR%,Z_(0S+EOAOAS65E;/%8(I.V?\
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M3F'SCM'6>#MGMFML;,*3W,C2"Q]W$=L,#7#B,$@$LQ $C&Q5$M3(5C6WM 1
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M5Q _LN<?_P!4^)"^^COQ1Q7]FVWUEB\TO/?].&L_[UY?_J%PLHQD:BE 1 1
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M>9)"72.)))-22=I))VDD[RMA,$$%K RUM6,CMHV!K&- :UK6BC6M:*!K6@
M   "@V+Y1^%]5_I"%NK0VVA3CCBDH;;0DUK6M9DE"$(21J4I2CZ$1>)F/Z 2
M:#>OXYS6-+G$!H%23N ZRK$WIO\ HF93LR51;GYATEGAVLR*-:XWIR2[)J,U
MSQ!^6_'DYHEA;-EA6*NI/H<3N8N99=>I1&^QQ^=] \H;G(N9EM5,=%C]A9 :
MMDDZC)3;&SYW9([YT4)UN=YCOS8G2\5QHCDQ/%>ZH\:.;(M#9+:T.T%MM4%E
MS./JE'6T>SZ<[B:RVU2TM/C=/58]CU574=#1UT.HI:6HAQZZJJ:JNCMQ(%;6
MP(C;46%!A16DMM--I2AM"22DB(A9Z&&*WB;! UK(&-#6M: &M:!0  ;  -@
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M#:1MHUC10 >9X=Y.\FI))*U*:@U#G-5YFXU#J6[GOLW=2%\LTSR^1[MVTGH
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M?RLK8FB*6('C>UD1B:]_&#;!I[FHR&L@W=!:UMY36<=$NMMZ>=%LZRPBN?\
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ME=&8\8K2.-L<9CA3VNV@CA:2-@+A&UO$[?5SJN))))))7GPX*R) 1 1 1 1
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MV\SZ*KRUF2O=K6.A?RFGP+I'69YLZTS#71"X;:V[M[8&\!]T)=(/.>/,5JM
M]R7D!H2:.]?C)<SDXR"),E)Y0VNS_P"6:V*T=M%1QP/(Z#OK%A+ERI\J3.G2
M9$R;,D/2YDR6\Y(E2I4AQ3TB3)D/*6Z_(?=6:EK49J4HS,S,S$;.<Y[B]Y)>
M34D[22=Y)Z25;&&&*WB;! UK(&-#6M: &M:!0-:!0  "@ V ; OP'Y7T0$0$
M0$0$0$0$0$0$7-462Y'B\PK'&;^ZQVP(NTIU%:SJB82>BBZ%*KWX[Y%T49?R
MOLF/M#<7%L_M+=[XW];7%I]$$+@W^,QN5A\FREO!<V_K)8V2-_>O!'S%ZVQR
MBY,Q6&8T;D3O6/&CM-L1X[&W,_9888903;3++3>0);:::;224I21$DBZ$.T;
MJ/4+6AK;^]#0* ">6@'[Y8?)RIY72R.EETU@'2N)))Q]H22=I))AJ23M).]=
M?O=[;ORE+B,FW)M7(D/-M-.HO=AY=;I=:8=)]AMQ-A;R"6VR^1+01]22KQ+Q
M'PFS68N?]XN[F2OKI7NW>:XKL;#0.A,40<7A<3;%I)'96=O'0D4)'!&*$C83
MTC8O+%K6ZM;CBU...*4MQQ:C6M:UF:EK6M1FI2E*/J9GXF8ZTDDU.]98UK6-
M#6@!H% !N Z@O\C^+^H"+M^%:^SW9-PUCNNL(R_/L@?-M+-%A6-7.4W#RG5=
MC26JRCA3IKAN+\$D2#ZGX$.7:6-[D)1!80RSSGU,;'/=Z#02NGSFHM/Z8LCD
MM27]GC\<VM9;F:.",4VFKY7,:*#:=JEAT)Z&W-W<!PK+-J+&M"8Q(-+BYNR;
M9,C)W(BDEU7!PG&2M[5F6E9]/(M'*E71)GW%[/=)F$Y.:PRM)+QD=E;GIE=5
M]/!&SB=7P/+%43F#W\N16C..UP5Q=:ARK=@;91T@#NIUU/V<9;\_ +@;0*;Z
M3M\:/0MXAZ4=K[_:*;CD9F40V'^[.66:C7D>6PI*_-B:\JWWF;!EP^J7&+F=
M;QEIZ?:R\>LSZ>Y-:6Q!;/D>._NQ3Z9XL0/@B&_PB1SP>I4#YH=_;G)KEDF/
MTH8=-85]1_129+PM.RCKR0 L(WAUM%;O!]45,M24=)C-178_C=/5X_0U$5J#
M4TE)7Q*JHJX3">UB'75L!F/#A164^"6VD)0DOD(2Q###;Q-@MV-9"T4:UH#6
M@=0 H / %2F^O[[*7DF1R<TMQD)GE\DLKW22/<=[GO>2YSCTEQ)*Y0?1<1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 11\<PO3,XM\RX\VVSC$2P_:+L8VH.W<
M$1'ILN)U""3'_"-@FSJ,TB-^6A';9,/2&V4FB._'ZFH8-JKE[IS5C3+>1=ED
MJ;)XZ-?X.(>ED'T8) V-<U6+Y,]Z+FOR4DCL\#>>6Z4#JNQ]U62WH3M[$U[2
MV<:DUA<UA<>*2.2E%5XY4^B?R]X]KFWF 4Z>1FO6/-=1=ZTKI1YI!CH,R05W
MK-QV9?\ O"TD:O\ JARX80@NKCK9F217/4G*'5.#)FL6>7V(]5$#V@'ST6UU
M?H#(.LA;5^4O?EY-\QFLL-0S'36HW4!BO7M\F<>GLKT!L5!N_I MG$[&M=O4
M04Z#-K)DJNLH<JOL(,AV)-@SH[L29#E,+4T_&E17T-OQY#+B32M"TDI*B,C+
MJ(M>Q\;S'("U[30@BA!'00=Q5R8)X+J%ES;/9);R-#FO:0YKFD5#FN%001M!
M!H1N7RC\+ZH"+L.+9=E>#7<+)L)R?(</R2N6;E?D&+75EC]W 6?@:X5M4R8D
M^*LR^RAQ)CD6UU<V<PN+.22*X;N<QQ:X>8YI!'G%==EL/B,]8OQ><M;:]QDH
MH^&>)DT3QU.CD:YCO/!4FFH?6A]0#4K<:$_M>OVM31"(FJG;V,U^4N+/_*5)
MRFN.@SR::RZ%]NMG"+I[)$9F9R%B^;6M\8 QURVYB'J9V!_HO'#(?/>55S67
M<B[O&L'/GCQ$F(O7[Y,=.^ #Z&!_;6C:?.VX\-=E,^,.^(]VA"9:3L#C!@63
M2"09/.X=L+(<&9<7]MZ*:8NL>V(ME!=4=2-Q9GVJ\?:+MS:TY^9%@_IV.@D=
M_HY71_QFR_LJOF:^30TK.\G3NJLA:QUV"YLX;H@;-YBFLP>G;0;QLV;?8&/B
M1,14PRJ3Q+R-J2IILY#3&X:R0PT^:"-UMF0YKJ*X^TASJ25J:;-1%U-*>O0N
MU;S]M:#BQD@=3;2<'YO9"OH#S%ADGR9F8#W"+5]L8JFA..>"1T$@7C@"1O <
M:;JG>NF9%\2+;.M2&L2XCUT%\G'"BS\BW1)M6EM=JB97(J*S65,MMSN[5*2F
M<HNA&DE>/<7$N.?TI!%KBV@]!?.3Z+1"W^,N[QOR9=HQ[7YC6,DD=!Q,AQK8
MS7I D??2 C> 3$.NG0L/]F>OMSBS1B3#PN-J34,=SJF-/Q3"Y&0Y P@T$1^=
M,V!<991ON]YF9*16LD1="Z=2,SQ7(\[=8W8++06MJWH+(RYWHRN>W^ %,VE_
MD]N0^$>V;-NS&9D'IF7%R(82? VTCMY0/ 9G=.VFP19;CY);]Y!V"++=>W]@
M;*=9D.2H4/*<DL9U)4O/$2754>.^<W04*'"+Q1#C,(/_  "-\KJ#-YQ_:9>Z
MGN"#4![R6M^A;Z5O[D!6PT7RRY>\NK<VVA\-CL6US0USH(6,ED W=K-0RRTZ
MY'N/A7B0Z=9R@(LW^,GIU<N.6;T*5JS55K$PV6MOOV;G!/8?KQEA?3K)C7MC
M'-_(D,]Q&XU3Q[&0@E$9M]#ZC,=.Z#U1J<AV-MG"T/\ +2>)%3K#B*N\(8'G
MP*">:7>3Y/<H&/BU9EHGYI@/]"M:7%X2/4NB8:0UVT=</A8:$!U59CXB>A-Q
MSTH=5EV_IQ\A]A138EII[&(Y4:FI9B#2X2(^*$\Y-R\V%FIM3EN^Y"DH(E'7
MM*^2PFE^3.!Q'#=9L^7WPH>$CAA:? S>^FZKR6GU@*U><X^_US*UP)L/R\C^
M+>G'U;VC'"3(2M.RIGH&V]10@6[1*PU'E#PIR*^O@5,&'65<*)6UM?&9AP*^
MOC,PX,&'&;2U'BPXD=#<>-&8:024(0E*4I(B(B(3$QC(F".,!L;10 "@ &X
M#8 .I4.N+BXNYWW5W(^6ZD<7/>]Q<YSG&I<YQ)+G$[2222=I7UC]KXH"("("
M("+J.?YQCFL<#S;9.82W:_$M>XCDF<93/8B29[\+',3IIM]=RV8,-MZ9-=C5
MD!U:6FD+<<-/:DC49$.+?7EOCK*;(71+;6")\CS0FC&-+G&@VF@!V#:>A=QI
MW Y+5.H+'3&%8),QD;R&U@87-8'37$C8HFESB&M#GO:"YQ#6UJ2 %#-FOQ 7
M"''&W4XQ1[MV#*+J4<Z7"J6DKEJ)QU'61*RS*Z.>PT;;9+(T1'5='$D:2/O[
M(GN^=^CX 1;LO)W='#&UH\\O>TC]Z?,WTNS@_D[^>V2<#E9\%CHNGM;F65XV
M#<VWMY6$U--LC1L.W=Q8-;/^(ZRN2S)BZ8XT8]3/EW%#O=GYO99*ROKU[52<
M4Q2LQ-;7;X&9(N5]?DZE\HPW(\^[EP+<3CXV.Z'32%_HL8&?7%/.E?DT<1$]
MLNMM47,\?JHK&U9 1]#<7#[@'S[8>85%+O;U5.='(%F9691O"\Q'&)GFI<Q+
M5;36N:=49_O2[!ESL>\C)[F XVOM4S86,MM22\2/QZQIFN96LLX#'<WCXK<^
MHA]J;0]!+:/</ YS@K;Z [I?(7ET]EUBL#!>95E*7%^3>2<0W.:V:L$;P=H=
M##&0=RCR6M;JUN.+4XXXI2W'%J-:UK69J6M:U&:E*4H^IF?B9C!2234[U8YK
M6L:&M #0* #<!U!?Y'\7]0$0$0$7/XOEF4X/>0<GPO)<@Q#):MPW:S(<7N;&
M@O*YU230IV#;5,F)/B.&A1D:FW$GT/H/O;7-S9S-N+21\5PW<YCBUP\QS2"/
M.*Z_*XC$YVPDQ6<M;>\QDHH^&>-DT3QU/CD:YCAX""I3M+^MISUU$S#KK;/L
M>W-1PD-,M5VWL::NIY,(+M<[\MQV5C&8SY3B?'SIT^89*(C,C+J1R3B.;VM<
M6!'+/'=PCHG9Q']^TLD)\+G.53M;]QGN^ZQ>^YM,?<X2_>22_'3&)E3NI;S-
MGMF-'K8HHQ3JV$27ZX^(\J'$M1MN\8K&&M/E^=<ZXV!&L4O=3Z.^5C.3454<
M;RR+JGK;.]_7H?;T[CD&PY^1$<.4QS@?712@_P ![6T_?GSE5_4OR:%XTF71
MVJHGM-:1WEHYE.JL\$LG%7I_H[:;]M:#.?67KI<&]E7=#CBG-O83=9':UM)7
M1,NU_'?0NTM9:8,*.Y)PW(<N8;0[+<0GS%&2$DX1J-)$KMS+'<Y=&Y"9EO\
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MKG+-79 QX$.JRPM08;-FVHXHPXNG<T^E?</F>VIX'-!HLX1F*@A 1 1 1 1
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M>NO?=6_8T_Q#^?GU'3_O2;^MI_#_ '!7^>-]_2!C?XA!^9#1GKKWW5OV-/\
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M_P"])OZVG\/]P5_GC??T@8W^(0?F0T9ZZ]]U;]C3_$/Y^?4=/^])OZVG\/\
M<%?YXWW](&-_B$'YD-&>NO?=6_8T_P 0_GY]1T_[TF_K:?P_W!7^>-]_2!C?
MXA!^9#1GKKWW5OV-/\0_GY]1T_[TF_K:?P_W!7^>-]_2!C?XA!^9#1GKKWW5
MOV-/\0_GY]1T_P"])OZVG\/]P5_GC??T@8W^(0?F0T9ZZ]]U;]C3_$/Y^?4=
M/^])OZVG\/\ <%?YXWW](&-_B$'YD-&>NO?=6_8T_P 0_GY]1T_[TF_K:?P_
MW!7^>-]_2!C?XA!^9#1GKKWW5OV-/\0_GY]1T_[TF_K:?P_W!7^>-]_2!C?X
MA!^9#1GKKWW5OV-/\0_GY]1T_P"])OZVG\/]P5_GC??T@8W^(0?F0T9ZZ]]U
M;]C3_$/Y^?4=/^])OZVG\/\ <%?YXWW](&-_B$'YD-&>NO?=6_8T_P 0_GY]
M1T_[TF_K:SEX<< =!\&F,]1I9.8R9.QW<>7D=EFUW O;'R,81;E4P:]Z#2TK
M<2$AR\DN.)[%*<6HC4KHA)%F.E-$831PG&([4NN"WC,C@X^)Q<(%&MH/&)/7
MYR@;G3WAN87/E^/=K@V38L8)NQ9:Q/B96?L^T<\.EE+G$1, -0  :#::YMC+
MU!: BCGY>>E]QMYK[)I-J;BG[-BY-08/6Z_@MX9E%3259T55?9+D<5;\6?C-
MT\Y/.PRN42G"=2DVR0781I,U8'JCEUI_5V09DLJ;@7#(1$.S>&CA:Y[A4%CM
MM7G;7=38K*<G.]5S-Y&Z8GTGHN/%OQ=Q?ONWFY@DED[62*"%P#F3Q@,X+=E!
MPDUXC7: ,5_X?[@K_/&^_I QO\0AC?YD-&>NO?=6_8U+/^(?S\^HZ?\ >DW]
M;3^'^X*_SQOOZ0,;_$(/S(:,]=>^ZM^QI_B'\_/J.G_>DW];3^'^X*_SQOOZ
M0,;_ !"#\R&C/77ONK?L:?XA_/SZCI_WI-_6T_A_N"O\\;[^D#&_Q"#\R&C/
M77ONK?L:?XA_/SZCI_WI-_6T_A_N"O\ /&^_I QO\0@_,AHSUU[[JW[&G^(?
MS\^HZ?\ >DW];3^'^X*_SQOOZ0,;_$(/S(:,]=>^ZM^QI_B'\_/J.G_>DW];
M3^'^X*_SQOOZ0,;_ !"#\R&C/77ONK?L:?XA_/SZCI_WI-_6T_A_N"O\\;[^
MD#&_Q"#\R&C/77ONK?L:?XA_/SZCI_WI-_6T_A_N"O\ /&^_I QO\0@_,AHS
MUU[[JW[&G^(?S\^HZ?\ >DW];3^'^X*_SQOOZ0,;_$(/S(:,]=>^ZM^QI_B'
M\_/J.G_>DW];3^'^X*_SQOOZ0,;_ !"#\R&C/77ONK?L:?XA_/SZCI_WI-_6
MT_A_N"O\\;[^D#&_Q"#\R&C/77ONK?L:?XA_/SZCI_WI-_6T_A_N"O\ /&^_
MI QO\0@_,AHSUU[[JW[&G^(?S\^HZ?\ >DW];3^'^X*_SQOOZ0,;_$(/S(:,
M]=>^ZM^QI_B'\_/J.G_>DW];3^'^X*_SQOOZ0,;_ !"#\R&C/77ONK?L:?XA
M_/SZCI_WI-_6T_A_N"O\\;[^D#&_Q"#\R&C/77ONK?L:?XA_/SZCI_WI-_6T
M_A_N"O\ /&^_I QO\0@_,AHSUU[[JW[&G^(?S\^HZ?\ >DW];3^'^X*_SQOO
MZ0,;_$(/S(:,]=>^ZM^QI_B'\_/J.G_>DW];3^'^X*_SQOOZ0,;_ !"#\R&C
M/77ONK?L:?XA_/SZCI_WI-_6T_A_N"O\\;[^D#&_Q"#\R&C/77ONK?L:?XA_
M/SZCI_WI-_6UR^/^@KP7Q^^I+Y,C=-JJDMZVW35W.<T$JHLE5LQF84"UC,83
M%>D5LPV?+?;0ZVI;2E$2DF?4OI!R5T9!,R8&[=P.#J.D:6FAK1P[,5!W$5&S
MI7#R/R@?/O(X^?'EN#A$\+X^TCM96R,XVEO'&XW+@'MK5I+2 X D'<IJ1+BH
M\@(@(@(HBM_^C[I3D;RV>Y59WG65*79W>OK?)=9,550[C&3,X!1X[C[=396$
MA2[%-=?5F-LLRTMI2KRE+2@TJ/O$79SE9B,]J@ZEO9I/&?$Y\(:W@?V36MX2
M3MHX, =3HK3K5Q>7G?,USRUY/#E+@+"T B@O(X+XR2"> W<LTQD8P49QQ/F<
MZ,DD<0!((%%+HE*4I)*2)*4D24I21$E*2+H1$1>!$1"4=RIV22:G:2OZ"_B\
M W9Q5XY<C8*X6[M,X%L-9QRBLW%U1QVLI@1RZ]&JG,:WW'*Z9'C_ /FDUGJ.
MCR^FL#GV<&8M()S2G$YHXP/G9!1[?W+@I#T-S:YE\M)Q/H7-Y#&MXN(QQ2DP
M//7);/XK>3_61N416X/A[N*V8N29VH]A;.TU.?-XVJV2]!V5B4/NZFREBNO%
M5.5K)I1]%>;>N&M)$75)]5'%^5Y&Z:NR7XN>XM'GH-)6#S [A?Z,A5Q=&?*,
M<VL*UL&L<;BLW VE7M#K*X=UU?%VEN*]'#:MH>L;!'5L+X=ODW2+DO:UW)IK
M/H3)$IIG(4Y;@%Y+ZK-/8Q :ILQID.$DR4?FV3:>G7HHS(B5@=]R(U#"2<?=
MVD[!Z[CB<?.X9&^B\*R>G/E(N5M\&LU/A,WCYW;S#Y/=Q-V=+S);2$='BPD[
MMF^F)>3>BEZC6.J=5%T?695%9)Q2Y>,[0U>\DTH-!)-J#;Y=36[YN]Y]J41E
M+]D^I%X=<8N.46O8*\-FV1HZ630_L.>UQ\X*7\7WX^[5D@!+GI;25U/%GL;X
M;Z[W1V\D8ITDO VBA*\FG>EAZ@]?)7%D<6=C..H)!J5!/'K.,9+22R[)E;>2
MXCAD1^))69I/P/H9=!UC^6^N8W<+L;<5\'"1Z(<1\U9?!WL>[I<Q":/5F-##
MZ[MF.V=;7Q-<//&W>-B_.+Z6OJ"S)#49KBQLI#CRR0A4IJC@QR,R,^KLN;<Q
MXK"/#^4M:4_XQ_&\N-</<&C&W%3U\('HEP \]?J7O7]W6&,ROU9BRUHJ>$RN
M/G-;&7'S "5Z7C_HQ>H]?J;4?'PJ2*LW$G+R#9FI:]+:FS(C)R"G.9%N1*Z^
MRHHQI/I\H["#E-KZ?_Y'@;UNFA'S.T+OF+&,CWVN[1CP0-1]O**>+#99!]:]
M3O)1'YHXZ^!928+\/5R_OE-/9OL+1^ PE>#K*+W*LKO6CZ$9&4"LQ2+3.(\3
M+K\Y$?4ODZ>(R2RY&:IGH;R>S@9]$][O0# W^&HHS_RC7)K'@LP6-SV0G&XF
M*"WB/[M]PZ0>X^>L_P#4_P .KHVB5%E[GWKL;8DALD.O5>$4M'K>F<>Z]RXL
MEZQ<SRXEQ$$?;WLOPG5].[[7U["S?&<A\-#1V6O;B=W5&UL3?,->T<1YA:3O
MV;E7C5_RDNO;\/AT3@,9C8S4"2ZEEO9 .AS0P6D;7=-'-E:-WC>F4N6A^!O$
M/C4N'-T_HG!\?R""E)1\RLX3V6YRVON0MQUC,<MD7>10O/>;2M3<:0RR2B+M
M0DDI(I0PNB]+:?(?BK*&.=NZ0CCD]T>7.'F @>!4[U_W@.<?,]KX-9Y^_N<=
M(=MLQPM[4C: #;6XBA=0$@%['.I6KB22<NAE"AU 1 1 1 1 1 1 1 1 1 1
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M20.-/ V+M-O@<6^<JY:N[_G(#3K7,PL^1S=T-@%I:OC9Q=3I+PVPX?GHVR>
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MI-_6T_A_N"O\\;[^D#&_Q"#\R&C/77ONK?L:?XA_/SZCI_WI-_6T_A_N"O\
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MUL)WS1>30R1.XWLX#Q%\TH(IN  V]*S\&;*O2 B B B B B B B B B B B
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M0$0$0$0$0$0$0$0$0$0$0$0$0$4:^Q_^U&>?^_LH_P!(3A@%_P#[Q/\ 1O\
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KKA7].L:'4YS_ ):_Z*/ZXQ9MR[_&VW_F;G[UG7LP[982@(@(@(@(@(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
MB5!.1PT*&@H    -24A$4@  !5(    !" 8    \856     "7!(67,  $SE
M  !,Y0%USO"5    ($E$051XG.W#L0T   C H/[_M&XNO@ )5:.JJJJJZGT6
4U.]'_^"=U#H     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_2a.jpg
<TEXT>
begin 644 image_2a.jpg
MB5!.1PT*&@H    -24A$4@  !5\    !" 8   #)G]XP    "7!(67,  $SE
M  !,Y0%USO"5    ($E$051XG.W#L0T   C H/[_M![@Z H)5:.JJJJJZNNQ
4O'%4\FRE"X\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_4a.jpg
<TEXT>
begin 644 image_4a.jpg
MB5!.1PT*&@H    -24A$4@  !3\    !" 8    8>-I     "7!(67,  $SE
M  !,Y0%USO"5    ($E$051XG.W# 0D   C L/<OK04L(&RPJE%55555??RT
4QKLT$PO<M-X     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140428450580176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Mar. 20, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 20,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CUMBERLAND PHARMACEUTICALS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001087294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">62-1765329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">255-0068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CPIX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1600 West End Avenue, Suite 1300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ D(IT6!PX9>H_ 0  / (   \
M  !X;"]W;W)K8F]O:RYX;6R-4<MNPD ,_)75?D 34(M41+B4/I"J%I6*^Y)U
MB,4^(J\#+5]?)U%4I%YZ\GILC6=F%^=(QWV,1_7E74B%KIF;>9:EL@9OTDUL
M(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&& 3L@!W".?W.
MNU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.%7HR#'9 C.4?
M>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/7<OQ"1T#K0S#,\6VP7#H
M:,1%=F6CSV&L0XAS^D^,L:JPA%4L6P^!AQP)7"<PI!J;I%4P'@H]KB@3K'H,
M+"&I=1BH9+=S*J?7=G#-(O<J0YJC#&AM!^&C6@L5!K!O<B )+LF5&U)=Z7FF
MMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( )"*=%@D'INBK0   /@!
M   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U
M4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&
MRF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=
M:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M
M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " "0BG1899!YDAD!
M  #/ P  $P   %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8
MH*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=
M47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEX
MZ7D;3?!-F<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=
M<.I[.T!*1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1
M=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#
MOI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4
M Q0    ( )"*=%@'04UB@0   +$    0              "  0    !D;V-0
M<F]P<R]A<' N>&UL4$L! A0#%     @ D(IT6'>H-3/M    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ D(IT
M6)E<G",0!@  G"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " "0BG18#0J*K6,$  "J$   &
M@($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ D(IT
M6)^@&_"Q @  X@P   T              ( !I0P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " "0BG18EXJ[',     3 @  "P              @ &!#P
M7W)E;',O+G)E;'-02P$"% ,4    " "0BG18'#AEZC\!   \ @  #P
M        @ %J$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ D(IT6"0>
MFZ*M    ^ $  !H              ( !UA$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ D(IT6&60>9(9 0  SP,  !,
M     ( !NQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&!10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cpix-20240320.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cumberlandpharma.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cpix-20240320.htm">cpix-20240320.htm</File>
    <File>cpix-20240320.xsd</File>
    <File>cpix-20240320_lab.xml</File>
    <File>cpix-20240320_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cpix-20240320.htm": {
   "nsprefix": "cpix",
   "nsuri": "http://cumberlandpharma.com/20240320",
   "dts": {
    "inline": {
     "local": [
      "cpix-20240320.htm"
     ]
    },
    "schema": {
     "local": [
      "cpix-20240320.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cpix-20240320_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cpix-20240320_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument",
     "longName": "0000001 - Document - Document and Entity Information Document",
     "shortName": "Document and Entity Information Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cpix-20240320.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cpix-20240320.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001628280-24-012261-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-012261-xbrl.zip
M4$L#!!0    ( )"*=%B;0^ V@Q@  &64   1    8W!I>"TR,#(T,#,R,"YH
M=&WM/6M7V[BVW^=7Z&;NF<):L;&==V@YBZ:TPVU+N<"LSKI?[E)L)='4L3V2
M#61^_=E;DAT[#PB40FC+EQ!;K_U^:$MY^>_K:4@NF9 \CEZ]<&WG!6&1'P<\
M&K]Z<7@^.#Y^\>^#7U[^EV7]^?KL WD3^]F412D9"$93%I KGDY(.F'D<RR^
M\$M*3D.:CF(QM2S=;1 G,\''DY1XCM?,F^5O13]P@E'3&5)K-&H-K:;3"2P:
M='S+]1U_Y,"S=MNOC_MLV&AWO6;7\GO=P&KVG)8U;/2ZEM/P6G34#CRO&=2#
M_K!)6=OU>PVW39L=)^BUVTXC:+5&08^Z7<;4O),48 :X(]GGUZ]JDS1-^GM[
M5U=7]O50A'8LQGN>XS;V>!3RB"'<-=/\6O)*^ZN&:>VX>W]^_'#N3]B46CR2
M*8U\5O2"4?FZ>1R<I]J>7Z>K6\\7M)<*&DG$,TV!<C".YUB.9[E>:1!+,K\R
M$'RWQ_'EC>.X+<OI6@W7C+,*7+?7Z^U=(Q;SR0(VAT^M-I\)7N#:&@4J8.(O
MZ\?$MWG3I995I.'K(94::?V0 K_66&3]<5X[>#EA-#AX.64I)=C?8G]G_/)5
M;1!'*?"N=3%+H)NOO[VJI>PZW5/0[!W\\LLO+U.>ANS 3_BUA2P+'.:\W-,/
M7^[IH8=Q,#MX&?!+(M-9R%[5 BZ3D,[Z41PQ6 "_[F-#)O2_/ A8I/Z%]R<@
M0(+[>O[K](R-7M6 W6LDHE,<B?'^4033S0:P.D'#XRA@U^_9K$9X\*HVLCRO
M=N  PSG=CM=KOMRKC'J'20Y!C@.4Y;<A'1>#-VH'(QI*MC3N7A40P49,@*9@
M<@7^D39]J80!9B:*K/T4L/ZJ)ODT"9%HZME$J(6546U?RP (H>:;3V+FE'$F
MU#<E4GT#G5H[0I<_9PI_^3<>X/<19X*H-;&5,C$X?E_%ZV+G@_Q1=?0$T!,'
M^3<09)&^ <UX@/" =K*0>1;?%<L,UC3-W^3?\TGV*G#G2"JPLE?BNSW@3LVB
MB!U^FV+\?\3>O(]AZRF/K E#[=WW>K;72M+]*QZDD[[K./^JJ:8'+V5"@2>&
M HFF_]?C+(V&:[9HR,=1WP<D,@$CI'08LKS!,!:P=LN/PY FDO7S?_9S\=**
MRU*=]J=4C&%]PSA-XVD?UP9V+.4^#<TD:C[]>KYLV]%+3P%':9#/;%[;\&IO
M^7FO:_><U:\<VU7/]]1X(G]ID :+JJD^  FBYE4--&$56+-\+TF)C$,>D%\=
M];>?T "M<-\A+HR23[&G8-\0N3AE_AY6$(M^/O@(.,@:T2D/9_T7%WP*8GS"
MKLA9/*71B[H$FP#&0_"1;BCY/ZSO=@'#ZNN5!JX#XRAR&&#=3A,0^\?)\<71
M&W)^<7AQ=%YEB.U:K8=L<'XT^./L^.+XZ)P<GKPA1W\.?C\\>7=$!I\^?CP^
M/S_^=/*$(#1O Z&)"/],Y03X)(VC.GEC#VSPLUK-WC9C7BW[[:>SCV1S:Y4[
MGMIV:V,%*JMKO5^T5&0MZ$9AI''2=T&F<@FS0C:"53G=TB.A5ZJ>;8@QK^&.
MO/MAS-N(5X%3SXY.+LC9T>FGLXN-H-RBU9]F0F84(H<T)N?,1V^3N WRZ8RX
MK9U@E\0C<@%A!+S*!$\Y3'QT[4_ K6#DT$_QM=MK-._,UJL,TZ-*PR)VFBNQ
M<W=!.%4NP9%V%&I$N_!@Z*_3?@!/K"D,,<%N5D!GUHQ18;&H</-J!Q^I\">@
M*^HJ+EMV][8<80@U,L492V*1DIW ? <X0V">E+!+#%.%>LV"W26 MH0]-E.6
M=PT=SMB82PSMTA-XDU.]@3KDX^NCLP]HZTY_/SS[>#@X^N/B>'#XX9P<GPSL
MS77IX_/!:LSL'%U34 ^( "2_*  G5!*9,!]]]X#PB/!4$E HP UBF1M6*,_6
M&N7Y+#S61L=V6IT;/=9-AW(=N]/TMFTH!6!O$Y=\G?^=^]=><DT6#"4Z!(ND
MT52IK>(60\\EE\+3$5/5IS /O[W\.+?)CW,WPZ,URW'DQP)TJDH7G:>@=0=Q
M%J5B-HB#JAG"[!/&O"E+1'R)X\SM3[-V<,&BB$G)5F0:*D%D&E0)V-Z$@!JE
M:TGXR(B^EPI_RT,&C8? &09I+<Q/N%:CT6YTUB)M$5V/R>^NK93V@@^M'SY7
M?K^@U\<F!>0KGJ_2I%T[:'N6VVFW&EYO T[^J9-N]NT4C7:47B&Q('$Z88+\
M!1&!#+B.&<#(\[(.4LW$F$;\'_5]]R'TQW<I$&N0/8BG4RYQ_X>@SB&:P6]#
MX[UY%ERK[X]AC^TS^]PF1],DC&? L56504YB>Q4^GSJA]VT,UV$0"##LYN,#
MC.?FVK)3.W#;CD,^8X &H2LYA" M8W5RGG$0>+?A.,L1R/VF'\"_G\1%?%7X
M'-W:P0F5DTL>ADL^1_V^TRA-]4F<@H?#U0[>A@Y0[P8'Z+YK.8UALO#_>*)=
M,9,C<VH'C8[G-+8HPM^,[W8,6*CQ3P5@ER<T)$?7S,]2?LG(IQ'(%Y/K8[FM
M 61S>B+7'@I&*Q1TP<=P6XOTV[T#FWR(0?^>3N)HP:-TO=J!UVI9CM/N;E/H
M?ZO6=5'KSI,<+R1)6<@2A)!$"L0Z>@EAAC:#4, HH"=@FX3][44#U++;RT;<
M/-P"%E/9L),X)8=)$H+!&8;KP=P6RNV\!2T)9E)G;812FO"5:H$'THV(3OU"
M9(]JE814YKF\]?+^U51;DPQ\=!SI;/^$^5]490U-P'XD@J-//(ROR9"%\17B
M"%\B)DG7>D]&/$1>YQ(8/V51 +A+8T#?- M3&K$XD^&,2/!'Y&BF>IH.\1 0
M07/7&E^4<F@9C -TB6;YNU$<PN38#VT:1Z]1DATP8N0=BY@ !7T<0=],^^J'
MMF?KY>[V[Y> O;]S^/BL?<=$_F?!4R 4NM]99#Q%N>Q #.,X'%+ >@JT+Q1W
MHW;PVZ^]3K.YO\ZN;PC\9\ ;XDY^'=CDCM,^*,X-)@'99522I+3C=)9!9-/T
M6H:CT^I.$VXP[;@=,GA[1KR&8T/#6U/$]V?)'Y?ESV.P4(#R:/P1E!EHM'!3
M?F\^(W[_BJW4S2:?HY%,#1Z7F=UM4O#O2OQ>V4XMN+WIV+KE[K+#]Z.SZZE@
MJ)VQ $V5'J!5%1!VH .]&=NV?K)MJ0) ,,LOX?-6?>TV \O;&>YNQL2Z[4\V
MOHV-CZ7,F+@',[?OP\RKN.K'9.8&LYH[_F;,;-K>E9F?AA-+CI0.'9B X"-9
M5>^CI-F$$@!T?Z-:K>W8B._U[([3N?,^?,-N.<T'V?'VH$/[YB+438=J-FRG
MT?Z:S7.#;KW+L52Z:MZ:$K0U=:W;MFV[.K5_@77_NK#(GQ _I%)NL-?ZXZ!'
M4)5B.Y]-AW&X4\K&?B5RS%[9]XR[$U.SI#B+Y;8 U.35A,.3N2ZMX'0SP9S[
M,:OQ]RB<.>5!$+(GPNX=HE)MOV:N-U327C@\G=H!.DY D?,T]K_42123A IR
M2<-L?=G*K8S_DS:;T\;H%ZU>"L)T@3"GQW\^%0D>1S<]$PKETI,[L[K@=#&B
M0/56W0%U>Z !#\_?'/XO>1?&$&V EQB"GT@^4O&%I3?2=O7&^1:ZQL=1@!$!
M(\,9\55"'SS/+Z#@F2IL6<BV<TE@B1!.H',Z)F,17Z43#"P2S,!320(V@BE4
M-:M.:#JMW)M>R&;J<OD&V?GM5[?=V5=)S;PQ5W6P"=;!XN:+CDZ\H>6M&&M5
M#7XQ*$8J\WZE8>U-=J"4%-UCY^6;AW9':PCPE"GNNY8$Y#"\4R ,- 0;!OJ>
M\U"!_H.BX%G$PL>C&T08]Z17Z@.^M/$V 6E7ZA"D/8I5$)U)IEH!W<WV'A[=
MYBJPUN=#D;QJKG"&DZNC^<BX$< &;P2[Y!+Z@0ZAD8])8^K[6+R+C?$$>D!%
M(/7&7K N@F_LT"*"+RL'>QUYOFM)<6^5E+ME(?.SMDV[H]*-L:9O7["08M'+
MTNG;N5^C'!IGWH4.P?_(TN4NMQW8O>O!X69Q<'A2'']-Z)A90\'H%XN.P"+T
M:7A%9Q(3"ZM/%S<]#?%7G"Y&,EE :D']M"^S*4C6;+]:V/'XU1GJ2.QQRJ:D
M:SLN^:3,_A$>39+KC61IT;VJI_A7)E,^FCU1E<EA:L'Z+>V@$94[1M5Q*N*Q
MH-.-<GG=IX%GM:KX%)'J*;@Z&:CBH1!T(3F=4% !/LN44R[)<>3;9 ?UWF^_
M=CTP=497J&_N_BX65(#6I*A \>!1FDDBLR0)=7ZXN"BEY%WA-(42+=7AEF<Y
M/QH4,W#<XXXBHXN+$4L+<3O[,N])-;FFBEQF#%#=AFJ)H5IYKL.+CP59YV#%
MVE%5/=62)06/<23B*4F!'&@>].=$Q-EX@J8&'OV.1Y$_4QY=Z=M??J/39!^6
M:M?)AP^#*H@P'KBM8T!3/FM='=]2SRD^QT&3O BPC@8H2W"6_V[5NXY3!S[!
M9Q)(QF1NGA;1XNM87B['\F@_=>?JNM1P\R65#>*J"7(X!%LD^1Q $JAK<ZI\
MMQ(;9I1\^A4&=MOE2YWGU21!U Z9JC="-D(Y04:*P^!6K,H)"^<'^Q3GJZ):
MA6(L6L<*J'.KL4 Z['16[G2>=UH0V#F5C@8XWAOF,U0"Q&TJZC3J)B$W9#YF
M[!@ X*L*U"R!YM@3/#3NZUQ>_A)+>\T$Q8!>6P](=G2A?6R31J-A>9VVT_*>
M(X'?+NF (%/*!9$"9G]:1)15GJZ7"0TN\ PBVQ"0)E![AM3LJ!FL&K8HRY ^
MUSG+9PI9- 8:FKDD"U5AF_:)]51TBGXNMC#\"(,.F>*_NG*10S[EJ:F",S15
MEJ"D5=()3=5:34?4QJHR+F+HBJLT> "OD;%Q /!N^#2;HMKRF2G:TXRD]1H.
MA:X]##>E ;/)Z8(@+*H3'%BQ')YD!=>=)>K6*%SB"K1I_3Q'<WT)B[@ 1)9^
MH8"L8V"B:,+2"004@,,IUE8%^#RD5T GF"0PZ .&*TR-!EE[!G'5A*S,7+@M
M""1VFKOK"[),"D-9 CK5(8\2\5JU80TDYV*!G;@I0ER"V<12"FS#"B;XTD3Q
M:61HHB49%94R/G087^KX2],S8!+DCQK4E-G9L,4B0:J+-#9UB1P9L+;AG[(Q
MQD5@-R5CB@>P)!0K:#6QE3+-AG]A_@S T\>FP%4(5"RPF:NY59JEC*LK#L1*
MZ&P)8U29=.,SH9N"@@$37N*Y $4'7\6V-'<B>%20>JX+-&'*XZH)D04B=>N7
M8G<,JUDDM8I0),Z5"OL[@U :FC1L!P4&L[ED![[\JPB4Q^ 1YNZ,9A^469@D
M5X^:$Y56R;THGI9%HZH*GB<]*PRM<(PF@J,0S4VIOK]!Z=T==[="+CJ7V1*O
MK]*4P H[WFXQ?*FV>1&1%=KGW8V2+U97B'B928P$YTRZ)* C]!# 'DCCR!A1
MK2M973%>>0#T\YE(*7YRX6=3?3^@+!]JT*I"YK 9 S2W< :?)U0&].^%%+O:
MSC*)]AR0V >EJBY;TP:EJ"RD 5X/R4Q%?BY#BU[:,),<?9[GR9ISVQ&P.>IA
M63%F$?#D : 4J*2+>\ AI +3='D,YX-MB. [QAB 0!'EGDG!'4:GYR8G6FO@
M(=*,05O!(Z5V.*B :<1'*_AE3-'*%:L-.1WR4%G%,IN4'J\UM<^/9J_I%SSB
M\P9\+\!75">O&0;K\,^ AL$56G<=;[YFXDL,'OX_=7(ZJ!-,=X+M7P@UZBK=
MRK$N#N/WD(V![>,$_#<0(IUZ0WK&QMF$MSPM3D1@-^6&Y33.U=6<WC8YA)D3
MU45FX !69BA3"_L "TEMK/ I4X,*")WJ:G\H3:D_P67BWLR$#\%,M&R78),T
M?H8A1%GZ],$564YV1Z"@P-7Q01SDW*4M6Q)U6D@1$3V *[Q>%A#ITP3\^5 1
M96Q.IN2'QAF&G$DLJX*" JZ"<NP2L$OPUQ,EE>P:]6PNZ69<]1"\JPS)^RR1
MOJA\>!ZN(BOIK8,YB[G 8HK_H=5 F8DTOWDIC\"[UGMM3<$S]@5/RE:WL"5H
M4N4:6XPK0%>J<F$/NF @@3.TF,5MH,J#1SDJ+>]9LOZ-V,2X$_08AB.H$L 5
MS5(5<^E$7![%8&RB2@W\(H =55H-,QW2R4+G8_)+F.&5<M'!W*RLNB0K=<AC
M&IG?RU"YD8'G%4N*)OG4]85%"3WZ59R!DPOS91'$DZ,L1(=89PPK*1YX9)C!
MG*&?&Z_2NF (J>&=Z=GE^ILC-N:0.QW3N6^?]DV<N-DN4;YG\H2[1$^[X[,I
M.A][OV= ,T0N>HY%TA%SD50H2P,"#OYC8'V(8V6KBC:26* 41XS\3L4P%IL4
M46RW!L/-5_12T30KD$,#LIR#C*;&^,-31B,3Q.#74\$O49I+SNH'^#"'5<\8
M;M'.,T6]EDW."Q6@QU999XI[WBHD WB!2_,4L-X3,(L?,H@Z1Z 9+SF[@@\&
M:$6KI:T^6GN_</Y+!\OENJ0U^.U &0%>21X8$:7:V!@>C6/<3UH<N!P[H.DS
MR;1<5.OY -S7KF;EXG:8$%HIZ8<5CC)T3 AFB/)%:UF!?\";&H%25D'!K*Y+
M$X2II(\%,R4+]96>3AW"B;\S'NB>ID%Q_W0=V])Y2,K\202,.)ZI,43*I8E^
MM6XNE2'@,[U6A#TJH"KCNH(JC?@JF'I/"V C?(HU#"; 7^0)XU8KOHNSM)SY
MA0=@]N@0'Z\B:F4)Z&V:!:R#!#"3A:G&^5]ZTT[6*_Q93%5-]IE( IU@0&3A
M_RI;C4YP&8VEX52&&GD>?0803: G;EV2$?53"$+>KA="[%3*J6!J4UE>O$&3
MRR^:6;/(Q)I%W OC8NZKY"W+$L,'S-<'Q.L$P 1&,[T,6G3>GRLW)7<0P=$S
M3CY2 H U)3" :^U6#K5KJ(^BKP-'^Z'SH^H(?RQ@&70:HWI!O$D5#(;HT2.:
MOPX20-DW :2?*X%Y*E=++$N-3J H^4:8D5= Q64(+K"ED-I/3I)PMI*=@:^"
MS$^5<N!*46OF*^UPF1U8 %4OQ,BGH#J]#K/ $BXI#TM+P#I79?X0G4.=U< ?
M8("W<Y4!WX7.<&CAT=%>CG!$,Z;<]9@J^XI52IGR_*FO.I,A*,! +3[7ZC@[
M=C155S@QAI1C4?C%:ECL+W-L@JY Z4"SA2_G*P 5H_((\*E3B$:\<411/-%H
M,<H<5AE/]3$HY O%>GG("F*D5(*YIA:0&!H5=QGC?PI2'I5TB1E:[]L W\8J
MKHVA(_>5'B-'%,\'P&>&FP&%VOBH"H?5VWKQT.A<+0G+/"A-34&1\JZ=@=R3
MM[I];2'K]P+"MBA"@5DP^JZ#-U&8C"+>.4STODVQ!=IPS19HOJY%ILQM V[A
MR<K>[(T*S'@:.4"W!%8)N*GP)%1%M<;;R"\0WBC&S3,6*BA)Z1>@>127K](
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M7OQQ=L.O]"ZO_HE2W8M'H\R.AMG]V.C6DOJJ*Q:"+)SI'>! ;_SH.^;SXV%
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M'KAU.QE VK. (T/6;6>7KYYQ?6AMS[B!\?O)J\TSV>J_=9Z\^A]02P,$%
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MR3$B?AU24<,3XG^&E)[3D&49]QAIS" AQS8A&X$15MAIK AUF(\2^F=J>W&
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MBQ=80H7[<G;T>*-]:?]S?W;T'U!+ P04    " "0BG18HQ [6FBC  !%CP0
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MZG"'QSBQ9@%;(@G%,"G,FJ2PG'=OGY\OR$@\?GYZ2BZ\@;E*1+#@I56;RVD
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MTE7V'\FV\89,P/<69X6V41#%PT?<A0B"+.#C@_ELMM=%M%'\BZJL4>>42O"
MA? ,PP'[2<+];HF/ALW #9X(+Q &$(?S\HA9Q4PH9XK7&!!L!,@&ZJT#-B\L
MGH_CL"M674I>H0 ^;\/!7K 8\$'@[=&T=9XG3B>@]F"9#-D6-Y3&MO)]F+*
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M ,'+]DO_?&+^OZ& &VS*-/6#>W14#VS?JZYC376W%[ .1?A*@N&7W)V>%7V
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MS 4V+/&0A R/HC]D,V_83V W&?'F\_+:+YP-.3PW+L?4Y_C^4H$\N3/JY,,
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M",9>>3@F?J39$D$!YM2?DF%^7"H&=IMEOHQQ:*M:G0JV_+R,5H564$)6(.,
MZ(9U[2G^,:O/U#V#;_O)VP0!Q%?5JM,_\#U\2HBMEI.VC9,8Q!Y&FWIH$:I;
M1Y1+(X@/]/Y<>2&E:Q@->H!H0_RJ7**[1Q\C:X@#J6%1,6SKQC2[%0/_'0OE
MS:<3RCO>FJKW0GGOJQ*)[Z>#TD)IFF(U5Y[5EY(0-T+J2"1#?E1NS:,?"+K9
MBC>,?,/VZ_1%UQ#A4-T;.1WPB/(F[>.FE KFQK(5>\_VY/1%FV%3R2+U&<%B
M^D;9-JQT1 $S,L>]8X> RYH0-!-.B;"NB < N:Q/=E(BPIPGA;;2\U[I>VDJ
M<6QR53 PO"4,:\;*)A#(),Y&*+R^/+%Z+\H?S&(Z<F*'D+_RGWUD_K/]5T.8
M(EM)<H^/@4_9IBQM 75;@WNI'N5.DWKO818W5'5T[BBS!1N)H)Q,:&BJ=!=.
M0EO+($\?[=L\0L;6M84D1M*MY\-S5&5RV$$J-B6LBY(H$B)&-+L4Y#G*[5:
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MTS^)?WF "9+8<R6G*>!AKT7A7O/4_Q0$/0,^6'0S ,:'Q QE_O(,#)W$LHK
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MN3W>OSC_^8?]1LHH;HU&)I<[.UQT0L*6<>,%=9K3KJ?+C&+H[E*[)+WNG(,
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M8\^QC;'][)3^_DT8WP()4FXN=]E%6_IT#>J0>#U]!,:)OC]I"XI2+SA&36Y
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ML"8!SUT\D<6V6ZOP5[(*MV'<K4%8/Y%N#<*M0?@+&X1.C0Q"%3LK,&66K99
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MELPH;&T?:6LHA,*W+%VIO2'N[ ]W=Q?TD<'#Y66O0^M6(D'^;CG=)OY\A6+
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MDKRB.XNU@X+[-1\]19T\@JN"C6_\6!F[%V%:Y!]!]Z,6!%T2;55N"JAQ[!J
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M,"YH=&U02P$"% ,4    " "0BG182$9ON8D"  #=!P  $0
M@ &R&   8W!I>"TR,#(T,#,R,"YX<V102P$"% ,4    " "0BG18!@]K\B<*
M  !]50  %0              @ %J&P  8W!I>"TR,#(T,#,R,%]L86(N>&UL
M4$L! A0#%     @ D(IT6-D.?&["!@  0S$  !4              ( !Q"4
M &-P:7@M,C R-# S,C!?<')E+GAM;%!+ 0(4 Q0    ( )"*=%BC$#M::*,
M $6/!  ;              "  ;DL  !E>&AI8FET,3%S86QE<V%G<F5E;65N
M="YH=&U02P$"% ,4    " "0BG18A&C8U^,,   -2@  %
M@ %:T   97AH:6)I=#4Q;W!I;FEO;BYH=&U02P4&      8 !@"/ 0  ;]T
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>cpix-20240320_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cpix-20240320.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier>
        </entity>
        <period>
            <startDate>2024-03-20</startDate>
            <endDate>2024-03-20</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001087294</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-03-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CUMBERLAND PHARMACEUTICALS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">TN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-33637</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">62-1765329</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1600 West End Avenue, Suite 1300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">255-0068</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CPIX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
